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ABSTRACT 
Staphylococcus aureus is a well known pathogen of man and animals. Despite 
the development of antimicrobial agents the staphylococcal infection still remains an 
important cause of morbidity and mortality. The spectrum of disease produced by this 
organism varies from pyogenic infections to toxin-mediated phenomenon. It also causes 
serious infections in man including deep-seated abscesses, bacteraemia, endocarditis, 
osteomyelitis, food poisoning etc. The main reservoirs of infection are infected cases and 
carriers who spread infection in a hospital or in a community through droplets in air or 
through fomites. Carriage in nose plays an important role in its epidemiology and 
pathogenesis. 
In animals too it causes a wide spectrum of diseases like intramammary 
infections in lactating animals, sporadic septicaemia in pigs, abscesses, synovitis, 
arthritis, osteomyelitis, dermatitis in poultry and ducks. Bovine mastitis is one of the most 
important bacterial diseases in dairy cattle throughout the world, and it is responsible for 
great economical losses to milk producers as well as to the milk processing industries. 
S. aureus can also multiply in many food items. 
Various global studies are available to characterize the Staphylococcus aureus at 
molecular level, however, the studies are fragmentary from India on the current aspect 
and especially in Staphylococcus aureus isolates obtained from samples of animal origin. 
Therefore, the present study was xmdertaken with the dims to evaluate the phenotypic and 
genotypic characters of Staphylococcus aureus, whicl might provide an understanding of 
the distribution of the clones and might aid in the dex'elopment of the steps to control S. 
aureus infections in humans as well as in animals. 
A total of 102 Staphylococcus aureus from human clinical specimens and 
100 from animal-originated (both animal-clinical and animal-originated food) samples 
were randomly selected for the study. All were tested phenotypically according to the 
standard methodology and confirmed as S. aureus. 
Among 102 human clinical isolates, maximum number of isolates were 
resistant to penicillin (98.03%) followed by cotrimoxazole (69.61%), tetracycline 
(68.63%), amoxycillin (64.7%), ciprofloxacin (60.79%), erythromycin (54.9%), amikacin 
(35.3%), oxacUlin (32.35%), cefaclor (32.35%), ceftriaxone (32.35%), ceftazidime 
(32.35%), cefepime (32.35%), chloramphenicol (23.53%) and gentamicin (27.45%). 
While none of the isolates were found resistant to vancomycin and teicoplanin. Out of 
these 102 clinical isolates, 80 (78.4%) were P-lactamase producers as identified by 
iodometric method. 
The isolates from animal-origin samples showed resistance to penicillin (93%), 
erythromycin (51%), tetracycline (49%), ciprofloxacin (39%), cotrimoxazole (54%), 
chloramphenicol (34%), amikacin (27%), oxacillin (27%), cefaclor (27%), ceftriaxone 
(27%), ceftazidime (27%), cefepime (27%), gentamicin (20%), and amoxycillin (19%). 
Only one isolate was found susceptible to all 16 antibiotics and none of the isolates was 
found resistant to vancomycin and teicoplanin. Out of 100 animal-origin isolates 
69 (69%) were found P-lactamase producers by iodometric method. Interestingly, both 
human and animal isolates showed multidrug resistance patterns. 
Methicillin-resistant Staphylococcus aureus (MRSA) is a major nosocomial 
pathogen worldwide and is often difficult to detect due to the heterogeneous nature of 
expression of oxacillin resistance. All the human and animal isolates were tested for 
oxacillin resistance by disc diffusion method, ;creen agar plate method, and for 
detection of mec A gene by PCR. Out of 102 human clinical isolates, 33 were 
oxacillin resistant by disc diffusion method, 32 by screen agar plate method and 34 
isolates were found positive for mec A gene b> PCR whereas 29% isolates from 
animal-origin samples were identified as MRSA by PCR, 27% by disc diffusion 
method and 26% by oxacillin agar plate method. The results of our study on PCR 
of MRSA seem to be promising for early and reliable identification of MRSA. 
Bacteriophage typing was performed in 102 human clinical isolates. Out of these 
isolates tested, only 55 (53.9%) isolates could be typed by the conventional set of 
phages at RTD. 47 non-typeable isolates were further tested at 100 RTD, they showed 
16.67%) more typeability. The total typeability at 1 RTD and 100 RTD was observed 
in 70.58%> of clinical isolates including 10 methici llin-producing strains. 
MRSA phage groups were ust d to type methicillin-resistant 
Staphylococcus aureus isolates of clinical specimens. A. total of 14 (41.18%), out of 
34 MRSA, were found typeable at RTD and 100 RTD using MRSA phages. The non 
typeable isolates at RTD could be typed at lOOx RTD and on addition 16.6% isolates 
were typed. Out of 100 animal-origin isolates none of the isolates were typeable at 
routine test dilution and at 100 RTD. Only two isolates (one from raw milk and the 
other from buffalo meat) could be typed by using MRSA phage groups at 100 RTD 
which belonged to phage group II. 
All 202 Staphylococcus aureus isolates were found positive for the 
presence of thermostable nuclease (nuc) gene by polymerase chain reaction. 
Coa gene was detected by PCR and twelve different electrophoretic patterns 
were observed in human clinical isolates, whereas 7 electrophoretic patterns were 
observed in animal-originated isolates. 
The molecular typing of the human-clinical isolates and 
animal-origin isolates was carried out by Coa-RFLP. after the digestion with Alu 1 
enzyme. Twelve types of coa -RFLP patterns were observed in human-clinical 
isolates. Among these 12 patterns, 7 group patterns, namely, group I, group II, group 
IV, group V, group VI, group VIII and group XI were noticed in MRSA isolates. Rest 
of the group patterns were in MSSA isolates. In 100 animal-origin isolates, 7 types 
of coa -RFLP patterns were observed. Four group patterns, namely, group II, 
group III, group I, and group VII, were noticed in 29 MRSA isolates from 
animal-origin samples. Rest of the group patterns were in MSSA isolates. In the 
present study, S. aureus isolates from animal-origin samples and human clinical 
specimens were found to differ in their gene patterns whereas animal clinical 
specimens and animal-origin food samples weie showed mixed Coa-RFLP gene 
patterns. Antibiotic resistance patterns in relation to Coa - RFLP pattern could not be 
inferred in isolates obtained from food samples due to variability of resistance 
patterns; 40 different types of patterns. 
We feel that Coa-RFLP technique could be incorporated as diagnostic 
tool to confirm the MRSA. Since the Coa-RFL? patterns of the MRSA strains were 
unique and distinct from the MSSA strains from both human and animal isolates of 
Staphylococcus aureus. Coa-RFLP is performed with primers, homologous to a 
conserved region with in the coa gene, in order to amplify the sequence encoding the 
C-terminals region of this molecule. Since the number of repetitive sequence varies 
within the coa gene, the resulting PCR products of individual strains can be of 
different lengths. Therefore we foimd different length and different patterns of 
S. aureus strains in coa RFLP. It is noted that there is extensive polymorphism with 
coa gene circulating in human and animal strains. We believe that the heterogeneity 
observed for the coa gene has a potential discriminatory power for fiirther 
epidemiological studies of medical and veterinary importance. 
For the detection of enterotoxin genes, namely enterotoxin A, enterotoxin 
B and enterotoxin C, PCR assays were used. A total of 202 isolates (102 human 
clinical isolates and 100 animal-origin isolates) were tested for the production of 
enterotoxin A, B and C. Of the 102 human-clinical isolates, 3 were found 
enterotoxigenic, out of which one stool sample showed presence of enterotoxin A, 
one vomitus sample showed enterotoxin B while one urine sample showed 
enterotoxin C. 
Out of 100 animal-origin isolates, a total of 13 were found 
enterotoxigenic. Out of which 2 were positive for enterotoxin A (1 from animal 
clinical raw milk sample and 1 from buffalo meat); 3 were positive for enterotoxin B 
(1 from animal clinical raw milk sample, 1 from a sweet, and 1 from cottage cheese) 
and 8 were found positive for enterotoxin C (1 from animal clinical raw milk, 1 from 
paneer, 3 from goat meat, and 3 from buffalo meat). 
Conclusions: 
On the basis of this study, following conclusions were drawn: 
• Multidrug resistance was noticed in both human clinical and animal-origin 
isolates. 
• None of the isolate was found resistant to vancomycin and teicoplanin in both 
clinical and food isolates. 
• Phage typing of the clinical isolates showed that only 70.58% clinical isolates 
were typeable using conventional phages at 1 RTD and at 100 RTD including 10 
methicillin-producers. Amongst these, maximum number (35.3%) of isolates 
belonged to phage group III. 
• Majority of the MRSA isolates were found non-typeable by conventional sets of 
phages. By using a set of MRSA phages they showed a ty|)eability of 41.8% 
(14/34). 
• In animal-origin, only 2% isolates were founl typeable using MRSA phages at 1 
RTD and 100 RTD both of them belonged to ^roup II. 
• MRSA were detected in human-clinical isolates bj disc diffusion method in 
32.35%, by screen plate agar method in 31.4P/o and by PCR in 33.33%. 
• 29% isolates from animal-originated samples were identified as MRSA by PCR, 
27% by disc diffusion method and 26% by oxacillin agar plate method. 
• All the coagulase positive Staphylococcus aureus isolated from clinical and 
animal-origin samples were found Tnase and Nuc gene producers. 
• 12 Coa-RFLP patterns were observed in human clinical isolates. Whereas 7 
types of coa -RFLP patterns were observed in animal-origin samples. 
Knowledge about the genetic variability within different populations may help in 
the identification of the most likely source of an isolate. 
• Coa-RFLP patterns were different for clinical and animal-originated food 
isolates and suggest a divergence between Staphylococcus aureus isolates of 
human and bovine origin. 
• Results of coagulase gene typing demonstrated that the MRSA and MSSA strains 
from clinical specimens could be grouped into 7 and 5 Coa-RFLP patterns, 
respectively. However, in food isolates 4 from MRSA and 3 from MSSA Coa-
RFLP patterns were observed. 
• The MRSA and MSSA strains did not share similar PCR-RFLP patterns and this 
could be initialized as a diagnostic tool to differentiate MRSA from MSSA. It 
offers an attractive option to be considered for rapid epidemiological analysis of 
S. aureus strains. 
• 102 human clinical isolates were tested for conmionly encountered enterotoxins; 
three of them were found enterotoxin producers, out of which 1 was positive for 
enterotoxin A, 1 for enterotoxin B and 1 for erterotoxin C. 
• Out of 100 animal-origin isolates, a total of 13 were found enterotoxogenic. Of 
which 2% were positive for enterotoxin A; 3% were positive for enterotoxin B 
and 8% were found positive for enterotoxin C. 
In nutshell, diversity between clinical and food isolates of Staphylococcus aureus was 
noticed and that the incidence of methicillin resistance was quite high in this collection of 
isolates. Concomitant high resistance to other classes of antibiotics was also noted. Phage 
typing was found to be of low discriminatory value whereas Coa-RFLP could 
discriminates a fairly large numbers of bacterial isolates and suggest that Coa-RFLP 
could be used as an epidemiological typing method for Staphylococcus aureus. 
Enterotoxin A and B were detected in our collection of clinical isolates, whereas all three 
enterotoxins were prevalent in food isolates with erterotoxin C being the predominant 
type. 
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1. INTRODUCTION 
Staphylococcus aureus is a well known pathogen of man and 
animals (Sandel et al, 2003; Cucarella et al, 2004; Salasia et al., 2004; 
Dar et al., 2006; and Orrett, 2008). Despite the development of 
antimicrobial agents the staphylococcal infection still remains an 
important cause of morbidity and mortality (Mathur et al, 2000; 
Coast et al, 2003; Kim et al, 2003; Sabour et al, 2004; and Haveri et al, 
2008). The spectrum of disease produced by this organism varies from 
pyogenic infections to toxin-mediated phenomenon (Shanson, 1981). It 
also causes serious infections in man including deep-seated 
abscesses, bacteraemia, endocarditis, osteomyelitis, food poisoning etc. 
(Brakstad, 1992). The main reservoirs of infection are infected cases and 
carriers who spread infection in a hospital or in a community through 
droplets in air or through fomites. Carriage in nose plays an important 
role in its epidemiology and pathogenesis (Lowy, 2002). 
In animals too it causes a wide spectrum of diseases like 
intramammary infections in lactating ammals (Waage et al, 1999; and 
Cucarella et al, 2004) sporadic septicaemia in pigs, abscesses, synovitis, 
arthritis, osteomyelitis, dermatitis in poultry and ducks 
(Jones et al, 1990). Bovine mastitis is one of the most important bacterial 
diseases in dairy cattle throughout the world, and it is responsible for 
great economical losses to milk producers as well as to the milk 
processing industries (Martin et al, 2003 and limery et al, 2006) and 
also poses antimicrobial resistance threats (Haveri et al, 2008; and 
Defra, 2008) in veterinary medicine, llie ability of Staphylococci to 
produce coagulase, an enzyme that clots plasma was first reported by 
Loeb in 1903. However, there is no convincing evidence that coagulase is 
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directly involved in pathogenicity. It has been proposed that the 
coagulase may inhibit phagocytosis and protect the cocci from 
antibacterial substances in tissue fluids by laying down a fibrin barrier 
around them and walling off the lesions. Its production is the principal 
criterion used by the clinical microbiologists for the identification of S. 
aureus isolates from human infection. 
A novel typing method for Staphylococcus aureus based on 
polymerase chain reaction amplification of the variable region of the 
coagulase gene followed by Alul restriction fragment length 
polymorphism (RFLP) was developed (Goh et al, 1992). 
S. aureus strains produce an extra cellular "Thermostable 
nuclease" (Tnase) a protein with a molecular mass of 17,000 KDa and is 
considered as a virulence marker. The nuc gsne is widely employed as 
the target gene for specific detection of S. aureus (Wilson et al., 1991; 
Kim et al., 2001; Tamarapu et al., 2001; imd Ramesh et al., 2002). Jasper 
(1973) found a close correlation between thermostable nuclease and 
coagulase production. PCR has the potential for the rapid diagnosis of 
Staphylococcous aureus infection. 
Balban et al., (2000) reported that food borne disease has a major 
impact on public health. In a study of tood poisoning in England, the 
most prevalent contaminated foods wer j ham (75%), poultry or their 
products, other contaminated food prodi'cts including fish and shellfish 
(7%) and milk products (8%). Contam.nation occurred most often at 
homes followed by restaurants and food stores (Wieneke et al., 1993). 
The milk and dairy products are probabl) the types of foods 
most frequently implicated in food poisoning outbreaks 
(Zehren and Zehreen, 1968; Troller, 1976: DeBuysen et al., 1985; 
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Genigeorgis, 1989; Leploute, 1994; Adesi}iin et al, 1998; and 
Asao et al, 2003). A variety of exoprote-ns produced by S. aureus cause 
disease in the mammalian host (Salasia tt al. 2004). The most notable 
virulence factors associated with S. aureus are enterotoxins 
(Dinges et al, 2000). Contamination of food with S aureus during 
storage could lead to the production of enterotoxin. This intoxication 
resulting from the ingestion of food containing preformed heat stable 
enterotoxins results in acute disease known as Staphylococcal food 
poisoning (Gilmour and Harvey, 1990 ana Su ,anc Wong, 1997). 
In the past, a number of techiiques have been developed for 
detection of Staphylococcal enterolDxin^ like immunodiffusion 
(Gasman et al, 1969), ELISA (Notermaas, 1983) reverse passive latex 
agglutination (Shingaki et al, 1981) and immunoblotting 
(Orden et al, 1992). But disadvantages of these methods are that they are 
slow, relatively insensitive, and are more expensive. In addition, they 
may give false positive results due to ir terfererce by f Dod components 
and protein A (Orden et al, 1991). Jol nson ei al, (1991) reported the 
PCR procedure, which rapidly and ; pecific.iUy delects genes for 
staphylococcal enterotoxins by using synthetic oligonm;leotide primers. 
Polymerase chain reaction offers the pos>ibility of specific amplification 
of the genes responsible for the SEs production (:>aiki, 1988). The studies 
on detection of enterotoxins from foods of animal origin and clinical 
specimens are available worldwide but there is paucity of literature on 
this aspect in India. 
The prognosis of patients with .V. aureus infections was 
extremely poor before the advent of antibiotics. In early days of 
antimicrobial era, most infections causec by S. aureus were sensitive to 
Introduction 
penicillin and other antibiotics. Subsequt ntly strains acquired resistance 
to previously effective antimicrobials (Duckworth, 1993). They 
developed resistance to penicillin by virtue of beta-lactarnase production, 
an enzyme, which destroys penicillin. Penicillin-resistant S. aureus 
strains persist in the environment, in caniers and in paramedical staff in 
hospitals and community (Klimek, 1976; Peacock et al, 1980; Locksley 
et al, 1982; www.net doctor co. Uk, 2009). The pathogen causes both 
nosocomial and community acquired infections. At a time when majority 
of nosocominal S. aureus isolates were already resistant to penicillin, the 
introduction in 1960 of newer penicillinase resistant semi-synthetic 
penicillin was seen as a major therapeutic breakthrough. These 
beta-lactamase resistant penicillins include methicillin, oxacillin, 
nafcillin, cloxacillin, flucloxacillin and others. Unfortunately, just one 
year later, the first methicillin resistant S. aureus (MRSA) was isolated in 
London (Jevons, 1961). Since then, there have been many reports of 
MRSA causing various infections throughout the world 
(Parker and Hewitt, 1970; Locksley et al, 1982; Rao et al, 1990; and 
Mathur et al, 1994). This form of resistance encompasses all resistant 
beta-lactam antibiotics including cephalosporins (Sabath, 1982). Beta-
lactamase in S. aureus can be either intrinsic or chromosomal and is due 
to the presence of a distinctive gene mec A, which encodes penicillin 
binding proteins (PBPs). 
The emergence of antibiotic resis".ant organisms and their spread 
in the community has been a subject of increasing concern 
(WHO report, 1983). S. aureus is one of the commonest causes of 
hospital-acquired infections and the emergence of methicillin-resistant 
Staphylococcus aureus is one of the worst nosocomial hazards. MRSA 
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can cause infections like pneumonia, postoperative infections, 
bacteraemia and other infections in community and referral hospitals. 
MRSA are often resistant to the per icillinase resistant penicillins, 
tetracyclines, erythromycin, gentamycir, clindamycin, neomycin and 
trimethoprim. Clones of multidrug-resistant MRSA have become 
notorious hospital acquired organism causing serious, even fatal, 
infections in patients admitted for other diseases. In addition to antibiotic 
resistance, MRSA is often more readily coloQized and transmitted. The 
outbreaks of nosocomial infections are difficult and expensive to control. 
It is difficult to identify factors, which contribute to the 
persistence of MRSA carriage. Excess've antibiotic usage has been 
incriminated as one of the factors. The transmission and acquisition of 
MRSA is a multifactorial process depending not only on organism factors 
but also on host factors. The reservoirs of MRSA are wounds, 
intravenous catheters, tracheostomies and sites of dermatitis. Some 
hospital personnel may become chronic carriers. 
The present study was therefore carried out to evaluate the 
phenotypic and genotypic characters of A", aureus, which might provide 
an understanding of the distributation of j-revalent Staphylococcus aureus 
clones in India and might help in the aevelopment of steps to control 
Staphylococcus aureus infections in man and animals. Moreover, 
understanding genetic diversity of the organism may have far reaching 
implications for public health intervention strategies such as tracking the 
global spread, and understanding the emergence of drug resistance in 
Staphylococcus aureus. 
Introduction 
Aims and Objectives 
Following were the aims and objectives of this study: 
1. Phenotypic characterization of Staphylococcus aureus isolates 
obtained from clinical and animal-origir food samples. 
2. To detect the presence of coagulase, thermostable nuclease and 
commonly encountered enterotoxin genes in the isolates. 
3. Molecular characterization by C )a-PCR-RFLP in clinical and 
animal-origin isolates. 
4. To study any similarity or diversity in isolates obtained from 
clinical and animal-origin samples. 
5. To study the resistance rates and piittems of Staphylococcus aureus 
isolates. 
LITERATURE 
2. REVIEW OF LITERATURE 
2.1. General description 
The genus Staphylococcus, includes 32 species; among them 
S. aureus has been identified as one of the most important human 
pathogen (Sheagren, 1984). The organism successfully adapts itself on 
the ectodermis of warm blooded animals. Some staphylococci are 
members of normal flora of the body surfaces of man and animals; others 
cause suppuration, a variety of pyogenic infections, food poisoning etc. 
Staphylococcus aureus causes infections in all age groups. It is 
responsible for sporadic infection: as well as epidemics 
(Locksley et al, 1982; and Thompson et al, 1982) and is the most 
common cause of infections in hospitalized patients (Dar et al, 2006). 
Staphylococcus aureus mainly spreads by person-to-person 
contact where the source may be an individual with an open draining 
lesion or an asymptomatic carrier. It may be transmitted by airborne 
droplets or contact with contaminated objects. 
2.2. Historical background 
Von Recklinghausen (1871) first observed staphylococci in pus 
obtained from human pyogenic lesions Further Robert Koch (1878) 
reported the presence of small spherical bacteria in pus, abscess and in 
infected blood of people suffering from pyaemia and named them as 
''Micrococci". Later in 1881, a Scottish surgeon Sir Alexander Ogston 
established the functional role of cocci in abscess and other suppurative 
lesions. In 1882, these cocci were nam( d as Staphylococcus. The first 
person to isolate pure culture of stoohylococci in laboratory was 
Rosenbach (1884). He gave the typica characteristic features of this 
organism and formal description of the ge lus. He divided staphylococci 
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into two species namely S. aureus and S. cibus on the basis of their 
orange and white-pigmented colonies, re: pectlvely. Third species known 
as S. citreus, was added by Passet (1885) based on their lemon yellow 
pigmentation. 
In 1963, Baird and Parker classified the Gram-positive, catalase 
positive cocci into three main groups; group I- Staphylococcus, 
group II- Micrococcus and group III- Sarcimi. Depending upon the 
production of enzyme coagulase, staphylococci were subdivided as 
subgroup I - which produced coagulase enzyme were designated as 
coagulase positive staphylococci (S. aureus, S. intermedius) and 
subgroups II- VI which do not produce coagulase were designated as 
coagulase negative staphylococci. Members of genera Staphylococcus 
and Micrococcus have been placed with Stomatococcus in the family 
"Micrococcaceae" (Privot, 1961). 
Genetic surveys of Gram-positive,». atalase positive cocci indicated 
that Staphylococcus aureus have a G - C content of DNA of 30-39 
mol%, whereas micrococci have a G ^ C content of 63-73 mol % 
(Silvestri and Hill, 1965). Staphylococcus and Micrococcus have been 
found to differ on the basis of DNA compositions, 0-F test, cell wall 
composition (Schleifer and Kandler, 1972), cytochromes, menaquinones, 
cellular fatty acids, polar lipids, DNA-rRNA hybridization and 
comparative oligonucleotide cataloguing of 16S rRNA 
(Ludwig er a/., 1981). 
Staphylococcus aureus are Giam-positive cocci measuring 
1.0 micrometer in diameter that occur singly, in pairs, tetrads, short 
chains and irregular grape like clusters. They are iionmotile and nonspore 
Review of Literature 
forming, catalase positive, facultative anaerobes growing better under 
aerobic conditions. Most species grow in the presence of 10% sodium 
chloride and at 18-40° C. They are susceptibile to furazolidone (100 |ag) 
and resistant to low level of bacitracin (0.04 unit). They are susceptible to 
lysis by lysostaphin and are relatively resi Jtant to lysis by lysozyme. 
2.3. Habitat 
The largest population of Staphylococcus aureus in the human 
body is found on the skin, mainly in the axillae, inguinal and perineal 
areas; and in the anterior nares (Kloos et al, 1991; and Kloos and 
Bannerman, 1994). Colonization by S. aureus may be found in 6% to 
24% of newborns after 3-4 days in a well baby nursery 
(Gooch et al., 1978). Among healthy adults, carrier rates of 11 % to 32 % 
were detected in the general population of the United States 
(Millian, 1960). 
The largest populations of cutaneous staphylococci are found in 
regions of the skin supplied with large numbers of pilosebaceous units 
and sweat glands on the skin and mucous membranes surrounding 
openings to the body surface. Staphylococcal populations living on 
human skin have been observed in the foUicular canals, opening to sweat 
glands, the cepacious lumen of sebaceous follicles, and on the surface and 
beneath the desquamating epithileal scales (Noble and Somerville, 1974; 
and Noble and Pitcher, 1978). 
Nasal carriage rates ofS. aureus range from 10% to 40% in normal 
adult population residing in the community. The organism is also found 
in the inguinal and perineal area. 
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Staphylococci have also been foui id in the pharynx, conjunctiva, 
mouth, blood, mammary glands, faeces, )ody discharges, excretions and 
intestinal, genitourinary and respiratory tacts of their hosts (Elek, 1959). 
The occurrence of contaminating staphylococci in various food products 
has been studied extensively (Bergdoll, 1989; Genigeorgis, 1989; Mossel 
and VanNetten, 1990; and Kloos and Lachica et al, 1994). The presence 
of enterotoxogenic strains of S. aureus in food stuff is regarded as a 
public health hazard because of the ability of ihese strains to produce 
intoxication or food poisoning. 
2.4. Cell morphology 
Staphylococcus aureus is uniformly gram positive in young 
(18-24 hours) cultures, nonmotile, nonflagellated, nonspore forming 
bacteria. It appears spherical with an average diameter of 0.5-1.5 |am. The 
size varies from strain to strain and influenced by the age of cultures and 
by the medium on which it is grown. The cells of old cuhures (>48 hours) 
are often Gram-variable to nearly Gram-negative. S. aureus mainly 
produces irregular clusters of cells. Organism divides in more then one 
plane to form irregular clusters. 
Encapsulated cells (form mucoid, glistening colonies) are 
surrounded by a capsule layer (>200 nm thickness) outside the cell wall 
(Wilkinson, 1983). Staphylococci may also have capsules that are thinner 
than 200 nm (microcapsules), which are not visible by light microscopy 
or staining by India ink method. Incidence of S. aureus strains exhibiting 
microcapsules is 80-90% (Hochkeppel et il, 1987). 
10 
2.4.1. Cell surface components 
Review ofUterature 
2.4.1.1. Cell membrane: It consists of lioid - protein bilayer, composed 
mainly of phospholipids and protein. It represenls a sele::tive barrier and 
fulfils many functions, including election irarisport, active transport, 
participation in septum formation and seg egalior of DNi^. Phospholpids, 
gloycolipids, menaquinones and caroteroids make up the major lipid 
components of the membrane. 
The pigments of staphylococci which constitute the lipid 
component of cell membrane are triterpenoid c irotenoids having a C30 
chain (Marshall and Wilmoth, 1981a). In S. aureus, carotenoids range 
fi-om colorless polyisoprene compounds such as squalence, 
diapophytoene and diaplophytofluence 0 the yellow, orange and red 
triterpenoid carotenoids. The main p gment is staphyloxanthin, a 
compound in which glucose is esterified. 
Various proteins have been isolated fi'om the membrane of 
S. aureus such as adenosine triphosphatase, polyprenolphosphokinase 
(Sandermann and Strominger, 1972), various oxidases and 
dehydrogenases (Theodore and Weinbach, 1974) and several penicillin 
binding proteins (PBPs), which ca alyze terminal reactions of 
peptidoglycan biosynthesis (Hayes et il, 1981; and Hartman and 
Tomasz, 1984). 
2.4.1.2. Cell wall: Peptidoglycan and teichoic acid are the major 
components of staphylococal cell wall. The peptidogl} can amounts to 
about 50-60% of the dry weigtht (Schleifer and Kandler, 1972) and 
teichoic acid amounts to about 30-50% :)f dry weight and is covalently 
linked to peptidoglycan. The peptidoglycj;n is the main stnactural polymer 
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in the wall and it plays an important re le iri maintaining the spherical 
shape of the cell. It is a heteropolymer coi sisting of glycan chains that are 
crossed-linked by short peptides. The glycan moiety is made up of 
alternating /?-l, 4 linked limits of N-a :etylglucosamine and N-acetyl 
muramic acid. Peptidoglycan antibodies can be found in normal human 
and animal sera. The Biological activities of peptidoglycans include 
endotoxin like properties (Pyrogenicit>, complement activation and 
generation of chemotactive factors), inflammatory skin reaction, 
inhibition of leucocyte migration, adjuvint activity, mitogenic activity 
and induction of immunosuppresive cells. 
The cell wall teichoic acids arj uitique ribitol (five carbon 
monosaccharide) phosphate polymers, '^ eichoic acid lunctions in the 
specific adherence of Gram-positive bacteria to mucosal surfaces. 
Precipitating antibodies to teichoic acids can be found ir sera of patients 
with staphylococcal infections (Daugharty et a!., 1967; and 
Crowder and White, 1972). 
2.4.1.3. Protein A (SPA): It is a group specific antigen found in the cell 
wall of about 90% strains of S. aureui (especially Cowan 1 strain). 
Protein A is bound to the cell wall peptic^ogl>can and it is also shed into 
the medium during growth of the bacteria. In S. aureus strains A676 and 
in many methicillin-resistant strains, SPA is an extra cellular protein 
excreted into the culture supernatant. 
2.4.1.4. Cell surface adhesins: Staphylococci have a group of cell 
surface proteins that act as adhesins (aho known as microbial surface 
components recognizing adhesive matri> molecules) and bind to extra 
cellular matrix proteins such as fibronectin, Fibiinogen, laminin, elastin 
and collagen etc. of their host. These p -oteins bind to eukaryotic host 
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cells via cell surface receptor proteins (integrins). The adhesins act as 
targeting factors, attaching bacteria to certain host tissues via matrix 
proteins. This is an early step in the process of pathogenesis, leading to 
colonization and subsequent invasion of host cells (Lindberg et al., 1990). 
2.4.1.5. Capsules: It is located external to cell wall and is mainly 
composed of antigenic polysaccharides (lutherland, 1977). The capsular 
polysaccharides are made up of different combination of 
either aminouronic acids or n-)n-aminouronic acids and 
N-acetyl-D-furosamine or galactose dipendent on particular strain 
(Wilkinson, 1983). S. aureus strains can be assigned to at least 11 
capsular serotypes based on capsular polysaccharides immunotyping. Of 
these serotypes 5 and 8 are associated with microcapsules and are the one 
of most frequently encountered in bactereamia and a variety of other 
infections (Hochkeppel et al, 1987). 
2.4.1.6. Slime: Is a complex extra cellular iubstances produced in 
varying amount by many Staphylococci. Ciiide slrme is a very 
heterogeneous substance, usually composed of a variety of 
monosaccharides, including mannose, galactose, glucose, glucosamine 
and glucouronic acid, proteins and small peptitles. 
2.4.2. Extra- cellular protenis 
The extra cellular proteins produced by Sfeiphylococcus can act as 
either toxins or as enzyme activator or non-toxic enzymes. These are as 
follows: 
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1A.1.\. Toxins 
2.4.2.1.1. Membrane damaging toxins: Dairiage the plasma membranes 
of eukaryotric cells (Thelestam, 1983). 
(a) Hemolytic toxins (Hemolysirs): Attack the membranes of 
erythrocytes, as well as some other ceils, Irora various host species, 
S. aureus produces at least 24 types of hemolysins known as "^P^y and 
< -^toxins. A high percentage (86-95%) of human S. aureus strains 
produce a-toxin. ^-toxin is produced by many strains of S. aureus. 
'^-toxin, also known as ^-hemolysin, is one of many virulence factors 
produced by S. aureus. The best characterized and most potent 
membrane-damaging toxin of S. aureus s a -to Kin. It is expressed as a 
monomer that binds to the membrane of susceptible cells. Subunits then 
oligomerize to form heptameric rings wi-h a central pore through which 
cellular contents leak, a-toxin is a single polypeptide chain having a 
molecular weight of 33,000 daltons and an isoelectronic point of 8.5. 
a-toxin is also known as a -hemolysin. 
In humans, platelets and monocytes are particularly sensitive to 
a -toxin. Susceptible cells have a specific receptor for a -toxin which 
allows the toxin to bind causing small pores through which monovalent 
cations can pass. The mode of action of alpha hemol>sin is likely by 
osmotic lysis. This toxin has been shown to be lethal in animals, causing 
respiratory paralysis, vascular and smooth muscles spasms and tissue 
necrosis. 
(b) Leucocidins: act on leucocytes (granilocj^es and macrophages). 
2.4.2.1.2. Pyrogenic exo-toxins: Superantigeis cause fever and shock in 
their hosts. These toxins are classified as su])erantigens (SAgs) and 
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include the enterotoxins and TSST-1 (t)xin shock syndrome toxin-1). 
Enterotoxin F is also known as toxic si ock syndrome toxin (TSST-1). 
Superantigens are potent activators of f lymphocytes resulting in the 
liberation of cytokines such as tumor necrosis factor and they bind with 
high affinity to mononuclear cells. These characteristics partly explain the 
florid and multisystem nature of the clinical conditions associated with 
these toxins. 
2.4.2.1.3. Enterotoxins: The most notaole ^ iriilence factors associated 
with S. aureus food poisoning are enterotoxins (Baleban et al., 2000; 
Joblonski and Bohanch, 2001; Jones et al, 2(t02; Asao et al., 2003; 
Lelair et al, 2003; and Alarcon et al., 2005). Enterotoxins are perhaps the 
best recognized causative agents of food poisoning; although their role in 
other diseases is being actively investigated (BergodoU, 1983). 
The first report that associated staphylococci with food poisoning 
was probably by Vaughan and Sternberg, in 1884 described an 
investigation of a large outbreak of illness in Michigan believed to have 
been caused by eating cheese that was contaminated with staphylococci. 
The genetics of iS. aureus enterotoxin prcduction have been well studies. 
The staphylococcal enterotoxin genes are carried either by plasmids (SED 
and SEJ) (Bayles and Landolo, 1989; and Zhang et al, 1998) by phages 
(SEA and SEE) (Betley and Mekalanos, 1985), by chromosomes (SEB, 
SEC, SEG, SHE, SEI, SEK, SEL, SEM, SEN, SEO, SEP and SEQ). 
Staphylococcal food poisoning (enteroto?,icosis) is classified as a disease 
of moderate severity and limited sprea«i (Anon, 1985). S. aureus can 
readily multiply in many food items, b it milk and dairy products are 
probably the types of foods most freqi ently implicated (Genigeorgis, 
1989; Lepoutre, 1994; Adesiyun et al, 1998; £ind Asao et al, 2003). Raw 
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milk and cheese have been repeatedly involved in staphylococcal food 
poisoning outbreaks (Zehren and Zehreen, 1968; Troller, 1976; and De 
Buyser et al, 1985). The SEC is an important cause of food borne 
intoxication and is commonly produced by S. aureus isolated from dairy 
cattle (Wilson et al, 1991; and McLauchKn et al. 2000). 
Heat treatment even at 60°C for 30 minutes could not inactivate SEC 
(Berja et al, 1967). Untreated mastitis is one of the main causes of 
continuous economical losses in the dairy industry. The presence of 
S. aureus in the food can be a potential risk for health, particularly if the 
food is not stored at the prescribed temperature (Thaciko\'a et al, 2003). 
Over the last few years PCR assa> has been developed to identify 
specific sequences for SEs by DNA amplification (Johnson et a/., 1991; 
Mullis and Erlich, 1998; and Saiki et al, 1998). 
DNA amplification method (Polymerase Chain Reaction) can show 
the presence of enterotoxogenic strains of 5. aureus before the expression 
of enterotoxins on the basis of specific gene sequences and in this way 
can detect the potential source of contamination. The advantage of the 
PCR method is that it is able to detect genes, for the production of 
staphylococcal enterotoxins even after heat treatment of food because 
the DNA remains unchanged (Tson and Chen, 1992; and 
Holeckova et al, 2000). S. aureus is a pathogen that ranks in top three 
causes of food poisoning outbreaks in Taiwan (Wang et al, 1983). 
S. aureus is also the third most common cause of confirmed bacterial 
food borne disease in United States (Bean et al, 1996). 
2.4.2.1.4. Epidermolytic toxins: The most dramatic manifestation of 
epidermolytic toxin is the scalded skin syiidrome where the toxin spreads 
systemically in individuals who lack ncutralizmg antitoxin: extensive 
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areas of skin are affected which, after th< development of a painfiil rash, 
slough off; the skin surface resembles s raiding. Such blistering lesions 
are seen mainly, but not exclusively, in small children. S. aureus 
mediated production of exfoliative toxin also results in a spectrum of 
blistering skin disorders ranging from localized bullous impetigo to a 
severe generalized form, scalded skin syndrome. The syndrome is a 
generalized exanthematous disease consisting of cutaneous tenderness 
and widespread superficial blistering am' denudation. Exfoliative toxins 
(ETs) are made by certain strains of S. i urevs (usually phage group 2). 
Exfoliatin A and B (ETA and ETB) are tv> o serologically distinct proteins 
produced by S. aureus. ETs are serine proteases that bind to the cell 
adhesion molecule desmoglein 1 and cleave it, resulting in a loss of cell-
cell adhesion. Consistent with the expression pattern of desmoglein 1, 
which is expressed in the upper part of the epidermis, the epidermolysis 
takes place usually between the stratum -.pinosum and granulosum. This 
results in a very thin-walled, flaccid I lister that is easily disrupted, 
exhibiting a positive Nikolsky sign. The pathophysiology of ET 
resembles that of the autoimmune )list(;rirLg disease pemphigus. 
2.4.2.1.5. Fibrin forming and flbrinolyt'c enizymes 
(a) Staphylocoagulase: Is a protein that clois plasma in the absence of 
Ca^ but requires a coagulase reacting factor (CRF). CRF reacts with 
coagulase and resulting coagulase-CPJcomplex (staphylothrombin) 
converts fibrinogen to fibrin (Drummoml and Tager 1963). 98-99% of 
S. aureus strains exhibit coagulase activi:y. Coagulase activity may also 
be exhibited by the species S. intermecius, S. hyicus, S. delphini and 
iS". schleiferi subsp. coagulans. 
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(b) Staphylokinase: Is a protein that exhibits fibrinolytic activity 
indirectly by binding to plasminogen, is produc ed by a relatively high 
percentage (60-95%) of human S. aureus strains of biotype A. 
1A.1.\.6. Bacteriolytic enzymes: Two types of bacteriolytic enzymes are 
produced by it, glucosaminidase and lyso itaphin. The foimer is produced 
by S. aureus and is active against bacillus and Micrococcus sp. 
Lysostaphin is produced by S. simulam biovar staphylolyticus. 
2.4.2.1.1. Hydrolytic enzymes: S. aurtus produces lipases, esterases, 
nucleases, urease, hyaluronidase and endopeptidase. 
2.5. Culture characteristics of Staphylococcus aureus 
They are aerobes and facultative anaerobes. Optimum temperature 
for growth is 37° C (ranging being 12-^ 4*' CO iuid optimum pH is 7.5. 
They can grow well on a variety of select; ve and non-selective media. 
2.5.1. On Nutrient agar 
After overnight incubation at 37° C, it foims colonies 1-3 mm in 
diameter, smooth, circular, entire, slightly raised (low convex), glistening, 
densely opaque with a butyrous consif tency. Older colonies become 
translucent and sticky. Most strains pr)duce golden yellow pigment. 
Pigment production occurs optimally i t 22° C and only in aerobic 
cultures. Pigmentation is enhanced on fat y media such as tween 80 agar, 
by prolonged incubation and by leaving ] lates at room temperatures, 1% 
glycerol monoacetate agar, and milk agar Pigment is not formed in liquid 
media. Nonpigmented strains are rot jncommon. These grow 
anaerobically and are often smaller and gi ayish in color. 
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2.5.2. On Blood agar 
Colonies are similar to those oa nutrient agar, but may be 
surrounded by a zone of p- haemolysis, es])ecially when the medium 
contains 5% sheep, ox, human or rabbi blood and is incubated in an 
atmosphere of 20% CO2. 
2.5.3. On MacConkey agar 
Colonies are smaller and are pink due to lactose fermentation. 
2.5.4. On Mannitol salt agar 
Yellow colonies 1mm in diameter are formed surrounded by 
yellow zones due to acid formation. 
2.5.5. On Baird- Parker agar 
Black colonies surrounded by opaque zone due to lecithinase 
activity. 
2.5.6. On other commercial media 
They grow well in a variety of commercially prepared liquid 
media including TSB, BHI, and nutrient broth, tryptose phosphate broth 
with or without addition of blood. 
2.6. Biochemical properties 
S. aureus ferments glucose, maltose, lactose, sucrose and mannitol 
with production of acid but no gas. Anaerobic itilization of mannitol is 
considered to be distinctive features of ^ aurem. It is catalase positive, 
oxidase negative, methyl red and Voges-I roskaucr test positive. Nitrate is 
reduced to nitrite and indole is not )roduced. S. aureus produces 
deoxyribonuclease (DNase), and heai stable nuclease 
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(Thermostablenuclease, TNase). S. aureus also produce phosphatase. 
S. aureus is sensitive to novobiocin but resistant to bacitracin. 
2.7. Resistance to physical and chemical agents 
Staphylococci survive well in the environment under both moist 
and dry conditions and in laboratory cultures such as sealed agar slopes. 
It withstands moist heat at 6O'* C for 30 minutes. It is readily killed by 
phenol and hypochlorite disinfectants at standard in use concentrations 
and by antiseptic preprations such as hexachlorophane, chlorhexidine and 
providone- iodine. 
2.8. Pathogenecity 
2.8.1. Pathogenecity of Staphylococcus aureus: 
The Staphylococci are normal inh ibitants of the body surface of 
man and animals. The ability to cause disease; is their secondary feature. 
The most important pathogen in the genus is Staphylococcus aureus that 
causes infections and epidemics (Locksle/ et al, 1982; Thompson et ai, 
1982; Kim et al., 2001 and Warren, 200.'^ ). It is the most common cause 
of infections in hospitalized patients (Orrett, 2002). 
S. aureus is transmitted mainly b\ person to person contact with 
the source being an individual with an open draining lesion or an 
asymptomatic carrier. Less frequently, it may be transmitted by airborne 
particles or contact with contaminated objects. 
2.8.1.2 Pathogenesis of Infections 
The five stages in the pathogenesis of S. aureus infection are 
(i) colonization (ii) local infection (iii) systemic dissemination and / or 
sepsis (iv) metastatic infection and 'v) toxinosis (Archer, 1998). 
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Approximately 35% of healthy individuals are colonizt:d by S. aureus, 
usually in the anterior nares, but also in the thioat (4 to 64 %), vagina and 
perianal area. The organism can be carried asymptomatically for weeks or 
months on mucous membranes but is oi ly transiently carried on intact 
skin. 
The infection can spread locally (eg. carbuncles, cellulitis, and 
impetigo or wound infection) or gain access to blood. Once in the blood, 
the organism spreads widely to peripheral sites in distant organs and 
septic shock can ensue. As a result of hematogenous dissemination, a 
number of specific staphylococcal infections can result (eg. endocarditis, 
osteomyelitis, renal carbuncle, septic irthritis, or epidural abscess). 
Finally if the organism itself does not ir ^ade the blood stream, specific 
syndromes can results from the local or s> stemic effects of specific toxins 
(eg. toxic shock syndrome, scalded skin syndrome, and food borne 
gasteroenteritis). 
Certain underlying conditions or behaviors can predispose 
individuals to staphylococcal infections, including diabetes mellitus 
(Cluff et ai, 1965), indwelling intravenous drug abuse 
(Mathew et ai, 1995) and AIDS (Jacobson et al, 1988), chronic skin 
disease like atopic dermatitis. The success of the organism as a pathogen 
and its ability to cause a wide range of infections are due to its extensive 
virulence factors. 
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Virulence factors of 
pathogenic activities. 
Staphylococcus aurem and their proposed 
Virulence factor 
Exoproteins 
a-Lysin 
P-Lysin 
X-Lysin 
5-Lysin 
panton-Valentine 
leucocidin 
Epidermoltyic toxins 
ETA and ETB 
Toxic shock S5Tidrome toxin 
Enterotoxins 
Coagulase 
Staphyloldnase 
Lipase 
Deoxyribonuclase 
Cell surfkce proteins 
Protein A 
Clumping factor 
Fibronecting-binding protein 
Cell wall polymers 
Peptidoglycan 
Teichoic acid 
Activity 
Formation of bioilim, causing respiratory paralysis, 
Vascular and smooth muscles spasm and tissue 
Necrosis, osmotic lysis in £jiimals 
Impairment of m smbreaie 
permeability; 
cytotoxic effects m phagocytic 
and tissue cells 
spectrum of blis ering skiii disorders ranging from 
localized bullous impetigo to a severe generalized 
form, scalded skjisyndrome. Cutaneou and tenderness 
and widespread superficial denudation.Cause 
blistering of skin 
Induces multis}'stem effects; supersjitigen effects 
Induce vomitin ; and diarrhoea; su)}erantigen effects 
Converts fibrin )gen to fibrin in plaama 
Degrades fibrir 
Degrades lipid 
Degrades DNA 
Reacts with Fc region oi IgG 
Binds to fibrio'iogen 
Bind to fibron-ctin 
Inhibits inflar mato-y response; e idotoxin-Uke 
activity 
Phage adsorpt on; rt ser 'oir of bound divalent 
cations 
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There are also specific global regulato.7 systems, such as agr 
and sar, that determine which virulence factors are produced at specific 
times during growth and in response to the local environment 
(Projan e? a/., 1997). 
2.8.1.3. Spectrum of infection 
Infections or syndromes for wh'ch S. aureus is a prominent 
pathogen. 
(a) Primary infections: 
Superficial infections 
> Folliculitis 
> Furunculosis or carbuncle 
> Impetigo bullosa 
> Cellulitis 
Deep infections 
> Surgical wound infections 
> Epidural abscess 
> Osteomyelitis 
> Pneumonia 
> Empyema 
(b) Secondary Infections: 
> Eczema 
> Decubitus ulcers 
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> Atopic Dermatitis 
(c) Generalized Infections: 
> Septicaemia 
> Hospital acquired bacteremia 
> Acute endocarditis 
> Septic arthritis 
> Botriomycosis 
> Renal carbuncle 
> Meningitis 
(d) Toxin -mediated diseases: 
> Food poisoning 
> Toxic shock syndrome 
> Scalded skin syndrome 
2.9. Staphylococcal antimicrobial resistance 
Antibiotic era started in early 1940 with the discovery of penicillin 
in 1929 by Fleming and the conclusi\e demonstration of usefulness 
in infection by Florey and Floery in the early 1940s. In 1944 to 1945, 
resistance rate of 12% to 22% was documented for S. aureus clinical 
isolates (Bondi, 1945; and Gallerdo E., 1945). The introduction of the 
semisynthetic P-lactamase-resistant penicillin, such as methicillin and 
oxacillin brought about a general decline in the prevalence of multiple 
resistant S. aureus during the early 196C5 (Shan son, 1981; Orrett et al.. 
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2006). Although resistance to methicillir was detected in approximately 
1% of isolates from the United Kingdom, such strains did not pose a 
serious threat to the overall effectiveness of the antibiotic (Parker et al., 
1974). By the late 1960s to early 1970s, stiains resistant to the semi-
synthetic P-lactams were isolated with in creasing freque icy in a number 
of countries including Australia (Rountne et al., 1968; and Rountree et 
al., 1973), Belgium (Klastersky et al., 971), France (Courtieu et ai, 
1964), Poland (Borowski et al., 1964), tht United Kingdcm (Parker et al., 
1974), and the United States (Barrett et al, 19t)8; and O, Toole et al, 
1970), Denmark (Bulow, 1971) and Switzerland (Kayser, 1975; and 
Kayser et al., 1972). These strains formed a sigrificant ])roportion of the 
S. aureus isolates. Most methicillin-resis'ant strains isolated at this time 
produced a (3-lactamase and were a so ''esistant to streptomycin, 
sulfonamides, and tetracycline; many demonstravCd additional resistance 
to chloramphenicol, erythromycin, aid ftisidic acid or to the 
aminoglycoside, neomycin (Lacey, 1975 i nd Orrett, 2006). 
Dermerec obtained first evidence of resistance to penicillin in 
S. aureus in 1945. Several studies conducted laler on confirmed genetic 
origin of drug resistance to penicillin (Barber, 1948; Rountree and 
Jhonson, 1949; Lederberg and Ledeber^',, 1952; Altermeier and 
Gulbertson Vetto, 1955). 
Prevalence of penicillin resistant clinic. 1 isolaies incriiased rapidly at 
Boston city hospital, Boston. A minimal inhioitory concentration (MIC) 
of greater than 0.04 microgram of penici lin per nl was found in 17% of 
S. aureus isolates prior to 1946; 75% of isolates m 1946 to 1949; 79% in 
1948 to 1949. An MIC of greater than 25 microgram / ml was found in 
28 % of the isolates in 1946 to 1947, and 73% in 1951. At present, 
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approximately 5% of 5. aureus isolates ; till are susceptible to penicillin 
(Parvez et al, 2004). Penicillin resistaj t S. aureus from US hospital 
obtained in 1971 to 1982 revealed a \1% decrease in susceptibility with 
about 90% isolates resistant to penicillii in 1982. High percentages of 
penicillin resistant 5. aureus were .epoited by various workers 
(Kosmidis et al, (1988) 80%; Vijayalakshmi et al, (1980), 98.6%; and 
Refsahl et al, (1992), 80.9%; Tambekar et al, (2007), 100%). During 
subsequent years after discovery of penicillin, other potent antibiotics like 
neomycin, streptomycin, tetracycline, chloramphenicol, macrolides and 
other newer antibiotics were discovered. Staphylococci quickly 
developed resistance to these agents. Tet-acycline was increasingly used 
during the 1950s to treat many different infections in hospitals, including 
penicillin resistant S. aureus infection. The fii-st tetracycline resistant 
staphylococci appeared within a few years of the introduction of 
tetracycline. The increased incidence of tetracycline resistance was 
almost certainly due to hospital cross infection by S aureus strains 
containing a plasmid for tetracycline resistance. Erythromycin was 
widely used to treat infections due to pei icillm and tetracycline resistant 
S. aureus soon after it was introdi ced irx 1952. Resistance to 
erythromycin in staphylococci appeired during 7-10 days of 
erythromycin treatment of patients with staphylococcal infection. 
In some hospitals erythromycin resistant staj^ hylococci with penicillin 
tetracycline erythromycin (PTE) or pencillin streptomycin tetracycline 
erythromycin (PSTE) patterns of resistance emerged and spread rapidly 
while in others erythromycin resistance became a problem only after 
many months (Lowburg, 1960). Cross-resistance to other macrolides, 
including oleandomycin and spiramycin was generally present in strains 
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resistant to erythromycin. Neomycin-resi stant S. aureus strains had first 
been detected in the United States in 195*' to ) 960 (Finegold et al, 1960; 
and Parker et al., 1970) and soon appeared els(jwhere (Jacobs et al, 1963; 
Robertson, 1963; and Rountree et al., 1965). Resistance to neomycin, and 
to the related aminoglycosides, kananycin and paromomycin, had 
emerged after a delay of approximately 1" years and was attributed to the 
widespread topical use of neomycin on the skin and in the nose 
(Lowbury et al, 1964; and Rountree it al, 1965). A similar delay 
occurred between the introduction of the aminoglycoside, gentamicin, in 
1964 and outbreaks of hospital infectic<ii in 1975 to 1976 caused by 
5'. aureus strains concomitantly resistant to gentamicin and to two other 
aminoglycosides: kanamycin and tobiamycin (Bint et al., 1977; 
Buckwold et al, 1979; McGowan et ill, )979; Speller et al, 1976; 
Wyatt et al, 1977 and Orrett, 2008). T'le extensive topical use of the 
antibiotic was implicated in the appearance a)id spread of these resistant 
strains (Noble et al, 1978; Wyatt et al 1977 and ISA.\R, 2007). Prior 
to these outbreaks gentamicin- resistant isolates were rare in France 
(Soussy et al, 1975), the United Kingdom (Uacey ei al, 1968; and 
Porthouse et al, 1976), and the United States (Pittman et al, 1965). 
Reports of S. aureus strains resistant to 1 oth gentamicin and methicillin, 
along with a wide range of other aiitibiotic s^ including penicillin, 
tetracycline, and streptomycin initially came from London, England 
(Shanson et al, 1976), in 1976, a though similar strains were 
subsequently reported to have been preseit in Dublin, Republic of Ireland 
(Cafferkey et al, 1985), and in the Unite 1 States (Crossley et al, 1979) 
at that time. 
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Chloramphenicol was occasionally used as a reserve drug in some 
hospitals to treat serious infection caused by 5 aureus strains which were 
resistant to penicillin, streptomycin, 1 Jtracycline, and erythromycin 
(PSTE), during the late 1950s. Koch (19(.0) reported a substantial 
increase in the incidence of chloramphenicol resistant staphylococci from 
2% of strains in 1953 to 34% in 1958. Crc ss-resistance among chemically 
unrelated antibiotics was first noted with chloramphenicol and 
erythromycin (Barber et al., 1958) and with er}thromycin and 
oleandomycin. In subsequent years, S. jureus developed resistance to 
these antimicrobial agents too. During tte late 1970's and early 1980's, 
strains of S. aureus resistant to multiple mtibiotics including methicillin 
and gentamicin were increasingly respoi sible for outbreaks of hospital 
infections in countries around tie world, e.g. Argentina 
(Schugurensky et al., 1984), Austria (>pitzy et al, 1979), Australia 
(Gilbert et al, 1982; King et al, 1982; Pavillard et al, 1982; 
Pearman et al, 1985; and Townsend et al, 1985), Belgium 
(Yourassowsky et al, 1981), Denmarl: (Espersen et al, 1982; and 
Rosendal et al, 1981), Republic of Irjland (Cafferkcy et al, 1985; 
Cafferkey et al, 1983; and More et al, 1981). England 
(Bradley et al, 1985; Price et al, 1980; ar d Shanson et al., 1985), France 
(El Solh et al, 1981; and Goulett et al, 1981), Bast and West Germany 
(Naidoo et al, 1983; and Wit et al, 1977), Greece 
(Giamarellou et al, 1981), Italy (Varaldo et al, 1984), Japan 
(Konno et al, 1982), and the United States (Craven et al, 1979; 
Haley e^  a/., 1982; Schaefler era/., 1984; mdWenzel, 1982). Even before 
methicillin was widely used, a strain of ^. aureus with natural resistance 
to this antibiotic was identified by Je/ons ir 1961 (Jevons, 1961). 
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Thereafter, methicillin resistant S. aureu r (MRSA) emerged as a major 
pathogen worldwide (CoUey et al, 1965; 3rossely et al, 1979; Fluckiger, 
1979; Sares, 1997; Michel et al, 1997; and Ayliffe, 1997). Since the 
introduction of methicillin into clinical use in 1961, the occurrence of 
MRS A has steadily increased and hospital home infections caused by 
such isolates have become a serious problem worldwide (Hashimoto, 
1994; Brown, 2006; Lee, 2001; Kerttula, '.004; Bukhari, 2004; and Orret, 
2008 ). In India, a varying prevalence r ite of MRS A (5.9 to 52%) has 
been reported (Chakravarthy et al, 19^8; Udayasankar et al, 1997; 
Mehndiratta et a/., 2001; Vidhani e? a/. 2001; Majumder er a/., 2001; 
Hanumanthappa et al, 2003; Arakere et al, 2005; Dar et al, 2006 and 
Tiwari et al, 2008). 
Mec the structural gene for PBP2', has been located on the 
chromosomal map of Staphylococcal aureus close to the novobiocin 
resistance gene nov (Kuhl et al, 1978). It has been showr to be additional 
DNA not present in isogenic sensitive st ains (Beck et al, 1986), and is 
probably transposable (Trees and Lando o, 1983). A specific region of 
this additional DNA was found to be h.ghl) conserved in MRSA and 
methicillin resistant coagulase negative sUiphylococci (MRCNS) 
collected over a 25 year period (Berger-Bachi, 1989; Hartman and 
Tomaz, 1989; and Murakami and Tonasz, 1989) is involved in the 
expression of methicillin resistance. 
. : • At pi ssenc no genetic model exists to 
explain heterogeneous and homogeieous resistance. Low-level 
methicillin resistance can result from the production of large amount of 
betalactamase, or increased production and/or modified 
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penicillin-binding capacity of normal PB^s (IvIcDougal et ai, 1986; and 
Tomasz et al., 1989). Such borderline lesistant Staphylococcus aureus 
strains (BORSA) seldom have minimal nhibitoiy concentrations (MIC) 
of methicillin exceeding 16 pg/ml, ami their clinical significance is 
through to be limited (Chambers et al, 1996). Song et al. (1987) have 
sequenced mec and found considerable h )mology between the promoter, 
the initial sequence of mec and staphylococcal P - lactamase. Earlier 
reports that mec was carried out on plasmids (Dombusch et al., 1969) 
may have been erroneous, or examples of temporary mec insertion into 
the plasmid, as described by Trees and l.andDlo (1988). Mec itself may 
have within it IS-like elements that may ict as a trap for other resistance 
determinants (Berger-Bachi, 1989). 
The prevalence of MRSA incr ;asecl rapidly worldwide, and 
glycopeptide antibiotics have been wid( ly relied upon to treat MRSA 
infections. Glycopeptide antibiotics are a class of antibiotic drugs 
composed of a glycosylated cyclic or polycyclic nonribosomal peptides. 
Significant glycopeptide antibiotic include vancomycin, teicoplanin, 
telavancin, bleomycin, ramoplanin and tlecaj)lanin. This class of drugs 
inhibit the synthesis of cell walls in sus>:eptible microbes by inhibiting 
peptidoglycan synthesis. The bind to the unino acids within the cell wall 
preventing the addition of new units to he peptidoglycan. In particular 
they bind to acyl-D-alanyl-D-alanine in peptidoglycan. They D stands for 
the dextro stereoisomer of the amino acids which is significant as amino 
acids are normal L or levo steroisomers. In 1996, the first documented 
infection caused by S. aureus with reduced susceptibilit]/ to vancomycin 
(vancomycin - intermediate Staphylococi us aureus (VISA) was reported 
in Japan (Hiramatsu et al., 1997). Walsh et al., 2002 has reported about 
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20 cases of VISA infection from sev ;ral countries. Furthermore, 2 
isolates of fully ancomycin-resistant Staphylococcus aureus were 
documented in the United States during 2002 (CDCP, 2002). To date, the 
resistance to vancomycin has not been reported from India (Salaria et al., 
2001; Arakere et al, 2005; Shittu et al, 2006; and Dar et al, 2006). 
Teicoplanin is a newer antibiotic chemically related to vancomycin. 
Liu et al 1996 have used teicoplanin and vancomycin in a randomized 
trial and have seen that treatment was successfiil in 17 (85%) of 20 
patients who were randomized to teicoplanin group and in 15 (75%) of 20 
patients randomized to vancomycin group. In addition nephrotoxicity was 
significantly higher with vancomycin. It has been also suggested that 
teicoplanin, given by inframuscular route, has a longer half life and can 
be given in once daily dosage (Glupcznski et al, 1986). However, there is 
no report about use of this drug in India (Salana et al, 2001). 
2.10. Typing oi Staphylococcus aureus'. Strain typing is an integral part 
of epidemiological investigations of no: ocomial infections. All typing 
system can be characterized in terms of typoability, reproducibility, 
discriminatory power, ease of performance, and ease of interpretation 
(Arbeit, 1995). 
2.10.1. Phenotypic Methods: 
Phenotypic methods are those that characterize the products of 
gene expression in order to differentipte sfrains. Prcperties such as 
biochemical profiles, bacteriophage type;, ancigcns present on the cell's 
surface and antimicrobial susceptibility proxiles etc. are examples of 
phenotypic properties that can be determined in the laboratory. Because 
they involve gene expression, these properties all have a tendency to 
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vary, based on changes in growth conditions, groAvth phase, and 
spontaneous mutation. 
2.10.1.1. Antimicrobial Susceptibility: Antimicrobial susceptibiHty has 
relatively poor discriminatory power because antimicrobial resistance is 
under tremendous selective pressur*; hi healthcare institutions 
(Tenover et. al, 1996) and often is associated with mobile 
genetic element (e.g. transposons and pla.imids) (Davies, 1994). Changes 
in antibiograms also may reflect spontaneous point mutation, such as seen 
in fluoroquinolones (Nakamura et al, 1989). Thus, isolates that are 
indistinguishable may manifest different antimicrobial susceptibilities due 
to acquisition of new genetic material over the time 
(Locksley et al, 1982) or the loss of plasmid (xVIickelsen et al, 1985). 
Conversely unrelated isolates may have indistinguishable resistance 
profiles, which may represent acquisition 3f the same plasmid by multiple 
species (a "plasmid outbreak"). 
2.10.1.2. Serotyping: Serotyping, a nonmolecular method, uses a series 
of antibodies to detect different antigenic: dett;mriinants on the surface of 
the bacterial cell. Serotyping is one of the classic strain t}/ping techniques 
that have been used over the years for epidemiological studies (Oeding, 
1978). 
2.10.1.3. Bacteriophage typing: The sti dy of bacteriophage typing was 
first made by an English bacteriologist. The phage typing of S. aureus 
became possible when Fisk (1942a, b) found a readily available source of 
phages with a narrow spectrum of activity on different strains of this 
species. The present phage typing system is a direct descendent of that of 
Wilson and Atkinson (1945) as modified ny Williams and Rippon (1952). 
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These workers showed that staphylococc' could be characterized by lysis 
using a single phage, but many differ ;nt patterns of lysis could be 
obtained with a set of phages. The difference between these patterns 
could be used to make fine distinction between Staphylopcoccus aureus 
strains. However the patterns given by strains of common origin were not 
always same. It was therefore necessar) to record the strength of the 
reactions and to take account of the known range of variability in 
interpreting the result. Phage typing pattom is expressed as a list of the 
phages by which staphylococci are lysed strongly, eg. 3c/55/71 or 80/81. 
Phage typing with stronger phages is n )t as reproducible as typing at 
routine test dilution (RTD). The strength- of phage for secondary typing 
should be RTD x 100 as it results in sliglit reduction in the percentage of 
typeable culture but increased accuracy. 
A basic set of typing phages w-is established by international 
agreement in 1953 and has since undergone several modifications 
(Report 1959, 1963, 1967, 1971, 1975). k number of new phages were 
introduced, either to characterize the pre-existent strains (e.g. phage 71) 
or due to a general fall in the typea')ilty rate which indicated the 
appearance of new strains either in hospitals or in the general populations 
(eg. phage 80, 81, 83A, 84, 94, 95 and 96). Tlie sub committee, on phage 
typing of staphylococcus, of the International Committee on 
nomenclature of bacteria has recommended methods to be used for 
propagating the phages, testing of phage liltrates and typing the strains of 
Staphyloccous aureus. The Staphyloi occal Reference Laboratory, 
Colinade, London, acts as the international center for staphylococcal 
phage typing. The International center issues to each national laboratory. 
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once every four years, a fresh basic set of freeze-dried phage 
preparations, together with corresponding propagating strains (PS). Each 
time the phages are propagated, they musi be tested by a standard 
procedure before being used in routine typing. 
Currently, the basic set for phage typing consists of 23 phages 
(Report, 1975). Typing phages are subdi\ided into small numbers of lytic 
groups, members of which appeared together in typing patterns, and 
divided staphylococci into corresponding phage groups (Williams and 
Rippon, 1952). Three main phage groups could be recognized and were 
subsequently numbered I, II and III. Strains lysed by phage 42D are 
rarely of human origin and form part of phage group IV. Phages 94 and 
96; and certan other phages not included in the basic set, belong to quite 
distinct lytic group for which the nimbcr V has been proposed 
(Asheshov et al, 1977). Phages 81, 94, i 5 and 96 cannot be allocated to 
any of the lytic groups. 
Group I 29, 52, 52A, 79, 80 
Group II 3A, 3C, 55, and 71 
Group III 6, 42E, 47, 53,.' 4, 75, 77, 83A, 84, 85 
Not allocated 81,94,95,96 
The commonest phage group repo? ted m different studies in India 
is group III (Dutta et al, 1976). The lim taticns of bacteriophage typing 
of S. aureus has clearly been recognized for nany years in the past 
(Mulligan et al, 1988, Khalifa et al, 1989; Blumberg et al, 1992; 
Zierdf e/ al, 1992; and Schlichting et al, 1993). 
Many laboratories over the world are concerned with the problems 
of nontypeable strains particularly whei these are resistant to many 
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antibiotics. In India, the incidence of unt ypeability remains high. At the 
National Typing Center Maulana Azad Mediciil College, New Delhi, 
during 1981-82, 53.4% of strains remained untypeable with the basic set 
of phages. To combat the problem of untypeability some methods were 
proposed. 
Heat shock treatment: Dowsett et al, (1984) proposed heat shock 
treatment. In this method imtypable strains were subjected to heat shock 
at 56°C for 3 minutes prior to application of basic set of phages. This 
method could type 27.35% of untypeable strains. 
Reverse phage typing: Danceret et al., (1988) oroposeil this method. It 
was carried out by inducing lysates of the sti^ ains by treatment with 
mitomycin C and inoculating these lysates on lawns of propagating 
strains and on indicator strains 1030, W57 and 18042. Patterns were read 
as those strains on which induced lysate; produced any degree of lysis. 
By this method 90.82% of untypeable str£ ins could be typed. 
Supplementary phages for MRSA: (Ru hardson et al., 1988): A large 
number of phages have been isolated either by Fisk's technique, to isolate 
new phages by cross culture method or by growing one of the original 
phages in the presence of a new strain of S. aureus and obtaining its 
variant. These new isolates and their utility in typing a significant number 
of strains as compared to phages of basic set led to many changes in the 
international set. Newly isolated phages must be stable in their 
characteristics and should be readily propagated at least 10,000 routine 
test dose and their use depends mainly on then typing potentialities. 
Richardson and coworkers isolated phages for MRSA strains from 
different places and evaluated this phage set as an aid to recognition of 
isolates of Thames EMRSA. In all, 577 i^ o^lates of MRSA were included 
35 
Review ofUterature 
in the study. Phage carried by all isolations from one country was spotted 
on to all isolates from that country; 19 phages were propagated to a 
sufficiently high titre (616-634). After iiispecting the lyric spectrum and 
taking into consideration case of propagation and stability, the phage set 
was reduced to 9 phages namely 616, 617, 618, 620, 622, 625, 626, 629 
and 630. These phages were found t) be a useftil adjunct to the 
international set for typing of MRSA. These supplementary phages were 
used by JE Coia, 1990, with increased typeabiliiy. Despite the problems 
of untypeability, phage typing still remains a cost effective method for 
epidemiological studies particularly on a large scale. 
2.10.2. Molecular typing: 
Genotyping methods are those that are based on an analysis of 
the genetic structure of an organism including polymorphism in DNA 
restriction patterns based on cleavage o? the chromosome by enzymes 
that cleave the DNA into hundreds of fragments or into 10 to 30 
fragments. Genotyping methods are less '/ulnerable to natural variations, 
although they can be affected by inserti» tn or deletion of DNA into the 
chromosome, the gain or loss of extra chromosomal DNA, or random 
mutations that may create or eliminate restriction endonuclease sites. 
Although not all molecular techniques art^  equally effective for typing all 
organisms, they can be characterized in terms of typeability, 
reproducibility, discriminatory power, ease of performance and 
ease of interpretation. Outbreak investigation o\^S. aureus are viewed as 
short-term events or as cases of local epidemics, and in these settings 
mainly genotypic methods are able to distinguish clonal spread from 
related isolates. In addition to tracking outbreaks, genotyping is used to 
36 
Review ofUterature 
distinguish between contaminating and infecting isolates and between 
separate episodes of infection and relapse of diseiise (Gouby et al., 1994). 
Over the last few years, se\ eral molecular techniques have 
emerged as the methods of choice for t>ping bacterial isolates, namely 
restriction endonuclease analysis (REA) ol plasmid DNA; REA of 
chromosomal DNA using frequent cutting enzymes and conventional 
electrophoresis; restriction fragment-lengfh polymorphism (RELP typing) 
analysis using DNA probes; pulsed-field gel electrophoresis (PFGE) and 
arbitrarily primed PCR (AP-PCR) and other related nucleic acid 
amplification based typing methods. 
2.10.2.1. REA of Plasmid DNA: Some strains of bacteria contain only 
a single large plasmid, often in the size range of 100 to 150 kilo bases 
(kb). Because it is difficult to differentiate plasmids in this size range, 
especially those that vary by only 10 kb tc 15 kb, some investigators have 
added a restriction endonuclease digest on step to try to increase the 
discriminatory power of agarose gel elecl-ophtresis (Pfaller et al., 1991). 
While this can be helpfiil, in large 3lasmics this produces many 
restriction fragments, which can make irterpietation difficult, especially 
when multiple large plasmids are present. 
2.10.2.2. Gel Electrophoresis Techniques for Analysis of 
Chromosomal DNA: There are two methods of typing organisms based 
on fragment patterns produced by cleaving cliromosomal DNA with 
restriction endonucleases. The first riethod, often referred to as 
conventional electrophoresis, uses a re itriction enzyme that cuts the 
chromosome into hundreds of pieces frequent cutter), followed by 
standard agarose gel electrophoresis. Lar ^ er fragment coalesce at the top 
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of the gel or do not migrate into the gel. 'Tie second method, PFGE, uses 
enzymes that cut chromosomal DNA inlrequently, generating 10 to 30 
bands, followed by a novel form of electrophoresis that can separate 
fragments from 1 kb up to 1,000 kb (1 mega biise). 
2.10.2.3. Pulsed-field gel electrophoresis (PFGE): Pulsed-field gel 
electrophoresis was first described in 1984 as a tool for examining the 
chromosomal DNA of eukaryotic orgaiism (Schwartz et ah, 1984). 
Subsequently, PFGE has proven to be a highl} effective molecular typing 
technique for many different bacterial species (Arbeit et al., 1995; 
Swaminathan et al, 1993; and Maslow et al, 1993). In this method, the 
bacterial genome, which typically is 2,000 to .i,000 kb in size, is digested 
with a restriction fragments ranging from 10 to 800 kb. Essentially all of 
these fragments can be resolved as a pa;tem of distinct bands by PFGE, 
using a specially designed chamber that \ osition the agaiose gel between 
there sets of electrodes that form a hexi^ gon around thti gel. Instead of 
applying an electric current to the gel in a single direction, as is done in 
conventional elecfrophoresis, in PFGE, the current is applied first in one 
direction from one set of electrodes, then shifts to the second set of 
electrodes for a short period of time (a p ilse), and then that shifts to the 
third set of electrodes. Thus, the electri.; fie-d that causes the DNA to 
migrate in the gel is provided in pulses hat alternate from three sets of 
electrodes. This causes the DNA to w ggk tlirough the gel and the 
back-and forth movement results in .he higher level of fragment 
resolution seen with the technique. In genera'', PFGE is one of the most 
reproducible and highly discriminatory typing techniques available and is 
currently the typing method of choice for many species. The major 
difficulties associated with PFGE are rehted 1o the technical demands of 
38 
Rfvkw ofUterature 
the procedure and initial cost of the eqi'ipmcnt. Preparation of suitable 
genomic DNA requires 1 to 3 days depending on the organism tested, and 
the equipment required (including the electrophoresis apparatus and 
transilluminator). 
2.10.2.4. Typing Methods Using PCR: Polymerase chain reaction has 
been used for several years for the direct detection oi' many types of 
infectious agents in clinical sample (Persing, 1993), has been adjusted for 
use as a typing tool (Welsh et al, 1990; Williams et ah, 1990 and Van 
Belkum, 1994). The hallmark of PCR is the ability to produce literally 
millions of copies of a particular DNA segment with high fidelity within 
3 to 4 hours time. The procedure requires template DNA which may be 
present in the sample in minute quantities; two oligonucleotide primers, 
which flank the sequences on the temple DNA to be amplified (thus 
defending the starting points for DNA polymers Eictivity); and a 
heat-stable DNA polymerase. Efficient amplification is accomplished 
readily for templates of less than 2,000 base pairs, although templates as 
large as 35 kb now can be amplified by using newer polymerases. A 
typical PCR assay requires double-stra.ided DNA melted into single 
strands; an annealing phase, in which -he ])riiners bind to the target 
sequences on the single strands and an extension phase in which DNA 
synthesis proceeds fi-om the primers along each strand of the temple 
DNA, thereby generating two new doubli.--stranded copies of the original 
template. After 30 such cycles, a single initial copy of template DNA 
theoretically can be amplified to 1 billion copies. 
2.10.2.5. Arbitrarily Primed PCR: ArMtrarily primed PCR also 
referred to as the randomly amplified polymorphic DNA assay is a 
variation of the PCR technique employing a single short (typically 10 
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base pairs) primer that is not targeted tc amplily any specific bacterial 
DNA sequence (Welsh et al, 1990). Rather, at low annealing 
temperatures, the primer will hybridize a- multiple random chromosomal 
locations and initiate DNA synthesis. If * me c-opy of the primer binds to 
one strand of DNA, and another copy of'he primer binds on the opposite 
strand of DNA but on proximity of the fii st primer, a DNA fragment will 
be synthesized and amplification of tiat fragment Avill occur. The 
resulting PCR products will represent a variety of different-sized DNA 
fragments that are visualized by agaiose gel electrophoresis. 
This approach has remarkable general applicability and has been 
applied to typing eukaryotic species, a: well as many bacterial species 
(Van Balkum et al., 1994). The reproducibility aiid discriminatory power 
of AP-PCR is a subject of active discussic-n and investigation. 
2.10.2.6. PCR-DNA Sequencing: DN^ L sequencing of hypervariable 
gene sequence has shown great promise as a typing tool 
(DuBose et al, 1988 and Dean et al, 1991). While this technique 
currently is not feasible for most laboratories, the availability of less 
expensive DNA sequencing machine may make this technique more 
accessible in the future. 
2.10.2.7. Coagulase restriction fragment length polymorphism 
(COA-RFLP): Molecular typing of staj hylccoixal isolates can provide 
usefiil clonal information of a staph} lococcol outbreak. Numerous 
methods for S. aureus typing have been described such as inter-IS 256 
spacer length polymorphisms, prot{;in A polymorphism 
(Frenay et al, 1994), coagulase gene polymorphisms (Goh et al, 1992) 
ribosome spacer DNA amplicon polymorphism (Kumari et al, 1997), 
ribotyping, restriction enzyme profiles cf plasniid DNA. Among these 
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methods PFGE has been demonstated to have advantages in 
discriminatory power, typeability and rep roducibility and has been taken 
as the "gold standard" for the typing of ;'. aureus even though it is labor 
intensive and time consuming in compare to other metnods. Coagulase 
gene restriction profile analysis, a PCR-based method is easy to perform 
and has high levels of specimen typability and reproducibility, and it has 
been used successfully for the typing of MRSA isolates 
(Hookey ^/^/., 1998). 
Coagulase is produced by all strains of S. aureus 
(Kloos et al., 1986). Its production is thj principal criterion used in the 
clinical microbiology laboratory for the i identification of staphylococcal 
infection in human beings and it is thought to be an important virulence 
factor. The sizes and DNA restriction endonuclcase site polymorphisms 
at the 3' coding region of the coagulase genr. have been utilized in 
PCR-based restriction fragment length pclymorphism (RFLP) analysis of 
S. aureus (Goh et al, 1992; Lawrence et al, 1996; Schwarzkopf 
et al, 1994; and Tenover et al, 1994). 
Shopsin et al (2000), reported tl at coagulase gene repeat region 
nucleotide sequences typing is a useful a Idition to short sequence repeat 
region sequencing typing for analysis < f S. aureus, including MRSA 
strains. Goh et al (1992), Schwaizkopf ei al (1994), 
Hookey et al (1998), Seifert et al (1999). Muehlheir et al (2003), 
Montesions et al (2002), War.g et al (2003), 
Cucarella et al (2004), Scherrer et al (2 )04), S.:herrer et al (2004) and 
Salasia et al (2004) used PCR-RFLI techn que for the typing of 
S. aureus strains using Alul enzyme a id observed distinct coa-RFLP 
patterns. 
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3. MATERIALS AND METHODS 
The present study was conducted in the Department of 
Microbiology, Jawaharlal Nehru Medica; College, A.M.U., Aligarh and 
the Department of Veterinary Public Health, tndian Veterinary Research 
Institute, Izatnagar, Bareilly during June 2003 to March 2006. The study 
aimed for evaluation of phenotypic and genotypic characters of 
Staphylococcus aureus isolates obtaine(^ . from clinical specimens and 
from foods of animal origin. 
3.1. Collection of Samples: 
3.1.1. Clinical Specimens: 
A total of 3514 human clinical S()ecimers including Pus, Urine, 
CSF, Throat swab. Ear swab, Conjuctival swab, Cervical swab. Semen, 
CSF, Aspirated Fluid, Stool and Vomitus were collected from the patients 
admitted in various wards or from outdo Dr patients of Jawaharlal Nehru 
Medical College and hospital, A.M.U., Aligarh. A total of two hundred 
thirteen raw milk samples were collected as animal origin clinical 
specimens from Indian Veterinary Research Institute, Izatnagar, Bareilly. 
The samples were collected in sterile containers / swabs according to 
standard techniques (Mackie and McCartney. 2000) for the isolation of 
Staphylococcus aureus. 
3.1.2. Food Samples: 
A total of 1006 food samples v s^re collected according to the 
methods described by Agarwal et al. (>003). The details of the food 
samples are provided below: 
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3.1.2.1. Milk products: About 2 gm each of Khoa (Milk concentrate 
used for the preparation of sweets), Paneer (cottage cheese), Chamcham 
and Sweets were collected with aseptic precautions in sterile glass 
containers. 
3.1.2.2. Raw meat: Meat sample used in this study were collected 
aseptically and quickly transported to laboratory under chilled conditions. 
3.1.2.3. Cooked meat Products: About 2 gm each of Kabab (a meat 
cutlet) and Salami were collected in the sterile polybags aseptically. 
3.2. Laboratory procedures: 
3.2.1. Direct Microscopic examination: Smears were prepared from all 
the clinical samples on clean sterile glass slides for Gram's staining. The 
smears were allowed to dry and then fixt d by passing through flame and 
stained by Gram's technique. The sm-ars were examined under oil 
immersion to look for Gram positive cocc i in dusters. 
3.2.2. Processing of food samples: 
(a) Processing of milk products: The samples were homogenized at 
room temperature in 10 ml of NS in sterile beakers. The homogenization 
was done by electrically operated food homogenizer and then used for 
bacterial isolation. 
(b) Processing of raw meat samples: 1 he surface of the collected meat 
samples were trimmed off with sterile scissors and forceps. From each 
sample, a small portion was taken and cut mto small pieces and then 
ground in 10 ml NS by electrically operated food homogenizer. 
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(c) Processing of cooked meat products: ITie collected meat products 
were homogenized in 10 ml NS using a homogeiiizer and them subjected 
to culture. 
3.2.3. Bacterial culture: 
All clinical and food samples, were cultured according to standard 
procedure appropriate to the type of specimen. 
Samples were streaked on 5% Sheep blood agar, nutrient agar and 
Baird-Parker agar medium and incubated for 24-72 hours at 37°C. The 
isolates were stocked in agar stabs and stored at 4^ C for further 
characterization. 
3.3. Phenotypic tests for identification / characterization: 
Staphylococci were identified as per standard methods 
(Mackie and McCartney, 2000). 
3.3.1. Colony Morphology: On nutrient agar and sheep blood agar: 
The circular, smooth, 1-3 mm, low convex, glistening and opaque 
colonies, which were easily emulsifiable. butjrous in consistency golden 
yellow/creamy colour, surrounded by zor e of p-hemolysis on blood agar 
were identified as the colonies of S. aureus. On Baird-Parker medium 
distinct black colored colonies were found. 
3.3.2. Microscopic Morphology: Smears were prepared from the 
colonies for Gram's staining to look for the characteristic morphology of 
Staphylococci. 
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3.3.3. Other tests: 
The Staphylococcal isolates weie further characterized on the 
basis of: 
3.3.3.1. Enzymatic Tests: 
3.3.3.1.1. Catalase Test: 
Requirement: 3% (VA/^ ) Hydrogen peroxi ie. 
Method: A drop of H2O2 was placed on h clean glass slide. Using a clean 
glass rod, small amount of colony to i)e tested was picked up from 
nutrient agar plate and immersed into H2O2 drop. Production of gas 
bubbles immediately indicates positive reaction. 
Controls: 
Catalase positive control: S. aureus oxford strain number 6571. 
Catalase negative control: Streptococcus s]3ecies 
3.3.3.1.2. Coagulase Test: 
Requirements: 
Rabbit plasma 
Normal Saline (0.85%) or Nutrient broth 
Controls: 
Coagulase- positive strain (S. aureis oxford strain number 6571). 
Coagulase- negative Staphylococci {S. epidermidis) 
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a. Slide coagulase test: (William and Harper, 1946): To detect 'bound 
coagulase' (Clumping factor): 
Method: A drop of physiological saline solution was placed on a clean 
glass slide and with minimum spreading one or two colonies of culture 
under test was emulsified in it. A conxol suspension from a known 
coagulase-positive and negative culture was also made to confirm the 
reactivity of the plasma. With inoculating wire, a drop of plasma was 
added at room temperature and mixed gently The wire was flamed and 
the procedure was repeated for control suspensions. The appearance of 
coarse clumps visible to the naked eye within 10 seconds indicates 
positive reaction. The absence of clumpiig or any reaction taking more 
than 10 seconds to develop was considere 1 as aegative. 
b. Tube Coagulase Test (Modified fr«»m Gillespie 1943): To detect 
'free coagulase': 
Method: 
A 1:10 dilution of rabbit plasma was prepared in saline (0.85% 
NaCl) solution. 0.5ml of the diluted plasna v^ as placed ;n a small sterile 
tube. Few colonies of Staphylococci ande^ test were emulsified in 
nutrient broth to give a dense suspension. Subsequently 0.1 ml of this 
suspension (about 10^  cocci) was add(d to the diluted plasma tube. 
Similarly control test with kno,vn coagulase-positive and 
coagulase-negative cultures were set up. A tube of unseeded diluted 
plasma was also included to confirm that it does not coagulate 
spontaneously. The tubes were incubMed at 37°C in a water-bath 
and examined for clot formation by tilting the :ube through 90° at 1, 2 and 
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4 hrs. and again if still negative, afttr standing overnight at room 
temperature. 
Test was read positive when the plasma had been converted into a 
stiff gel when the tube was tilted or inverted. Test in which the plasma 
remained wholly liquid or showed only a flocculent or ropy precipitate or 
free flowing was read as negative. 
3.3.3.1.3. DNAse Test (Lachica et al, 1971): 
Requirements: DNA agar (Oxoid DNAse Agar) with 0.1 yo toluidine blue 
obtained from Hi Media. 
Method: 
Petriplates were prepared by pouring toluidine blue DNA agar. 
After solidification, 2 mm diameter wells (10-12 wells per plate) were 
made and agar plugs were removed by aspiration, 0.01 ml each heated 
sample (15 min. in boiling water bath) (f BHI broth culture was added 
into wells on prepared plates, and incubated at 35°C. Positive reaction 
was the formation of a bright pink halo extending at least 1 mm from the 
periphery of well. The results were note.! after 4 hrs. of incubation and 
observed up to 18 hrs. 
3.3.3.1.4. Phosphatase Test: 
Requirements: Phenolphthalein diphosphate agar (Hi Media), liquor 
ammonia solution (SG 0.88). 
Method: Test strain was streaked on the phenolphthalein diphosphate 
agar (PPA) plates and incubated for 18-20 hours at 37°C. After 
incubation 01-02 ml ammonia solution was placed in the lid of petridish 
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and culture plate was inverted above it. Bright pink colonies were 
considered as positive. The test was performed using the method of 
Agarwale/^/., 2003. 
3.3.3.1.5. P- Lactamase Production: 
All the isolates of Staphylococ :tis aureus w ere tested for 
P-lactamase production using iodometric -nethod. 
lodometric Method 
Penicillinase hydrolyses penicillin to penicilloic acid, which reduce 
iodine and reverse the formation of the blue colour when latter complexes 
with starch. The presence of penicillinase in a test system is shown by 
decolorization of Starch-iodine complex The test was performed using 
the method of Sykes (1978). 
Requirements: 
Starch solution: 1% soluble starch :iolution was prepared by 
dissolving starch at 100*^ 0. 
Iodine Reagent: 
Iodine 2.03gm 
Potassium Iodine 5.32gni 
Distilled Water 100ml 
Method: 
A heavy suspension (about 10^  colony units / ml) was prepared 
in wells of a microtitre plate from an overnight culture of test organism in 
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0.1 ml solution of benzylpencillin (6 m^/ ml in 0.1 mol/liter phosphate 
buffer, pH 7.3). The control tests with pe liciDinase negative and positive 
cultures v e^re also set up. The microtitre plate was incubated for one hour 
at 37°C, and then two drops of freshly prepared 1% solution of soluble 
starch was added to each well. In positive test, the blue colour was lost 
rapidly (within 10 seconds). In negative test blue colour persisted for at 
least 10 minutes. 
3.3.3.2. Biochemical Tests: 
All the isolates were subjected to va ious biochemical tests: 
a. Production of acid from Sugars: 
Each isolate was tested for production of acid from glucose and 
mannitol (both aerobically and anaerobically) and from trehalose 
(aerobically). 
Method: Carbohydrate test solution were inoculated by test culture from 
nutrient agar plate and incubated ovemigat at 37*^ 0. Reddish pink colour 
of the medium indicates positive reaction, 
b. Hugh and Leifson's O/F test: 
Hugh and Leifson's O/F test was performed to see the ability of test 
strain to produce acid from glucose aerobically and / or anaerobically. 
Method: Using a sterile straight wire test organism was stab inoculated 
throughout the length of sugar tube in duplicate. After inoculation the 
surface of one tube was covered with a 1-2 inch layer of sterile liquid 
paraffin. The tubes were then incubated st 37*^ C for 5 days. Development 
of yellow colour indicated acid producti( m. ^ c^id production in the open 
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tube only indicated oxidative utilization of carbohydrate. Acid production 
both in open (with paraffin) and sealed tube indicated fermentation of 
sugar (1953). 
c. Acetoin Production : Voges-Proskaui r test: 
Requirements: 
Glucose Phosphate Peptone \/atei 
40% Potassium Hydroxide (KOH) 
5% a-naphthol in absolute alcohol 
Method: A large drop of broth culture of the strain under test was 
inoculated into 2 ml glucose phosphate peptone water tube and incubated 
at 30°C for 18-48 hours. 
The presence of acetoin production was detected by Barritt's 
method (1936): 
1 ml of 40% Potassium hydroxide and 3 ml of 5% solution of 
a-naphtol in ethanol was added and shaken vigorousl)' for at least 30 
seconds. Positive reaction was indicated by the development of pink 
colour with in 5-10 minutes, becoming ro ie red colour in 30 minutes. The 
test was performed using the method of Nackie and McCartney, 2000. 
d. Bacitracin Sensitivity: 
Bacitracin sensitivity was done to c ifferentiate bet^ veen Micrococci 
and Staphylococci. S. aureus were resistant to bacitracin. 
Resistance to bacitracin was tested on Mueller-Hinton agar 
medium (Hi Media) with 0.04 units of bacitracin disc (Hi Media). 
Resistance to bacitracin was reported whe i zone of inhibition of growth 
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was found less than 10 mm. 
e. Novobiocin Sensitivity: 
Resistance to Novobiocin distinguishes S. saprophyticus from 
other Staphylococci. Sensitivity to novobiocin was tested on 
Mueller-Hinton agar medium (Hi Media) with paper disc (7mm diameter) 
containing 5 i^g of novobiocin. Sensitiv ty to novobiocin was reported 
when zone of inhibition was >15 mm in d ameter-
3.3.3.3. Antimicrobial drug sensitivitj test: 
(a) Antibiotic sensitivity test was doie by the disc diffusion method 
as proposed by Kirby Bauer (1961). 
Requirements: 
(i) Media: 
Mueller-Hinton Agar (Hi Media) 
Mueller-Hinton agar supplemented with an additional 5% NaCl 
(for Methicillin sensitivity) 
(ii) Antibiotic discs (Hi-Media): C>mmercially available antibiotic 
discs obtained from (Hi Media) were used for antibiotic sensitivity 
testing. The antibiotics and their contents vvere: 
Antibiotics Abbreviation Disc potency 
Penicillin G P 10 units 
Amikacin 
Amoxycillin 
Ak 
Ac 
30 i^g 
30 ng 
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Chloramphenicol 
Ciprofloxacin 
Co-Trimoxazole 
Cefoclor 
Ceftriaxone 
Cefepime 
Ceftazidime 
Erythromycin 
Tetracycline 
Gentamycin 
Oxacillin 
Vancomycin 
Teicoplanin 
C 
Cf 
Co 
Cj 
Ci 
Cpm 
Ca 
E 
T 
G 
Ox 
Va 
Te 
30 i^g 
- ^g 
25 ^g 
30 ng 
30|ig 
30 i^g 
30 ^g 
30|iig 
30 i^g 
10 ng 
1 unit 
30 i^g 
30 ng 
All antibiotic discs were stored ir, refrigerator. On removal from 
the refrigerator fr)r use, the vials were left at room temperature for about 
an hour to allow the temperature to equilibrate, thus preventing the 
amount of condensation that occurs inurediately after. Before use each 
lot of antibiotic disc was tested with stano ard strain oiS. aureus 6571. 
The results were interpreted according to the standard table 
provided by the supplier. 
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(iii) Standard control Strains: 
Oxford S. aureus 6571 
S. aureus (MRSA) in-house control 
(iv) Test strains (Bacterial inoculum) 
(v) Opacity Standard (0.5 McFarland) 
(vi) Sterile Nontoxic cotton swabs. 
Inoculum: 
Test strains of Staphylococcus aureus and standard oxford 
S. aureus 6571 were isolated on nutrient ngar. 4-5 identical colonies were 
picked up from both strains (standard and test strains) and inoculated in 
5ml of nutrient broth separately and incubated at 37*^ 0 for 4-6 hours. The 
density of the suspension was compared with the opacity standard tube 
i.e. 0.5 McFarland standard. 
Method: 
Drug sensitivity test for all antibiotics \vas carried out on Mueller-
Hinton agar plate (Hi Media). While, foi melhicillin resistance oxacillin 
discs were used on Mueller-Hinton agar s appbmented with 5% NaCl and 
incubated for 18-24 hour at 35°C. 
The test strain was applied on the surface of the Mueller-Hinton 
agar plate using sterile swabs and allowed to dr> for 10 minutes at room 
temperature. The antibiotic discs havii.g the standard strength were 
lightly pressed on the surface of agar so is to ensure firm even contact of 
the disc with the seeded agar. Care was tlso :aken to make sure that the 
placed discs straddle the gap uniformly at both sides and are about 1 cm 
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away from the rim of the plate. The plates were then incubated for 
overnight at 37"C. 
(b) Oxacillin agar screening (6^g/nil) 
Inoculum: 2-5 colonies from overnight growth on a non-selective 
agar medium were suspended in broth or saline to a turbidity that 
matched with 0.5 Mc Farland standard. Tae suspension was diluted 1: 10 
times and was adjusted to 10' cfu/ml. 
Method: Plates were inoculated within 30 minutes after preparation 
of the inoculum since longer delay may lead to changes in inoculum size. 
By using a pipette, 0.001 to 0.002 ml of suspension of 10' cfu/ml was 
delivered to agar surface resulting in the final desired inoculum of 
approximately 10'* to 10^  cfii per spot. After inoculation plates were 
incubated for fiill 24 hrs. at 35^C. 
Interpretation: The presence of more than one colony or a haze of 
growth was considered as resistanct. 
3.3.3.4. Bacteriophage typing: 
Phage typing was done by the standard method described by Blair 
and Williams (1961) at National Staphylococcal Phage Center, 
Department of Microbiology Maulana Azad Medical College, New Delhi. 
For the propagation of the phages, testing- of phage filfrate and typing the 
strains of Staphylococcus aureus isolates the propagating strain was first 
sub cultured onto a blood agar plate. A s ngle colony was picked up and 
the phage pattern was checked using the 23 phages of the basic set at 
routine test dilution (1 RTD) and lOOx RTD. 
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Propagation of the phages: 
The phages were propagated on ther homolog3Us propagating 
strains. The aim of propagation was to orodice a phage suspension of 
adequate dilution. 
Propagation methods: 
(a) Propagation in liquid medium: 
The following phages were propaj ated in liquid medium: 55, 71, 
53, 95 and 96. 
(b) Propagation in soft agar: 
The following phages namely 29, 5 2, 52 A, 79, 80. 3A, 3C, 6, 42E, 
47, 54, 75, 77, 83A, 84, 85, 81, and 91 were propagated in soft agar. 
Determination of RTD: The phage preparation was diluted in ten-fold 
step. One drop of each dilution was then applied to a nutiient agar plate 
spread with the homologues propagating strain. Fhe plaie was incubated 
at 30°C overnight. The RTD (routine isst <iilution) was taken as the 
highest dilution of a phage that gave just 1 ;ss tian conflu(;nt lysis. 
Determination of 100 x RTD: The phage preparation was diluted in 
100-fold steps. One drop of each dilution was then applied to a nutrient 
agar plate spread with the homologues propagating straii. The plate was 
incubated at 30^0 overnight. The lOOx RTD (routine test dilution) was 
taken as the highest dilution of a phage t lat gave just le^ .s than confluent 
lysis. 
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Performance of phage typing: 
The basic set of phages, consistirig of 23 phages was used for 
typing the strains of Staphylococcus aurevs. 
A Single colony of Staphylococcus aureus was inoculated into 5ml 
nutrient broth and incubated at 37° C foi 4 to 6 hours. This culture was 
used to inoculate 4-inch peteridishes containing nutrient agar 
supplemented with 0.04% fused calciun chloride. The plates used for 
typing were freshly made and dried for ^5 minuies. The broth culture of 
the test strain was added on the surface of the plate with a Pasteur pipette 
and the excess broth was pipetted off. These; \\ere then left for drying 
with lids open for one hour at room temperatuie. 
The phages were loaded in a bl )ck iiontaining 27 wells, using 
sterile Pasteur pipettes. Phages were deli e^red from the loading chamber 
to agar plate with the help of mechanical multi-loop/ phage applicator. 
After each application, the prongs of tte applicator were dipped in 
spirit and were sterilized by flaming. After the charged phages had dried, 
the plates were incubated at 30°C for 18 i^rs. The readings were taken on 
the following day. 
Interpretation of the lytic pattern: 
The plates were examined by indii 3ctl> tnmsmitted light against a 
dark background and read semi-quantitati /ely. 
Strains that were non-typeable at ] RTD Avere typed at lOOxRTD. 
Non-typeablity was recorded when tho strains was non-typeable at 
lOOxRTD. 
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The phage patterns were recorded as ft Hows: 
-H-, CL = Confluent lysis (Strong n action) 
+ =Moderate lysis 
± = Weak lysis 
o = inhibition reaction 
NT = Not typeable 
Conventional Phages 
Lytic Group of Phages 
I 
II 
III 
Non - allocated 
Designation of Phages 
29,52,52A,79,80 
3/1, 3C, 55,71 
6, 42E, 47, 53, 54, 75, 77, 
83A, 84, 85 
81,94,95,96 
TYPING OF METHICILLIN-RESISTANT Staphylococcus aureus 
BY MRSA PHAGES 
All methicillin resistant staphylococcal stains were phage typed 
using 9 supplementary MRSA phages. 
The 9 phages used were: 
M3, M5, M12, M8, MR25, 622, C30, C3), C38 
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3.4. Tests for genotypic charactenzation: 
Genotypic characterization was done using polymerase chain 
reaction for thermostable nuclease gene, coagulase gene, enterotoxin 
genes and methicillin gene. 
3.4.1. Polymerase Chain Reaction (PCR): 
Standardization of PCR: 
Standardization of Polymerase CI ain Reaction (PCR) was done 
using the standard strains of S. aureus obtained from IVRI, Izatnagar. 
3.4.1.1. Template DNA Preparation / Extraction: 
Various methods of cell lysis and release / extraction of DNA as 
described below were compared for their use in PCR assay. 
3.4.1.1.1. Genomic DNA Extraction: 
By Phenol Chloroform Extraction: 
All isolates under study were cu'tured in Tryptone Soya Broth 
(TSB, oxide Ltd. England) at 37°C for 18h. Bacteria were pelleted @ 
8000 rpm for 10 mins. Pellet was resuspended in 2ml TE buffer. 40 ^1 of 
lysozyme (50 mg / ml) was added, vortexed to mix properly and 
incubated at 37°C for Ih. Then 400 i^l SDS (10%) and 30 ml Proteinase-
K (20mg / ml) was added and incubated i-t 37'^ C for 2h. After incubation, 
800 i^l of NaCl (5M) and 800 i^l CTAB ;iO%, Preheated at 65°C), were 
added and incubated in water bath at 65'C for 30 minutes. The aqueous 
phase was extracted with equal amount of Phenol + Chloroform (1:1). 
The phenol-chloroform extraction step v/as repeated as to the extracted 
aqueous phase, 0.6 volume of isopropanol and 0.1 volume of 3M sodium 
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acetate (pH 5.2) were added. The components were mixed properly, and 
kept at -20°C for 8-1 Oh. Centrifugation a( 20,000 rpm for 10 minute was 
performed to collect DNA pellet. The pe let v^ as washed twice with 70% 
ethanol and air-dried. Finally the pellet w as dissolved the pellet in 400 |il 
of TE buffer containing 20 )xg RNase / ril (MBl Fermentas) and kept at 
65 °C for 1 hr. Subsequently cooled and siored at -20°C till further use. 
3.4.1.1.2. By Using Bacterial Cell Lysate: 
(a) By Triton X-100: 
As per the method described by Wang et. al, (1992), cells were 
pelleted and suspended in 50 -100 i^l ol 1% Triton X-IOO. It was then 
heated in a boiling water bath for 5 minut';s and snaps chilled. 
(b) By SDS: 
The bacterial cells were pelleted and suspended in about 20 |il of 
0.05% SDS and heated in a boiling water bath for 5 minutes and snap 
chilled. 
(c) By Sonication: 
About 100-200 ,^1 of BHI broth culture was subjected to sonication 
and was used in PCR. 
(d) By Boiling and Chilling: 
In this method about 0.5-1.0 ml of BHI broth culture was subjected 
to vigorous heating in a boiling water bath for 10 minutes and then snap 
chilled. From this about 5 ^ 1 was used as a template in PC'R. 
For standardization with DNA exti action, initially all the methods 
described above were applied on the itandard strains. As all these 
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methods showed comparable results, ve jubsequently followed the 
boiling and chilling method for the DNA extraction from the test strains. 
3.4.2. Specificity of the PCR: 
About 0.5|il of overnight BHI cultures was subjected to heating in 
a boiling water bath and then snap chilled in ice. Fhe PCR was performed 
as described below and agarose gel electri (phoresis as described in section 
3.5, and observed for any product generated from other bacteria. 
3.4.3. PCR amplification of thermostab e nuclease gene (Nuc): 
PCR amplification was performed by ising tlie primers as used by 
Brakstad et al, (1992) with slight modifications. The thermostable 
nuclease gene (nuc) was amplified b}' standard PCR protocol. The 
template was prepared as described in 5.4.1.1.2 (d). Sequences of the 
primers used were 
nucl- G C G A T T G A T G G T G A T A C G G T T 
n u c 2 - A G C C A A G C C T T G A C C A A C T A A A G C 
Size of the amplified product - 447 bp 
Reactions were carried out on 50|xl as follows. 
DNA 
lOx PCR buffer 
MgCl2 (1.5mM) 
dNTP's (2mM) 
Primers (10 pmol/ |il) 
Taq DNA polymerase - (•. 
{\\xJ\i\ Labware, USA) 
Milli Q water to make volume 50 ^ 1 
5|il 
5^1 
1.5^1 
5 III 
Nl-2.0^1 
N2- 2.0 \i\ 
4^1 
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The PCR tube containing the read on mixture was flash spun in a 
micro centrifuge to get the reactants at the bottom. The reactions were 
performed in a master cycler Gradient thermocycler (Eppendrof, 
Germany) with a preheated lid. 
The PCR programme included der aturaticn at 94' C for 5 minutes 
followed by 34 cycles of denaturation 94°(' for 1 minute), annealing 
(55°C for 1 minute) and extension (72°C; for 1 minute). Final extension 
was carried out at 72°C for 10 minutes After the reaction, tubes with 
PCR products were held at 4°C until fiither analysis / confirmation by 
agarose gel electrophoresis (1.5% a};arose) described as in 3.5. 
gene Ruler 100 bp DNA ladder was us( d as molecular weight marker. 
3.4.4. PCR and nested PCR amplificatiun ol coagulase gene {cod): 
PCR and nested PCR were ptrfonned for amplification of 
coagulase gene. 
3.4.4.1. PCR ampUncation of coagulase gene {cod)'. 
By using the primers Goh et al, (1992) with sHght modification 
the coagulase gene {cod) was amplified by standard PCR protocol. 
Template was prepared as described in 3.4.1.1.2 (d). Sequences of the 
primers used were 
Coa 1- A T A C T C A A C C G A C G G A ' : A C C G 
Coa 2- GATTTTGGATGAAGCGGATT 
Reactions were carried out on 50 |iI as follows 
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DNA 
lOxPCR buffer 
MgCl2 (1.5mM) 
dNTP's (2mM) 
Primers (10 pmol /|il) 
Taq DNA polymerase 
4^1 
5^ 1 
1.5 \i\ 
5\A 
COH 1 - 2.00 ^il 
cca 2-2.00^1 
0.<^1 
(lunit / reaction, Lab ware, USA) 
Milli Q water to make volume 50 |j I. 
The PCR tube containing the reaction mixture was flash spun in a 
micro centrifuge to get the reactants at the bottom. The reactions were 
performed in a master cycler Gradient thermocycier (Eppendrof, 
Germany) with a preheated lid. 
The PCR programme included der.aturaticn at 94"C for 5 minutes 
followed by 34 cycles of denaturation (H °C for 1 minute), annealing 
(56 °C for 1 minute) and extension (72°( for 1 minute). Final extension 
was carried out at 72 "C for 10 minutes. Afler the reaction, tubes with 
PCR products were held at 4°C until father analysis / confirmation by 
agarosegel electrophoresis (2% agarose) oescribed as in section 3.5. Gene 
Ruler '^^  100 bp DNA ladder plus was use i as molecular weight marker. 
3.4.4.2. Nested PCR amplificatioii of coaguliise gene {cod)'. 
Nested PCR was standardizec as pe: methcd described by 
Goh et al. (1992) with slight modificati ms. All isolates were tested in 
duplicates. Depending on the intensity of the primary amplicon generated 
by primer set no. 1, 2 microlitre of undiluted to 1:10 diluted primary 
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amplicon was taken for nested PCR. Th2 internal primer set no. 2 was 
used to generate nested PCR products. Sequences of the primers used 
were 
coa N - 1 CGAGACC AAGA' TC^ VAC AAG 
coa N - 2 AAAGAAAACCAc :TCAC ATCA 
Reactions were carried out on 50 |ii as follows. 
Size of the amplified products - Ranged between 440 bp to 915 bp 
1st PCR product 
lOx PCR buffer 
MgCl2(1.5mM) 
dNTP's (2mM) 
Primers (10 pmol / )j,l) 
Taq DNA polymerase 
2.0|i.l 
5^ 1 
1.5 i^l 
5^ 1 
coa 1-2.0|J1 
coa 2- 2.0^1 
0.4 |xl 
(lu/ nl. Lab ware, USA) 
Milli Q water to make volume 50 \y i. 
The PCR tube containing the reaction mixture was flash spun in a micro 
centrifuge to get the reactants at the b< -ttoni. In this study the previous 
PCR product used as template. The reactions were perfoimed in a master 
cycler Gradient thermocycler (Eppendrof. Germany) with a preheated lid. 
The PCR program and other procedures were same as described 
earlier for the first amplification of coa g{ ne. 
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3.4.4.3. PCR restriction analysis: 
Restriction enzyme digestion: 
For the confirmation of the PCR product generated by primer 
set no. 1, restriction digestion with Alu 1 was done. To about 10|al of 
nested PCR product, 6 unit (0.6 |j,l) of Alu 1 was added (Bangalore, 
Genie) with 2\i\ of lOx buffer and the vo ume was made up to 20 ^1 with 
autoclaved miUi Q water and incubated a1 37°c for overnight. The enzyme 
activity was stopped by adding 4}il of 6x loaclin[5 dye. Then the digested 
product was subjected to agarose gel el<;ctrophoresis (2% agarose) and 
observed for the products of desired molecular Nv^ eight. All isolates were 
again tested in duplicate. 
3.4.5. PCR amplification of enterotoxin gene (SEA, SEB and SEC): 
A total of 202 isolates (102 human clinicl isolatiis and 1 DO animal-origin 
isolates) were tested for production of enterotoxin A, enterotoxin B and 
enterotoxin C. PCR amplification for en erotoxin genes were performed 
by using the methods described by John on et al. {\99\) (for SEA and 
SEB) while the method of Chen et al (20)0) was used for SEC with 
slight modification. Templates were prepared as described in 3.4.1.1.2 
(d). Sequences of the primers used were 
For SEA SEA - 1 TTGGAAACGC JTTyvA.\ACG/^ 
SEA - 2 GAACCTTCCC ATCA.\AAACA 
Size of the amplified product - 120 bp 
For SEB SEB - 1 TCGCATC/ AACTGACA^ ACG 
SEB - 2 GCAGGTAC T C T A : A A G T G C C 
Size of the amplified product - '^ 78 bp 
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For SEC SEC-1 ACATTAGTGATAAAAA.\CTGAAA 
SEC - 2 TTGTAAGlTCCCATTATCAAAGTG 
Size of the amplified product - 2'.A bp 
Reactions were carried out on 50|j,l as follows 
DNA 
lOxPCR buffer 
MgClzCl.SmM) 
dNTP'S(2mM) 
Primers (10 pmol / 
-
-
-
-
'\i\) -
Taq DNA polymerase 
4^1) 
5^ 
1.5^ 1 
5nl 
forward - 2.0 ^1 
reversed -2.0 \i\ 
0.41^ 1 
(lu / ^1, Labware, USA) 
Milli Q water to make volume 50 pi. 
The PCR tube containing the reaction mixture was flash spun on a 
micro centrifuge to get the reactants at the bottom. The reactions were 
performed in a master cych;r Gradient thermocycler 
(Eppendrof, Germany) with a preheated lid. 
The PCR programme included deraturaticn at 94'C for 5 minutes 
followed by 34 cycles of denaturation (9 i °C for 30 seconds), annealing 
(55 °C for 30 seconds) and extension (72"C for 20 seconds). Final 
extension was carried out at 72°C for 10 minutes. The PCR products were 
characterized by gel electrophoresis on 2.5^0 agarose gel (Q. Biogene, 
USA) as described in 3.5. 
Gene Ruler™ 100 bp DNA ladder was m ed as molecular weight marker. 
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3.4.6. PCR amplification of methicillii> resistance gene (mecA): 
By using the primers as used by I rasaJ et al. (2000), with sHght 
modification, the methiciUin resistant gene {mec A) was amplified by the 
standard PCR protocol. Template was prepared as described in 
3.4,1.1.2 (d). Sequences of the primers used were 
mecA l - A G T T G T A G T T ( r T C G G G T T T G 
mec A 2 - A G T G G A A C G A A G G T A T C A T C 
Size of the amplified product - 604 bp 
Reactions were carried out on 50 |x as f jllows. 
DNA - lOul 
lOx PCR buffer - 5^1 
MgCl2 (1.5mM) - 1.5^1 
dNTP's (2mM) - 5^1 
Primers (20 pmol / i^l) - mec Al - 2.0^1 
mec A2 - 2.0^1 
Taq DNA polymerase - 0.4|iJ 
(1 unit/reaction. Lab ware, USA) 
Milli Q water to make volume 50 p I. 
The PCR tube containing the read on mixture wa? flash spun in a 
micro centrifuge to get the reactants at he bottom. The reactions were 
performed in a master cycl;r Gradient thermocycler 
(Eppendrof, Germany) with a preheated li 1. 
The PCR programme includes denatu atioii at 94°C for 5 minutes 
followed by 34 cycles of denaturation {9AXl for 1 minute), annealing 
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(54°C for 1.5 minutes) and extension (72'C fo;" 1 minute). Final extension 
was carried out at 72°C for 10 minutes. After the reaction, tubes with 
PCR products were held at 4°C until fu ther analysis / confirmation by 
agarose gel electrophoresis (2% agirose) described as in 3.5. 
Gene Ruler^^ 100 bp DNA ladder was us.;d as molecular weight marker. 
3.5. Agarose gel electrophoresis: 
Agarose gel was prepared by boiling molecular biology grade 
agarose (Bangalore, Genie) in 0.5-x TBE buffer to dissolve it completely. 
After cooling it to about 50°C, ethidium bromide (SRL) was added to the 
agarose solution to a final concentration of 0.5 jig / ml. Before dissolving 
the agarose, the gel-casting platform was placed on a leveled surface and 
the open sites were sealed with adhesive t ipe. Tht; gel comb was then 
placed across the gel-casting platform, so tiiat the teeth of the comb 
remained 1mm above the base of the phtfonn. The molten agarose was 
then poured on to the gel-casting platform and it was kept undisturbed for 
about an hour to solidify the gel. After the gel solidified the comb was 
taken out and adhesive tape was removed The set gel with the gel-casting 
platform was then submerged in the elect ophoresis tank with the wells at 
the cathode end of the tank with sufficien; quantity (about 1 mm level) of 
electrophoresis buffer (TBE, 0.5x) above he surface of the gel. 
About 10 |il of PCR products was )aixed v i^th 2 |il of bromophenol 
blue (6x) loading dye and loaded into the well. Electrophoresis was 
performed at 6 V/cm and the progress ol' mobility was monitored by the 
migration of the dye. At the end of electrophoresis the gel was visualized 
under UV transilluminator / gel docume itation system for the bands of 
desired molecular weight. 
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4. RESULTS 
In the present study out of 3f 14 human clinical specimens 
1417-yielded bacterial growth and of which 409 were S. aureus. Of these 
409 S. aureus isolates, 102 were randomly selected for further study. 
Similarly, 1219 samples of animal-origin, including 213 milk samples 
as animal clinical specimens and 1006 food samples were cultured and 
918-yielded bacterial growth. Of which 401 were S. aureus of which 100 
animal origin food isolates were randomly selected for further study. Out 
of 102 Staphylococcus aureus studied from human clinical specimens, 
38 were fi-om pus samples, 10 from urine samples, 1 from CSF, 2 from 
lA^ catheter tips, 3 from body fluid, 3 from ear swab, 3 from throat swab, 
14 from conjuctival swab, 14 from cervical swab, 7 from stool samples, 6 
from vomitus samples and 1 from semen specimen. Of the 100 isolates of 
S. aureus from animal origin food, 29 were obtained from raw milk 
(clinical isolates of animal origin), 4 froin chamcham (a sweet prepared 
from milk), 3 from other sweets, 9 from khoa (milk concenfrate used in 
sweets), 6 from paneer (cottage cheese), !7 from raw goat meat, 20 from 
raw buffalo meat, 1 from kabab (Meat cutlet) emd 1 from salami sample. 
4.1. Characterization of Staphylococcus aureus: 
Phenotypic characterization: 
All the isolates were phenotypically characterized using 
conventional methods, in direct microscopy examination 89 human 
clinical samples showed Gram-positive c( cci in clusters. 
All isolates from human clinical specin'cns and animal-origin samples 
were found positive for catalase test, DNase test, phosphatase test, tube 
coagulase test and were oxidase negative. Out of 102 human clinical and 
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100 animal-origin samples, 100 (98,03%) £ind 98 (98%) were found 
positive for slide coagulase test respectively; all (100%) strains showed 
fermentation of glucose, mannitol and trehalose. Acetoin production was 
seen in all the human and animal-origin str^ ains. All the 202 (100%) 
strains of clinical and animal-origin isolates were found sensitive to 
novobiocin and resistant to bacitracin. 
4.2. Further characterization of Staphylococcus aureus strains: 
The characterization was mainly based on: 
• Antibiotic susceptibility 
• Bacteriophage typing 
4.2.1. Antibiotic susceptibility testing: 
To detect the susceptibility of \.tap}xylococcns aureus isolates 
against various antibiotics, in vitro antibiotic sensitivity was carried out 
by disc diffusion test according to the msthod of Bauer et a/ (1961). In 
this study 16 commonly used antibiotics, namely, amoxycillin, penicillin, 
cotrimoxazole, chloramphenicol, tetracycline, erythromycin, oxacillin, 
ciprofloxacin, cefaclor, ceftriaxone, ceftazidime, cefepime, gentamicin, 
amikacin, vancomycin and teicoplanin were used (fig-1). 
(i) Antibiotic susceptibility of human cl.nical isolates: 
Antibiotics sensitivity of 102 humrn clinical isolates revealed that 
maximum number of isolates were resistant to penicillin 100 (98.03%) 
followed by cotrimoxazole 71 (69.61%), tetracycline 70 (68.63%), 
amoxycillin 66 (64.7%.), ciprofloxacin 62 (60.79%)), erythromycin 56 
(54.9%), amikacin 35 (35.3%), oxacillin 33 (32.35%), cefaclor 33 
(32.35%), ceftriaxone 33 (32.35%), ceft.izidime 33 (32.35%.), cefepime 
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Fig - 1 Photograph showing antimicrobial sensitivity on 
Meuller-Hinton agar medium 
Results 
33 (32.35%), chloramphenicol 24 (23.53%) and gentamicin 28 (27.45%) 
in descending order (fig- 2) while none of the isolate was found resistant 
to vancomycin and teicoplanin (Table - 1). 
In this study, methicillin resistance was noticed in 33 (32.35%) 
isolates by disc diffusion method and in 32 (31.35%)) by agar screen 
method using 6 |Jg oxacillin while 77 (67.65%) of clinical isolates were 
found methicillin sensitive Staphylococcus aureus. 
o 
o 
.£3 
< 
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Fig- 2. Bar diagram showing antibiotic resistance profile of 
Staphylococcus aureus isolated from different human clinical 
specimens 
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Results 
(ii) Antibiotic susceptibility of animal-origin isolates: 
The isolates from animal-origin samples showed resistance to 
penicillin 93 (93%), erythromycin 51 (51%), tetracycline 49 (49%), 
ciprofloxacin 39 (39%), cotrimoxazole 54 (54%), chloramphenicol 
34 (34%), amikacin 27 (27%), oxacillin (27%), cefaclor 27 (27%), 
ceftriaxone 27 (27%), ceftazidime 27 (27%), cefepime 27 (27%), 
gentamicin 20 (20%) and amoxycillin 19 (19%) in descending order 
(fig- 3). One isolate was found susceptible to all the 16 antibiotics and 
none of the strain was found resistant to vancomycin and teicoplanin 
(Table - 2). 
In this study, methicillin resistance was noticed in 27 {21%) 
isolates by disc diffusion method and in 26 (26%) by agar screen method 
using 6 |Jg oxacillin while 73 (73%) of animal-origin isolates were found 
methicillin sensitive Staphylococcus aureus. 
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Fig- 3. Bar diagram showing antibiotic resistance profile of 
Staphylococcus aureus isolated from different animal-origin samples 
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Results 
(iii) Drug resistance patterns of human clinical isolates: 
The drug resistance patterns of human clinical isolates showed 
resistance to two drugs in 3 (2.94%) isolates, three drugs in 10 (9.8%) 
isolates, four drugs in 18 (17.65%) isolates, five or six drugs in 25 
(24.51%) isolates, seven or eight drugs in 16 (15.67 %) isolates whereas 
resistance to more than ten or more drags was found in 30 (29.47%) 
isolates. None of the isolate was found resistant to a single drug 
(Table - 3). 
Table- 3. Drug resistance patterns of 5'. aureus isolated from human 
clinical specimens 
Resistant to Patterns (n) Total numbe(%) 
Ten or more 
drugs 
Seven or Eight 
drugs 
P Ac Ak E G Cf C Co Ox Cj Ci Ca Cpm(2) 
P Ac Ak E T Cf C Co Ox Cj Ci Ca Cpm(2) 
P Ac Ak E T G Cf Co Ox Z] Ci Ca Cpm(5) 
P AcAkETGCfCOxCjCiCaCpm(l) 
P AcAkETCfCOxCjCiCaCpm(l) 
P AcAkETCfCoOxCjCiCaCpm(2) 
P AcAkTGCfCoOxCjCiCaCpm(2) 
P AcAkETCCoOxCjCiCaCpm(2) 
P AcAkETGCfOxCjCiCaCpm(l) 
P AkETCfCoOxCjCiCaCpm(5) 
P AcAkETCfOxCjCiCaCprn(l) 
P AcAkGCfCoOxCjCiCaCpm.:2) 
P AcAkCfCCoOxCjCiCaCpmi 1) 
P AcAkGCfCoOxCjCiCaCpma) 
P AkECfCoOxCjCiCaCpm(T) 
E TCfCoOxCjCiCaCp a(l) 
PETCfCCoCpm(l) 
PAcETGCfCo(l) 
AcTCfCCoCjCpmOx(l) 
PAcAkECfCCo(l) 
PAcAkCfCCoOx(l) 
PAcAkETCfCo(8) 
PAcETGCCo(l) 
PETGCfCCo(l) 
PAcAkEGCfCo(l) 
30(29.47%) 
16(15.67%) 
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Five or Six 
drugs 
Four drugs 
Three drugs 
PAcGCfCo(l) 
PAcETCf(2) 
PAcTGCo(l) 
PAcETCo(2) 
PAcTCfCo(l) 
PAcAkTCo(2) 
PTCfCCo(l) 
PTAcCfCo(l) 
PTCfECo(l) 
PTCECo(l) 
PAcTCoCf(l) 
PAcECoCf(l) 
PETCoCf(2) 
PEAkTCfCo(2) 
PAkAcECf(l) 
PAkAcTC(l) 
PAkAcCCo(l) 
PAkECfCo(2) 
PAkAcETCo(l) 
PCAcCo(l) 
PCfCCo(l) 
PAkTCo(l) 
PAcCfCo(l) 
PAcET(3) 
PGET(3) 
PAkAcC(l) 
PTGCf(2) 
PAcET(2) 
PTGCo(l) 
PEAcCf(2) 
PAcCo(l) 
PTE(l) 
PCCo(6) 
PCAc(l) 
PCCf(l) 
25(24.51%) 
18(17.65%) 
10(9.80%) 
Two drugs P(3) 3 (2.94%) 
Single drug 
Total 
Nil 0 (0%) 
102 (100%) 
Abbreviation Key: 
P = Penicillin G, Ak = Amikacin, Ac = Amox cilliri, C = Chloramphenicol, 
Cf= Ciprofloxacin, Co= Co-Trimoxazole, Cj= Cefaclor, Ci = Ceftriaxone, 
Cpm = Cefepime, Ca = Ceftazidime, E = Erythr )mycin, T = Tetracycline, 
G = Gentamicin, Ox = Oxacillin 
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(iv) Drug resistance patterns of animal-origin isolates: 
In animal-origin samples the drug resistance patterns showed resistance 
to one drug in 8 (8%), two drugs in 9 (9.0%) isolates, three drugs in 18 
(18.0%) isolates, four drugs in 16 (16.0%) isolates, five or more than five 
drugs in 25 (25.0%) isolates whereas resi stance to ten or more drugs was 
found in 23 (23.0%) isolates. One isolate was found sensitive to all drugs 
(Table - 4). 
Table- 4. Drug resistance patterns of .S\ aureus isolated from animal-
origin samples 
Resistant to 
Tenor 
more drugs 
Five or 
more drugs 
Patterns (n) 
PETGCfCCoAkOxCjCiCaCpm(2) 
PETCCfCoAcAkOxCjCiCaC|)m(l) 
PETGCAcAkOxCjCiCaCpm( 2) 
PETCCoAcAkOxCjCiCaCpnr (2) 
PETGCoAcAkOxCjCiCaCpn (3) 
PETGCf Co Ox Cj Ci Ca Cp i(2) 
PETGCoOxCjCiCaCpm(l) 
PETCfCCoOxCjCiCaCpm(l) 
PTGCfCoOx Cj Ci Ca Cpm (1) 
PAkTECoOxCjCiCaCpm (1) 
ECfCoAcAkOxCjCiCaCpm(!) 
PETAc Ak Ox Cj Ci Ca Cpm(2) 
ETCfCAcAkOxCjCiCaCpm( 1) 
ECCoAcAkOxCjCiCjCpm(2) 
TECfCoOxCCjCiCaCpm(l) 
PETG Cf Co Ac Ak (3) 
AkTGCoOxCjCiCaCpm(2) 
PAkET0xCjCiCaCpm(2) 
PTAk Ox Cj Ci Ca Cpm (1) 
PECfGCoC(2) 
ETCfCoAcAk(l) 
PETCAcAk(l) 
PTGCfCiCo(l) 
PETCfCo(2) 
PECfCCo(2) 
ETCAcAk(l) 
PETCfC (1) 
PAkECfC (2) 
PECAkCf(l) 
PETGCfC (3) 
Total numbers (%) 
23 (23%) 
25 (25%) 
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Four drugs 
Three drugs 
Two drugs 
Single drug 
Total 
AkTCfCo(2) 
PETC(l) 
PETCo(l) 
ETGCo(l) 
PAcET(2) 
GCfCCo(l) 
PGCCo(l) 
PTCCo(2) 
PEGCo(l) 
PECo(2) 
PGTC(2) 
ETC(l) 
ETCo(l) 
PTCo(2) 
PCfCo(l) 
PET(l) 
PGT(3) 
PTCf(l) 
PECf(4) 
TCCo(2) 
PEC(2) 
PAc(l) 
GT(3) 
ET(1) 
ECo(l) 
PT(1) 
PE(1) 
AkCf(l) 
P(2) 
Cf(2) 
T(3) 
C(l) 
16(16%) 
18(18%) 
9 (9%) 
8 (8%) 
99* (99%) 
* 1 strain was found sensitive to all antibiotics. 
Abbreviation Key: 
P = Penicillin G, Ak = Amikacin, Ac = Amoxycillin, C = Chloramphenicol, 
Cf = Ciprofloxacin, Co = Co-Trimoxazole, Cj == Cefaclor, Ci = Ceftriaxone, 
Cpm = Cefepime, Ca = Ceftazidime, E = Eryihrcmycin, T = Tetracycline, 
G = Gentamicin, Ox = Oxacillin 
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A.1.1. Bacteriophage typing of Staphytococcus aureus isolates from 
human clinical specimens and animal-origin samples: 
(i) Routine bacteriophage typing of human clinical isolates: 
Bacteriophage typing was performed in 102 clinical isolates and 100 food 
isolates. Out of the 102 human clinical isolates tested, only 55 (53.9%) 
of isolates could be typed by the conventional set of phages at RTD 
(Table - 5). 
Table-5. Bacteriophage typing of Staphylococcus aureus isolates from 
human clinical specimens at 1 RTD 
Source 
Pus 
Urine 
Cx. Swab 
Semen 
Conj Swab 
Ear Swab 
ThroatSwab 
Stool 
Vomitus 
Body Fluid 
Cathetertips 
CSF 
Total 
Total no. 
of 
isolates 
tested 
38 
10 
14 
1 
14 
3 
3 
7 
6 
3 
2 
1 
102 
IRTD 
Typeab 3 groaps 
I 
0 
2 
1 
3 
(2.94%) 
II HI 
1 
7 f 
1 : 
2 f 
4 ! 3 
2 ' 
1 1 
& 
2 ! 3 
1 
1 
20 ' 25 
(19.6%) (24.5%) 
Non 
allociited 
Mixed 
group 
I & III = 3 
I & II = 2 
III&IV = 1 
I & IV = 1 
7 
(6.9%) 
Typeable 
isolates 
15 
4 
11 
0 
7 
2 
2 
6 
5 
2 
1 
0 ^ 
55 
(53.9%) 
Distribution of isolates into phage groups revealed that maximum number 
of isolates 25 (24.51%) were typed in group III followed by 20 (19.61%) 
in group II, 7 (6.9%) were in mixed group and 3 isolates (2.94%) in 
group I. No isolate was found in the nonallocated group. 47 (46.07%) 
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isolates remained untypeable at 1 RTD. On testing these 47 un-typeable 
isolates at 100 RTD, they showed 16.6'% (17/102) forther typeablity. 
Among these 17 isolates typed at 100 R' 'D, 10 isolates were methicillin 
resistant. Majority of these isolates b.:longed to group III (23.4%) 
followed by 4 (8.5%) in mixed group and 2 (4.3%) in group II (Ta|]^^'^. - ^' 
Table- 6. Bacteriophage typing oi Staphylococcus aureus isolaies^ y^ 
from human clinical specimens at 100 RTD \ M^  1 H 
xs 
Source 
Pus 
Urine 
Cx-
Swab 
Semen 
Conj 
Swab 
Ear 
Swab 
Throat 
Swab 
Stool 
Vomitus 
Body 
Fluid 
Drain 
Tip 
CSF 
Total 
Total 
no. of 
isolate 
tested 
23 
6 
3 
47 
100 RTD 
Typeable groups 
I II 
2 
2(4.3%) 
III 
3 
2 
3 
1 
1 
1 
11(23.4%) 
Non 
allocated 
^ < ^ . . " — ' 
Mixed 
group 
I & III = 
3 
i & i n = 
1 
4(8.5%) 
V - - ^ ^ •'! < , 1 , 
Typeable 
group 
8 
2 
3 
1 
0 
0 
0 
1 
1 
1 
0 
0 
17(36.2%) 
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The total typeability of clinical isolates at '.. P.TD and 100 RTD was 
found to be 70.58% (72/102). Typeability pattern of isolates obtained 
from different human clinical samples is shown hi table- 7. 
Table- 7. Bacteriophage typing of human clinical isolates of 
Staphylococcus aureus from various samples at 
(1 RTD and 100 RTD) combined 
Source 
Pus 
Urine 
Cx.Swab 
Semen 
Conj.Swab 
Ear Swab 
ThroatSwab 
Stool 
Vomitus 
Body Fluid 
Drin Tip 
CSF 
Total 
Total no.of 
isolates tested 
38 
10 
14 
1 
14 
3 
3 
7 
6 
3 
2 
1 
102 
Typeabie no. 
of isolates (%) 
23 (60.5%) 
6 (69%) 
14 (100%) 
1 (100%) 
7 (50 /o) 
2 (66.65%) 
2 (66.66%) 
7 (100%) 
6 (100%) 
3 (100%) 
1 (50%0 
0(0%) 
72 (70.; 8%) 
Nontypeable no. 
of isolates (%>) 
15 (39.47%) 
4 (40.0%) 
0 (0%) 
0 (0%) 
7 (50%) 
1 (33.33%) 
1 (33.33%) 
0 (0%) 
0 (0%) 
0 (0%) 
1 (50%) 
1 (100%) 
30 (29.41%) 
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• total no of isolates 
• a t l R T D 
DatlOORTD 
D total typeable isolates 
• total nontypeable 
isolates 
clinical isolates 
Fig- 4. Bar diagram showing bacteriophage typing at RTD and 
100 RTD from various human clinical isolates 
(ii) MRSA phage typing of human clinical isolates: 
MRSA phage groups were used to type methicillin resistant 
Staphylococcus aureus isolates of human clinical specimens. A total of 
14 (41.18%), out of 34 MRSA, were found typeable at 1 RTD and 
100 RTD using MRSA phages. Briefly, at 1 RTD out of 15 pus isolates, 
3 (20.0%) were typeable and belonged to mixed group; 4 (100%) from 
Cx. swab were found typeable (one in group III and 3 in mixed group); 
and 1 (100%) from drain tips (group I). Whereas all isolates from urine, 
conj. swabs, ear swabs, throat swabs, stool, vomitus, body fluid and CSF 
were untypeable at 1 RTD (Table - 8). 
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Table- 8. Bacteriophage typing of methrcillia resistant S. aureus 
isolates from human clinical s pecimens using MRS A phages 
at 1 RTD 
Source 
Pus 
Urine 
Cx. Swab 
Semen 
Conj.Swab 
Ear Swab 
ThroatSwab 
Stool 
Vomitus 
Body Fluid 
Drain tip 
CSF 
Total 
Total 
No. of 
Isolates 
Tested 
15 
4 
4 
0 
4 
1 
1 
1 
1 
1 
1 
1 
34 
1 RTD 
Typeable Groups 
I 
1 
1(2.91%) 
II III 
1 
1(2.91%) 
Non 
allocated 
Mixed 
Group 
i & n i = 
3 
1&2 = 3 
6(17.71%) 
Typeable 
Group 
3 
0 
4 
0 
4 
0 
0 
0 
0 
0 
0 
0 
8(27.5%) 
However at 100 RTD two pus isolates, out cf 12, were typeable in 
mixed group; 3 urine isolates (one belonged to group II and the other to 
group 111), one vomitus (group III) wei; foiinc typeable, whereas rest 
could not be typed (Table - 9). 
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Table- 9. Bacteriophage typing of meth'cillin resistant S. aureus 
isolates from human clinical specimens at 100 RTD 
Source 
Pus 
Urine 
Cx. 
swab 
Semen 
Conj. 
swab 
Ear 
swab 
Throat 
Swab 
Stool 
Vomitus 
Body 
Fluid 
Drain 
tip 
CSF 
Total 
Total no. 
of 
isolates 
tested 
12 
4 
0 
0 
4 
1 
1 
1 
1 
1 
0 
1 
26 
100 RTD 
Typeable groups 
I II 
1 
1(3.8%) 
III 
2 
1 
3(11.5'/o) 
Non 
alloc 
ated 
Mixed 
group 
I & III = 2 
2(7.7%) 
Typeable 
group 
2 
3 
0 
0 
0 
0 
0 
0 
1 
0 
0 
0 
6(23.1%) 
The MRSA obtained from various humjin clini(;al samples and 
their combined bacteriophage typing results (at 1 RTD f 100 RTD) are 
shown in table- 10 and fig- 5. 
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Table-10. Human clinical isolates of methicillin resistant 
Staphylococcus aureus in relation to combined bacteriophage typing 
at 1 RTD and 100 RTD 
Source 
Pus 
Urine 
Cx.Swab 
Semen 
Conj.Swab 
Ear Swab 
ThroatSwab 
Stool 
Vomitus 
Body Fluid 
Drin Tip 
CSF 
Total 
Total no. of 
isolates tested 
15 
4 
4 
0 
4 
34 
Type£ ble 
isolates. (%) 
5(33.53) 
3 (75.0) 
4(100) 
0(0) 
0(0) 
0(0) 
0(0) 
0(0) 
1 (100) 
0(0) 
I(IOC) 
0(0) 
14(41.18) 
Nontypeable 
isolates (%) 
10 (66.77) 
1(25) 
0(0) 
0(0) 
4(100) 
1(100) 
1(100) 
1 (100) 
0(0) 
1(100) 
0(0) 
1(100) 
20 (58.82) 
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No. of isolates 
Methicillin-resistant clinical 
isolates 
•total no of isolates 
i | a t 1 R T D 
DatlOORTD 
D total typeable isolates 
•total nontypeable 
isolates 
Fig- 5. Bar diagram showing MRSA phage typing at IRTD and 
100 RTD from various human clinical specimens 
(iii) Routine bacteriophage typing of animal-origin isolates: 
Out of 100 animal-origin isolates none of the isolate was found typeable 
at routine test dilution and 100 RTD. 
(iv) MRSA phage typing of animal-origin isolates: 
MRSA phage groups at routine test dilution were used to type 
methicillin-resistant Staphylococcus aureus isolates of animal-origin 
samples. None of the isolate was found typeable at 1 RTD. These 26 
isolates were further tested at 100 RTD. Out of which only two isolates 
(one from animal clinical sample (raw milk) and the other from buffalo 
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meat) could be typed which belonged to phage group II at 100 RTD 
(Table- 11) (fig-6). 
B total no of isolates 
• at 1 RTD 
D at 100 RTD 
D total typeable isolates 
• total nontypeable 
isolates 
food isolates 
Fig- 6. Bar diagram showing MRSA phage typing at IRTD and 
100 RTD from various animal-origin samples 
4.2.3. p - lactamase production: 
Out of 102 human clinical isolates 80 (78.4%) were P-lactamase 
producers whereas of 100 animal-origin isolates 69 (69%) were found 
P-lactamase producers by iodometric method (fig- 7). 
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Fig - 7 Photograph showing Beta lactamase test by 
Idometric method 
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4.3. Genotypic Characterization: 
The preparation of templates for PCll assay was done by the 
following methods, 
1. Genomic DNA extraction: by phenol chloroform extraction 
method 
2. Bacterial cell lysates: by using 
a) Triton X-100 
b)SDS 
c) Sonication 
d) Boiling and Chilling 
Out of these template preparation methods, the template prepared 
by phenol chloroform extraction method gave clear-cut amplification. 
Heat lysis method (Boiling and Chilling) also gave same amplification 
equivalent to that of phenol chloroform extraction. However, template 
prepared by triton X-100 method, SDS, and sonication method did not 
yield any PCR product. As the conventioi al phenol chloroform extraction 
method is time consuming, the boiling a id cliilling method was used in 
subsequent genotypic studies. 
4.3.1. Results of PCR for coa gene: 
The detection of the coa gene was done by Polymerase Chain 
Reaction using the primer set described b;/ Goh ef al. (19')2). 
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4.3.1.1. PCR for coa gene of human clii ical isolates: 
Coa gene could be amplified in all ths human clinical isolates. 
Twelve different electrophoretic patterns were observed in these isolates. 
Thirty strains (29.4%) showed a distinctive bands of 500 bp and 590 bp, 
22 strains (21.6%) showed bands of 480 bp, 680 bp and 800 bp, 10 strains 
(9.8%) showed band of 500 bp and 580 bp, 8 strains (7.8%) showed 
bands of 500 bp, 720 bp and 800 bp, 7 ;trains (6.9%) showed bands of 
500 bp, 580 bp, 700 bp and 800 bp, othc 7 strains (6.9%) showed bands 
of 580 bp, 700 bp and 800 bp, where a;- other 5 strains (4.9%)) showed 
bands of 480 bp, 500 bp and 580 bp, other 4 strains (3.9%) showed bands 
of 550 bp, 780 bp and 900 bp, 3 strains each (2.9)% showed 500 bp, 
580 bp and 720 bp: and 550 bp, 800 bp and 900 bp respectively, 2 strains 
(1.9%) showed bands of 470 bp, 700 bp, 790 bp and 920 bp, whereas 
1 strains (1.0%) showed bands of 550 b]., 600 bp and 820 bp, (fig- 8). 
Maximum numbers of strains showed ii band pattern of 500 bp and 
580 bp and were obtained from pus isolates. 
4.3.1.2. PCR for coa gene of animal-origin isolates: 
In 100 animal-origin isolates 7 electrophoretic patterns were 
observed. Forty seven strains (47%) showed a band pattern of 900 bp, 
17 strains (17%) showed bands of 650 bp and 700 bp, 13 strains (13%) 
showed bands of 590 bp, 680 bp and 700 i^ p, 8 strains (8%)) showed bands 
of 600 bp, 7 strains {!%) showed bands of 650 bp, other 7 strains (7%) 
showed bands of 650 bp and 750 bp, whe.eas 1 strain {\%) showed bands 
of 500 bp and 820 bp (fig- 9). 
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M M 
1000 
Fig-9 Electrophoretogram showing coagulase gene patterns 
of animal-origin food samples run on 2% agarosegel. Lane M 
shows molecular weight marker (lOObp). Lanes Ito 7 shows 
groups 1 -7 respectively 
Results 
4.3.2. Results oicoa - RFLP: 
The molecular typing of the coa gene of the 202 (102 human 
clinical isolates and 100 animal-origin isolatt^ s) isolates was carried out 
by primer-specific Polymerase Chain Re{ ction (PCR), after the digestion 
WxXhAlu 1 as described by Goh et.al, 19S 2. 
4.3.2.1. Results oicoa - RFLP of huma n clinical isolates: 
A total 12 types of coa -RFLP patterns were observed in human 
clinical isolates. Majority 30 (29.4%) of strains showed bands of 243 bp 
and 405 bp were classified in group XII followed by 22 strains (21.6%) 
in group III showing bands of 81 bp, M3 bp while 10 strains (9.8%) 
were characterized by distinctive bands p itteni of 162 bp and 243 bp and 
were characterized in group VI. Eight trains (7.8%) liaving bands of 
405 bp and 567 bp were categorized in ?roup IX. Seven strains (6.9%) 
each showed bands of 81bp, 162 bp, 243 bp, 324 bp, 405 bp and 162 bp, 
324 bp, 405 bp, respectively, and were classified in group I and group 
VIII. Five strains (4.9%) and 4 strains (3.9%) each showed bands of 
81 bp, 162 bp: and 162 bp and 324 bp, respectively, were classified in 
group VII and group II, 3 strains (2.9%) < ach were classified in group IV 
and group X consisting of band patten s of 162 bp, ?.43 bp, 324 bp, 
567 bp and 162 bp, 332 bp, 405 bp, nspectively. Two strains (1.9%) 
showed band patterns of 162 bp, 243 bp, 40f> bp belonged to group XI. 
However, 1 strain (1.0%) of group V showed band pattern of 243 bp, 324 
bp (fig- 10). Heterogeneity was observed in specimens of a similar type. 
For example, S. aureus isolates from cervical swabs belonged to six 
different coa-RFLP (Table-12). 
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Electrophoretogram showing coagulase gene pattern of clinical 
specimens run on 1.5% agarosegel. Lane M shows molecular 
weight marker (lOObp). Lane 1 to 12 shows groups 1-12 
respectively 
8 9 10 11 12 M 
bp 
567 
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324 
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81 
Fig- \oElectrophoretogram showing coa-RFLP gene pattern 
of clinical specimens run on 2% agrosegel. Lane M shows 
molecular weight marker (100 bp). Lane 1-12 shows 
groups 1-12 respectively 
Results 
(i) coa -RFLP patterns in MRSA and ^ SS^: 
Among these 12 patterns, 7 groups patt :ms, namely, group I, group II, 
group IV, group V, group VI, group VIi: and gi"oup XI were noticed in 
MRSA isolates. Rest of the group pattern:, were ui MSSA isolates. 
(ii) coa -RFLP patterns of MRSA in relation to antibiotic resistance 
patterns: Out of 34 methicillin resistant Staphylococcus aureus isolates 
from human clinical specimens 7 (20.6%) belonged to Coa-RFLP pattern 
of group I where majority of strains were resistant to six or more 
antibiotics; 10 strains (29.4%) belonged 13 Cca-RFLP group VI and 4 
strains (11.8%) of Coa-RFLP group II were also found resistant to six 
or more antibiotics. While 7 (20.6%) .^trains belonged to Coa- RFLP 
group VIII having resistance to five (^ r more antibiotics. Coa-RFLP 
group IV and group XI having 3 strains (8 8%) and 2 (5.9%) strains, 
respectively, also showed resistance to fi /e or more antibiotics, however, 
only one strain (2.9%) which belonged to Coa-RFLP group V showed 
resistance to five antibiotics (Table -13 . 
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Table - 13. Resistance patterns in huhian clinical MRSA isolates in 
relation to Coa-RFLP groups 
Coa-RFLP 
groups 
Group I 
Group II 
Group IV 
Group V 
Group VI 
Group VIII 
Group XI 
Total no. of 
isolates (%) 
7 (20.58%) 
4(11.76%) 
3 (8.82%) 
1 (2.94%) 
10(29.41%) 
7 (20.59%) 
2 (5.88%) 
Resistance patterns 
(n= no. of isolates) 
P i T G C C f C o C a (2) 
P iTCCfCoCa (4) 
P ti T G Cf Co Ca (1) 
P • T C Co Ca (2) 
P •TGCfCa(2) 
PTGCfCoCa(2) 
P C C f C o C a ( l ) 
P H T C f C a ( l ) 
P E T G C f C o C a ( 5 ) 
P}LTCfCoCa(5) 
P E T G C C f C a ( l ) 
P ' .TCCfCa( l ) 
P i T C C f C o C a ( l ) 
P ' ; C C f C o C a ( ] ) 
P' .}CfCcCa(2) 
P C C f C o C a ( l ) 
P G C f C o C a ( l ) 
E T C f C o C a ( l ) 
Abbreviation Key: 
P = Penicillin G, A = AmpicUin, Ak = Amikacin, Ac = Amoxycillin, 
C = Chloramphenicol, Cf == Ciprofloxacin, Co = Co -Trimoxazole, 
Cj = Cefaclor, Ci = Ceftriaxone, Cpm =- Cel'epme, Ca = Ceftazidime, 
E = Erythromycin, T = Tetracycline, G = Gentamicin, Ox = Oxacillin 
Among these 12 patterns, Sgroups patten.s, nsmely, group III, group VII, 
group IX, group X, and group XII were noticed in MSSA isolates. 
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Antibiotic resistance patterns in relation t'.> Cca - RFLP pattern could not 
be inferred in isolates obtained from clinical specimens due to variability 
of resistance patterns; 40 different types c f patterns were observed. 
4.3.2.2. Results of coa - RFLP of animal-origi]! isolates: 
In 100 animal-origin isolates, 7 types of <i;oa-RFLP patterns were 
observed, majority (47%) were classified in group VI with band of 
405 bp followed by 17% strains characterized by distinctive band patterns 
of 243bp and 324 bp in group V, 13% strains in grouj) I consisting of 
162 bp, 250 bp and 405 bp, 8% strains sh )wec. btnds of 81 bp and 324 bp 
belonged to group VII, and 7% strains sh jwed bands of 324 bp and were 
characterized as group II, 3% strains of group IV showed band patterns of 
162 bp and 405 bp, 1 (1%) strain of group HI showed band pattern of 
162 bp and 324 bp. Five out of 29 animal-origin clinical isolates (raw 
milk) were classified in group VII and group II with band patterns of 
81 bp, 324 bp and 324 bp (Table-14) (^ig-ll). Mixed Coa-RFLP gene 
patterns were observed in animal clinic il specimens and animal-origin 
food samples. To appreciate the reprodi cibility of coa-RFLP the test 
was performed in duplicate. The reproducibility was good as similar 
results were obtained in both the tests. 
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Fig-11 Electrophoretogram showing Coa-RFLP gene patterns 
of animal-origin food samples run on 2% agarosegel. Lane M 
shows molecular weight marker (lOObp). Lanes Ito 7 shows 
groups 1-7 respectively 
V^sults 
Table- 14. Coagulase gene restriction fragntent length polymorphism 
of 5. aureus isolates from animal-origin samples 
Specimens 
Animal 
clinical 
specimen 
(Raw milk) 
No. of Isolate 
tested 
29 
Coa- RFLP-Groups 
II III 
0 
IV V VI 
8 
VII 
Chamcham 0 0 0 0 
Sweet 
Khoa 
Paneer 
Goat Meat 
Buffalo Meat 
27 
20 
0 0 
0 
0 0 
15 
14 
0 
0 
0 
0 
Kabab 
Salami 
0 0 0 
0 0 0 
0 0 
0 
Total 100 13 17 47 
(i) coa -RFLP patterns in MRS A and MSSA: 
Among these 7 patterns, 4 group patten s, namely, group II, group III, 
group I, and group VII, were noticed in J9 MRSA isolates from animal-
origin samples. Rest of the group patterns were in MSSA isolates. 
(ii) coa -RFLP patterns in relation to antibiotic resistance patterns: 
Out of 29 methicillin resistant Staphylococcus aureus isolates from 
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animal-origin samples 8 (27.6%) belonged to C0.3-RFLP pattern of group 
VII where majority of strains were resist Jit to six antibiotics. While 13 
(44.8%) strains belonged to Coa- RFJ .P group I having resistance to 
five antibiotics. Coa-RFLP group II hav ng resistance to seven or more 
antibiotics was noticed in 7 strains (24 1%). h<3wever, only one strain 
(3.4%) showed resistance to three antibiotics and belonged to Coa-RFLP 
group III (Table-15). 
Table - 15. Resistance patterns in animal-origin MRSA isolates in 
relation to Coa-RFLP groups 
Coa-RFLP 
groups 
Group I 
Group II 
Group III 
Group VII 
Total no. of 
isolates (%) 
13 (44.82%) 
7(24.14%) 
1 (3.45%) 
8 (27.59%) 
Resistance patterns (n= no. of 
isolates) 
ETCfCoCa(l) 
P E T CDCa (1) 
ETCCfCa(l ) 
E C Co Ca (2) 
P E r C Ca (2) 
E C Co Ca (2) 
T G Co Ca (2) 
P E T Ca (2) 
PE rGCCfCoCa(3) 
PE rCCfCoCa(l ) 
PErGCfCoCa(2) 
PTGCfCoCa(l) 
PTCa( l ) 
P E r G C Ca (2) 
P E T C Co Ca (2) 
P E r,G Co Ca (4) 
Abbreviation Key: 
P = Penicillin G, C = Chloramphenicol, Cf = 
Co = Co -Trimoxazole, Ca = Ceftazidime, E =--
T ^ Tetracycline, G = Gentamicin, 
Ciprofloxacin, 
Erythromycin, 
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Among the 7 patterns noticed in isolatef from animal-origin samples, 3 
group patterns, namely, group IV, group V, and group VI were noticed in 
MSSA isolates. Antibiotic resistance patLems in relation to Coa - RFLP 
pattern could not be inferred in remaining isolates obtained from animal-
origin samples due to variability of resistance patterns; 40 different types 
of patterns. 
4.3.3. Results of PCR for Thermostable Nuclease Gene (nuc): 
Two hundred and two coagulase positive staphylococcus aureus isolates 
including 102 human clinical and 100 ai.imal-origin isolates were tested 
for the presence of thermostable nuclease (nuc) gene by Polymerase 
Chain Reaction using the method of Bnikstad et al. (1992) with slight 
modification. All the 202 isolates showed a 270 bp amplified product 
after gel electrophoresis which is specific for the presence of nuc gene in 
staphylococcus aureus (fig-12). 
4.3.4. Results of PCR for Enterotoxin Genes (SEA, SEB and SEC): 
For the detection of enterotoxin genes, na nely enterotoxin A, enterotoxin 
B and enterotoxin C, PCR assay was us ;d to amplify specific base pair 
products. A total of 202 isolates (102 human clinical isolates and 100 
animal-origin isolates) were tested for production of enterotoxin A, 
enterotoxin B and enterotoxin C. For the enterotoxin A and enterotoxin B 
modified method of Johnson et al. (1991) was used, which gave 120 bp 
(fig- 13) and 478 bp (fig- 14) gene speci.ic products, respectively, while 
the modified method of Chen et al. (2001) was used to amplify 
enterotoxin gene C which showed a g,ene specific 234 bp (fig- 15) 
product. 
Of the 102 human clinical isolates 3 were found 
enterotoxogenic, out of which 1 from stctol sample were found 
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M M 
bp 
120 
Fig-13 Electrophoretogram showing 120 bp amplicon of SEA 
gene on 1.5% agarosegei. Lane M showslOObp ladder. 
Lanes 1 to 4 shows positive samples. Lane 5 shows 
negative sample. 
M M 
bp 
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1000 
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Fig-14 Electrophoretogram showing 478 bp amplicon of SEB on 
1.5% agarosegel. Lane M shows lOObp ladder. Lanes 1 to 2 
shows positive samples. Lanes 3-5 shows negative samples. 
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Fig-15 Electrophoretogram showing 234 bp amplicon of 
SEC gene on 1.5% agarosegel. LaneM shows lOObp 
ladder. Lanes 1 to 6 shows positive samples. Lane 7 
shows negative sample. 
Resuts 
positive for enterotoxin A, 1 from vomitiis showed presence of 
enterotoxin B while the other 1 from ui ine !5ample shows presence for 
enterotoxin C (Table - 16). 
Table- 16. Prevalence of staphylococca enterotoxin genes in 
Staphylococcus aureus isolat .s from clinical specimens 
Specimens 
Pus 
Urine 
Cx. Swab 
Conj. Swab 
Ear Swab 
ThroatSwab 
Semen 
Stool 
Vomitus 
Body Fluid 
Drain tip 
CSF 
Total 
No. of 
Isolates 
tested 
38 
10 
14 
14 
3 
3 
1 
7 
6 
3 
2 
1 
102 
No. of samples positive for 
enterotoxins 
SEA 
1 
1 
SEB 
' 
0 
1 
1 
SEC 
1 
1 
Total 
0 
1 
0 
0 
0 
0 
0 
1 
1 
0 
0 
0 
3 
Out of 100 animal-origin isolates a lotal of 13 (13%) were found 
enterotoxigenic. Of these 2 were positive for (interotoxin A (2%) (1 from 
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clinical specimens of animal (raw milk) s tmple and 1 from buffalo meat); 
3 (3%) were positive for enterotoxin B (1 :Tom clinical specimens of 
animal (raw milk) sample, 1 from sweet and 1 from cottage cheese) and 
8 (8%) were found positive for enterotoxin C (1 from clinical specimens 
of animal (raw milk), 1 from paneer, 3 from goat meat and 3 from 
buffalo meat) (Table-17). 
Table-17. Prevalence of staphylococcal enterotoxin genes in 
Staphylococcus aureus isola tes from animal-origin 
samples 
Specimens 
Animal origin 
clinical 
specimens 
(Raw Milk) 
Chamcham 
Sweet 
Khoa 
Cottagecheese 
Goat Meat 
Buffalo Meat 
Kabab 
Salami 
Total 
No. of 
Isolates 
tested 
29 
4 
3 
9 
6 
27 
20 
1 
1 
100 
No. of samples positive for 
enterotoxins 
SEA 
1* 
1* 
2 
SEB 
1* 
1 
1 
3 
SEC 
1* 
1 
3 
3* 
8 
Total 
3 
0 
1 
0 
2 
3 
4 
0 
0 
13 
*Enterotoxins (SEs) were detected from different samples. 
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Antibiotic resistance patterns of enterotoxigenic strains: 
Among the 16 enterotoxigenic Staphyloccccus aureus isolates, 
13 different antibiotic resistance patteras v/ere observed. All of the 
enterotoxigenic isolates from human clinical specimen showed resistance 
to methicillin. However all of the straii s exhibited different antibiotic 
resistance pattern. Out of 13 enterotoxi^jenic animal-origin isolates 10 
different antibiotic resistance patterns were observed. Eight of them also 
showed methicillin resistance. The resistance patterns of enterotoxogenic 
isolates are shown below in table- 18. 
Table- 18. Antibiotic resistance patterns found in enterotoxigenic 
isolates 
Enterotoxin detected 
(n) 
EntA 
(3) 
EntB 
(4) 
EntC 
(9) 
Food (2) 
Clinical (1) 
Food (3) 
Clinical (1) 
Food (8) 
Clinical (1) 
Antibi 3tic )*esistance pattern (n) 
AcAkOxCjCiCaCpm(l) 
P E T G Co Ox Ci Ci Ca Cpm (1) 
P Ak E T Cf Co Ox Cj Ci Ca Cpm (1) 
P E T G ( l ) 
P T Ak Ox Cj Ci Ca Cpm (2) 
P Ak E Cf Co Ox Cj Ci Ca Cpm (1) 
PETGCoCfAcAk(2) 
P E T G Co Ox Cj Ci Ca Cpm (2) 
P E T G ( ) 
T E Cf Cc Ox Cj Ci Ca Cpm (1) 
PTAkO: CjCiCaCpm(l) 
P G E Co a ) 
P E T G (;f Ox Cj Ci Ca Cpm (1) 
Abbreviation Key: 
P = Penicillin, Ak = Amikacin, Ac = Amoxycillin, C = Chloramphenicol, 
Cf= Ciprofloxacin, Co = Co-Trimoxazole, Cj = Cefaclor, Ci = Ceftriaxone, 
Cpm = Cefepime, Ca = Ceftazidime, E = Ery-hromycin, T = Tetracycline, 
G = Gentamicin, Ox = Oxacillin. 
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4.3.4. Results of PCR for Methicillin resistant Staphylococcus 
aureus (MRSA): 
Methicillin resistant Staphylococcus aureus (MRSA) is a major 
nosocomial pathogen worldwide and is often difficult to detect due to the 
heterogeneous nature of expression of oxacillin resistance. A total of 
102 clinical and 100 animal origin food isolates were tested for oxacillin 
resistant by disc diffusion method, by screen agar plate and detection of 
/wee A gene by PCR. For the detection of wee A gene by PCR, primers 
described by Prasad et al. (2000) were used which gave a clear cut 
specific 604 bp amplified product (fig. 16). 
Out of 102 human clinical isolates 34 (33.4%) showed the presence 
of mec A gene. Phenotypically, 33 (32.35%) strains were oxacillin 
resistant by disc diffusion method and 32 (31.37%)) strains showed 
resistance by screen agar plate method (fig-17). 
Fig- 17. Contrasting pie chart showing data values of MRSA 
isolates from human clinical isolates by using various 
methods 
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M M 
bp 
604 
Fig-16 Electrophoretogram showing 604 bp amplicon of MecA gene 
on l.Syo agarosegel. Lane M shows lOObp ladder. Lanes 1 to 
2 shows positive samples. Lanes 3-5 shows negative samples. 
Results 
Briefly, out of 38 isolates j-om pus, 39.5% were found 
positive for mec A by PCR, whereas 36.8% showed resistance to 
oxacillin by disc diffusion and screen agar methods. Among conj. swab 
and cervical swab, 28.6% isolates each and 40% from urine samples were 
found resistant by all methods. The comparative detection of methicillin 
resistance by these three methods in relation to the clinical samples is 
shown in table -19 (fig. 18). 
Table- 19. Detection of Methicillin reiistant Staphylococcus aureus 
isolates from human clinical specimens by various 
diagnostic methods 
Specimens 
Pus 
Urine 
Cx. Swab 
Conj. Swab 
Ear Swab 
ThroatSwab 
Semen 
Stool 
Vomitus 
Body Fluid 
Drain tip 
CSF 
Total 
Total no. of 
isolates 
38 
10 
14 
14 
3 
3 
1 
7 
6 
3 
2 
1 
102 
Methicillin resistant isolates detected by 
Disc Diffusion 
14 (36 8) 
4 (40.0) 
4 (28.6) 
4 (28.0) 
1 (33.3) 
1 (33.3) 
0(0) 
1 (14.J) 
1 (16.'.') 
1 (33.-i) 
1 (50.')) 
1(100) 
33(32.35%) 
Screen Agar 
14 (36.8) 
4 (40.0) 
4 (28.6) 
4 (28.6) 
1 (33.3) 
0(0) 
0(0) 
1 (14.3) 
1 (16.7) 
1 (33.3) 
1 (50.0) 
1 (100) 
32(31.37%) 
PCR 
15 (39.5) 
4 (40.0) 
4 (28.6) 
4 (28.6) 
1 (33.3) 
1 (33.3) 
0(0) 
1 (14.3) 
1 (16.7) 
1 (33.3) 
1 (50.0) 
1(100) 
34(33.4%) 
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Figures in parentheses indicate percentage 
In 100 animal-origin isolates, 29 showed the presence of mec A gene 
(fig-16) and of these, 27 strains were oxacillin resistant by disc diffusion 
method and 26 strains by screen agar plate (fig-19). 
Fig- 19. Contrasting pie chart showing data values of MRSA 
isolates from animal-origin isolates by using various methods 
Briefly, out of 29 samples of animal clinical specimens (raw 
milk) 15.0% isolates were found methicillin resistant by disc diffusion 
test, whereas 14.0% isolates showed resistance to oxacillin by screen agar 
method and presence of mec A gene by PCR. In chamcham, sweet, 
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cottage cheese, buffalo meat and m at cutlet samples similar 
resistance pattern was found by all the three meihods. However, in khoa 
only 2% isolates were observed methicillin resistant by PCR whereas 
other two methods failed to detect resistance. In goat meat only 2% 
isolates showed oxacillin resistance by disc diffusion and agar screen 
method but 3% were detected by PCR. The comparative detection of 
methicillin resistance by these three methods in relation to the food 
samples are shown in table - 20 (fig- 20). 
Table- 20. Detection of Methicillin n sistant 5. aureus isolates from 
animal-origin isolates by various diagnostic methods 
Samples 
clinical 
specimens of 
animal origin 
(raw milk) 
Chamcham 
Sweet 
Khoa 
Cottage chesse 
Goat meat 
Buffalo meat 
Meat cutlet 
Salami 
Total 
Total no. of 
isolates 
29 
4 
3 
9 
6 
27 
20 
1 
1 
100 
Methicillin resistant isolates detected by 
Disc Diffusion 
15(15%) 
2 (>%) 
2 (2%) 
0 (0%) 
3 (3%) 
2 (2%) 
2 (2%) 
1 (1%) 
0 ()%) 
27(27%) 
Agar Screen 
14 (14%) 
2 (2%) 
2 (2%) 
0 (0%) 
3 (3%) 
2 (2%) 
2 (2%) 
1 (1%) 
0 (0%) 
26(26%) 
PCR 
14 (14%) 
2 (2%) 
2 (2%) 
2 (2%) 
3 (3%) 
3 (3%) 
2 (2%) 
1 (1%) 
0 (0%) 
29(29%) 
Figures in parentheses indicate percentage 
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5. DISCUSSION 
Staphylococcus aureus is an impc rtani microorganism producing 
various diseases in man and animals. A variety of exoproteins produced 
by Staphylococcus aureus contribute to the pathogenesis in human and 
animal host (Salasia et al, 2004). In man, it is an important cause for both 
nosocomial and community acquired infections like post-operative 
wound infections, pneumonia, bacteraemia, food poisoning and other 
infections. In animals it causes a wide spectrum of diseases like 
intramammary infections in lactating mimals (Waage et al, 1999; 
Cucarella et al, 2004), sporadic septicemia in pigs, abscesses, sinusitis, 
arthritis, osteomyelitis, dermatitis, in poultry and ducks. The studies 
exploring the staphylococcal enterotoxin genes are elementary from our 
country and also the molecular studies characterizing the isolates at the 
genotypic level are fragmentary. Moreo\'er, we could not get any study 
evaluating the relatedness or diversity of Staphylococcus isolates 
obtained from clinical and food samples. Therefore the present study was 
conducted specially to characterize the Indian S. aureus isolates at 
phenotypic and molecular level, to find out the existing enterotoxins, and 
to look for any relatedness or diversit> of the isolates obtained from 
clinical and food sources. 
Hemolysis is considered to be one of the important virulence 
markers of Staphylococcus aureus. The workers have reported 
P-hemolysis ranging from 86 to 97% (Ko:,trzyiiski and Kozanecki, 1990). 
In our study 77.4% human isolates shov ed P-hemolysis on sheep blood 
agar. The clinical isolates showing p-iemolysis also had multidrug 
resistance character. 
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59% of food isolates showed p-hemol>sis on i^ heep blood agar in the 
present study. Kohler-Samouilidis (1977) repoited 48% of 
Staphylococcus aureus of animal origin with hemolytic property on sheep 
blood agar. Rosec et al., (1997) observe! 30.5^o hemolysing producing 
isolates among 231 food isolates of Staph >lococcus aureus. 
The ability of Staphylococci to p oduoe free coagulase, an extra 
cellular enzyme which activates a coagulase reacting factor (CRP) is 
normally present in plasma and clots plasma by conversion of fibrinogen 
to fibrin, and contributes to its pathogenicity It has been proposed that 
coagulase may inhibit phagocytosis and protect the cocci from 
antibacterial substances in tissue fluids )y laying down a fibrin barrier 
around them and rendering them resistant to opsonization and 
phagocytosis. Its production is the princijial citerion used by the clinical 
microbiologists for the identification of S. aureus strains from human 
infections. Staphylocoagulase a majoi phenotypic determinants of 
S. aureus exists in multiple allelic forms, partly because of the existence 
of gene variants within the 3'-end coding region. This region contains a 
series of repeating 81-bp DNA sequences which differ both in the number 
of tandem repeats and the location of ttie Alul restriction sites among 
different isolates. 
In our study, a comparative analy .is of 202 isolates (102 human 
clinical isolates and 100 animal-origir isolates) was carried out to 
re-appraise the discriminatory power of t'le coagalase slide test, tube test 
and PCR. All of the human clinical isolates included in the present study, 
were found positive for coagulase enzyme by slide and tube coagulase 
test as well as by PCR. However, 98 isolates obtfiined from animal-origin 
samples were positive for tube coagulaf s te5;t, slide coagulase test and 
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coagulase-PCR. Remaining four isolate were found j)ositive by tube 
coagulase test and coagulase-PCR, b it misled detection by slide 
coagulase test. Olney Vieira-da-motta zt al, (2001) reported 10.1% 
strains negative by the slide test. In ano<,her study, 3.9% of clinical and 
10% of food isolates were found negatiAe by sbde test (Bachhil, 1998). 
The discrepancy could be because of detection tsrgets, as slide coagulase 
test detect bound coagulase and tube coagalase test detect free coagulase. 
In the present study, all the co{ gulase positive Staphylococcus 
aureus isolated from human clinical ai'd animal-origin samples were 
frirther tested for the thermonuclease pre duction on DNA-toluidine blue 
agar plates for confirmation of Stai hylococcus aureus. It is an 
endonuclease, degrading both DNA and PJSfA, and the enzymatic activity 
can resist 100°C temperature for at least 1 hour. The TNase protein has 
been well characterized and its gene, th( nuc gene has been cloned and 
sequenced. Thermonuclease productior w£S observed in 100% of 
S. aureus isolates from human clinicai specimens ard animal-origin 
samples in this study. The results of pres( nt study were also supported by 
the findings of Jasper (1973), Lachica et il. (1971) and Das (1988), who 
reported that TNase is a reliable iidicator for confirmation of 
Staphylococcus aureus. 
In the present study Nuc gene was also detected by Polymerase 
chain reaction in all the human clinical and animal-origin isolates. Similar 
results were found by Kim et al. (2001). The nvc gene was found in all 
the strains obtained from animal sources '^ specially, milk and milk 
products. 
Accurate and rapid typing of S. aureus is crucial for control of 
infectious organisms and numerous methods have been described for 
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typing of S. aureus i.e. immunoblots, antimicrobial resistance and 
bacteriophage typing. Bacteriophage typing scheme for S. aureus was 
been introduced internationally from 1951. Although it is a cost-effective 
approach for typing of a large number of referred isolates the typeability 
is poor. 
In this study, 70.58% human clinical isolates were found typeable 
by bacteriophage typing at 1 RTD and at 100 RTD. Among these, 
majority (35.3%) of them belonged to phage group III followed by 21.6% 
in phage group II and 10.9% in mixed group. Hanumanthappa et al., 
(2003) found 61.43% typeable clinical isolates by using conventional 
phage typing and observed that majority of isolates 55.81% were typed in 
phage group III. While in another Indian study by Kandle et al., (2003), 
out of 289 clinical isolates 113 (39.11%) strains could be typed. Among 
the typeable strains 5.53% belonged to phage group I, 11.4% to group II, 
8.9% to non allocated group and majority of 13.14% strains were typed in 
group III. 
Majority of MRSA were non-typeable by conventional sets of 
phages and hence these isolates were tj^ ped using a new set of MRSA 
phages. In the clinical isolates typeability of 41.18% at 1 RTD 
and 100 RTD was seen among 34 methicillin-resistant 
Staphylococcus aureus. Briefly, at 1 R.TD out of 15 pus isolates, 
3 (20.0%) were typeable and belonged to mixed group; 4 (100%) from 
Cx. swab were found typeable (one in group III and 3 in mixed group); 
and 1 (100%) from drain tips (group I). Whereau all isolates from urine, 
conj. swabs, ear swabs, throat swabs, stool, vomitus. Body fluid and CSF 
were found nontypeable at 1 RTD. 
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However at 100 RTD two pus isolates, ou; of 12, were typeable in 
mixed group; 3 urine isolates (one belonged 1o group II and the other to 
group III), one vomitus (group III) were foiinc typeable, whereas rest 
could not be typed. Similarly, Vidha'ii ei al. (2003), studied 188 
iS". aureus isolates from wound infection of which 79 were MRSA. Using 
MRSA phages at 100 RTD 41.8% of MRSA isolates could be typed. 
Mathur et al. (2000), studied 300 MRSA clinical isolates, of which 
17.6% could be typed by conventional set of phages and group III 
predominated. When tested with MRSA phages 45.6% strains could be 
typed into 5 phage patterns. Phage 622 was pi-edominant followed by 
M3/M5. MR8/MRP MR 25, 30/33/38 and mixed group. 
In animal-origin isolates, 2% isolates were found typeable using 
conventional phages at 1 RTD and 100 RTD belong to group II. 
195 S. aureus isolates were studied in Canadian dairy herds by 
Sabour et al. (2004). 63.1% of them were lys-^ d by phage group I and III 
while 32.8% could not be typed. 
S. aureus has been recognized as PJI important pathogen in human 
and animal diseases. Emergence of antibiotic resistance is a major 
problem all over the world. Constant and irrational use of antibiotics in 
both human and veterinary medicine, especially in developing countries 
coupled with current knowledge of transfer of antibiotic resistance 
between various bacteria makes it essential to monitor the susceptibilities 
of known pathogenic bacteria to antibiotics (Linton, 1997). Increasing 
trend in irrational usage of antibiotics as therapeutic and growth promoter 
in veterinary practice also leads to multidrug resistant S. aureus. 
Similarly indiscriminate usage of antibic tics and non-compliance to the 
antibiotic treatment in human beings are Some of the important causes of 
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increasing drug resistance observed among various microbes 
(Linton, 1977). 
Although antimicrobials were initi ally very effective, but the fast 
emergence of drug resistant Staphylococcus aureus strains have created a 
problem in the control and treatment of various infections. 
In the present study, 98.03% of r'. aureus isolates from human 
clinical specimens showed resistance tc penicillin. Most of the reports 
from previous studies have revealed that, S. aureus from various sources 
had resistance to penicillin ranging between 59.89% to 98.96% (Das, 
1988; Sanjeev and Mahadeva Iyer, 1988; Kar et al. 2003; Norazah et al. 
2003; Shamsuzzarman et al. 2003 and Audu and Kudi, 2004). In an 
study, Murugan et al, (2008) noted 100% penicillin resistant strains 
among 2314 clinical isolates of S. aureus. 
Resistance to chlorampheniol was observed in 23.53% strains in 
the present study. This is comparable t* 23.1% resistance obtained by 
Archer et al. (1991), Orrett (2008) noted 13.3% resistance but Refsahl et 
al. (1992), reported higher resistance (79.4%) to chloramphenicol. In our 
study 64.7% strains were resistant to amoxycillin. AssaduUah et al. 
(2003), and Vidhani et al. (2001) reporte(* 89.3% and 100% resistance for 
amoxycillin. Among cephalosporins, in the present stud>, 32.35% strains 
were resistant to cefaclor, cefotaxime, eel:azidime and cefepime. 
In this study, 32.35% were found resistant to oxacillin. 
Vidhani et al. (2001) found 57.6% methicillin resistant Staphylococcus 
aureus, Anupurba et al. (2003) reported 54.8% MRSA, 
Majumder et al. (2001) reported 52.9% MRSA from patients and healthy 
carriers. Whereas in a study done by, Murugan et al, (2008), noted 
42.86% MRSA among patients. Cotrimcxazole resistance was found to 
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be 69.61% in present study, whereas Pulimood et al. (1996) and 
Assadullah et al. (2003) and Orrett 2003) reported cotrimoxazole 
resistance in 97.1%, 53.5%)and 93.6% strains respectively. Pal et al. 
(1991), reported cotrimoxazole resistance in 89.6% strains. 
Amongst aminoglycosides in the present study, 27.45% and 
35.3% strains were resistant to gentamicin and amikacin respectively. 
Mathur et al (2000), reported 44.5% aiid 38% and Orrett (2008)noted 
96.8% and 94.1% resistance to gentamicn and amikacin respectively. In 
other studies, variable resistance to -gentamicin has been reported 
(Assadullah et al. 2003; and Anupurba ei al. 2003). 
Among the fluoroquinolones, 60.''9°/o strains were found 
resistant to ciprofloxacin. This is in comparison t») the study of 
Mathur et al. (2000), Assadullah et al. (2003), Anupurba et al. (2003) and 
Orrett (2008) who reported resistance in 50.8%, 45.8%, 84.1% and 95.2% 
isolates respectively. 
Resistance to erythromycin was obiervt;d m 54.9°/3 of strains. This 
was in accordance with the findings ol Majumder et al. (2001), who 
reported resistance to erythromycin in 33.5%. Mathur et al. (2000), 
reported resistance to erythromycin in 92% isolates respectively. Orrett 
(2008) noted 98% resistance erythromyci)i strains. 
In the present study, out of 16 antibiotics tested, a multidrug 
resistance phenomenon was observed amc-ng the animal-origin isolates. 
The frequency of resistance to different antibiotic s were penicillin (93%), 
tetracycline (49%)), erythromycin (51%), ciprofloxacin (39%)), 
chloramphenicol (34%), amikacin (27°/), cefaclor (27%)), ceftriaxone 
(27%), ceftazidime (27%), cefepime (27' -b), oxaMUin (27%), gentamicin 
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(20%), cotrimoxazole (54%) and amoxyc illin (19%). These isolates were 
found sensitive to vancomycin and teicoplanin. 
In this study, 93% of S. aurevs isolates from animal-origin 
sources showed resistance to penicillin Previous studies have shown 
varying resistance to penicillin ranging from 59.89% to 98.96% (Das, 
1988; Kar et ah, 2003; Norazah et al, 2 303; Audu and Kudi, 2004 and 
Chao et al, 2007). 
Overall, tetracycline resistance was 49°/o in this study with varying 
resistance (0-70%) among isolates obtained li-ora food sources like raw 
milk, raw meat, cooked meat and food products made by milk. Similar 
resistance profile (63.0% to 90.8%) has been reported by many other 
workers (Gonlugur et al. 2003; Norazah . f al. 2003; and Audu and Kudi, 
2004). Chao et al, (2007) noted 49 4% resistance among animal 
specimens The resistance to cotri.noxiizole, ciprofloxacin and 
chloramphenicol in this study was found in 54%, 39% and 34% isolates 
respectively. 
In this study the resistance to amikacin, gentamicin and amoxicillin 
was noticed in, 27%, 20% and 19% strains respectively. Martin et al 
(2003), reported 38.1% resistance to amoxycillin in fcod isolates. For 
gentamicin, varying resistance (2.5 to 98.3%) had been reported by 
various workers (Corti et al, 2003; Norazah et al, 2003; and 
Shamsuzzamanef a/., 2003). 
In the present study, 27% ofS. aureus isolates from food samples 
showed resistance to cefaclor, cefotaxime, ceftazidime and cefepime. 
Methicillin resistance was obtained in 27% isolates. A varying prevalence 
rate of MRSA (6.9% to 52.9%) has been reported (Chakravarthy et al 
1988; Udayasankar et al 1997; Mehndiratta et al, 2001; Vidhani et al 
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2001; and Hanumanthappa et al, 2003; 5axena et al.,2003; Anupurba et 
al.,2003; and Kim et al., 2004 and Th'ari et al., 2008). The varying 
prevalence rates may be due to variation in the nature of isolates tested, 
methods of detection used in different ge(.graphical areas 
Methicillin resistant Staphylococcus aureus (MRSA) strains were 
identified as early as 1961 immediately after the introduction of 
methicillin in clinical settings (Barber, 1961). These strains have 
probably arisen by a succession of mi'tatic<ns and the acquisition of 
resistance plasmids. MRSA strains have emerged worldwide as a major 
cause of nosocomial infections (Michel e.' al. 1997). Methicillin resistant 
Staphylococcus aureus is also an emergiag issue; in veterinary medicine 
(Defra, 2008). MRSA strains are diffici:lt to eradicate because of their 
multiple drug resistance, thereby complicating the management of 
infections in animals too. The need to differentiate MRSA from MSSA in 
clinical specimens. This demands a rapid and accurate method of MRSA 
detectionfor proper management and prev<;nt}on of transmission of 
S. aureus in clinical settings. Though vfirious methods for detection of 
MRSA have been recommended, the hel ;rogeneous nature of resistance 
to methicillin and oxacillin by many strains make their recognition 
problematic. In this study for detection of Methicillin resistance various 
conventional methods (disc diffusion and screen agar plate) and 
polymerase chain reaction were used. Among the 102 human clinical 
isolates, percentage of MRSA detected by disc diffiision method, screen 
plate agar method and PCR was very similar (31 to 33.4%). 
Adaleti et al. (2008), studied 416 clinical isolates, 210 (51%) 
isolates were found positive for mec A I'ene by PCR. In their study, 26 
mec A negative strains were falsely ident fied as MRSA by disc diffusion 
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method and by Screen agar plate method. However, in our study we 
missed only one mec A positive isolate as MF.SA by disc diffusion and 2 
isolates by screen agar method. These variations might be because of 
variations in the phenotypic expression of oxecillin resistance gene such 
as heterogenous expression of methicillin-resistance. 
Among the 100 animal-origin isolate», percentage of MRS A 
detected by disc diffusion method, screen plate agar method and PCR was 
very similar (26% to 29%).The results (f this study of MRSA by PCR 
seem to be promising for early and reliable identification of methicillin-
resistant Staphylococcus aureus. 
For rapid detection of MRSA targeting of mec A gene by PCR has 
been used by several workers (Suzuki et ai 1992; Jonas et al. 2002; and 
Louie et al. 2002). The reported mec A :;ene positivity in S. aureus was 
between 33.07% to 66.66% (Vannuffel et al 1995 Louie et al. 2000; 
Louie et al. 2002; Merlino et al. 2002 and Haveri et al., 2008). 
In the present study sensitivity for \'anc(3mycin anc teicoplanin was 
found in 100% human clinical and animal-origin isolate .^. This finding is 
in accordance to Kim et al. (2003), AssaduUah et al. (2003) and 
Murugan et al., (2008). Nosocomial infections with Staphylococcus 
aureus necessitate prompt recognition of the infectious chain as well as a 
rapid investigation and exclusion of infeciious sources. 
The conventional typing procedures (e.g. phage typing) and genotyping 
method like pulsed-field gel electrophoresis (PFGE) are labor intensive, 
time consuming and can be performed only in few laboratories. An 
attractive typing technique for S. aureus utilizes >;he polymorphism of the 
coagulase (coa) gene as an epidemiological marker. This is simple, rapid, 
discriminatory and reproducible method for typing this pathogen 
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(John, 2002). The range of patterns with in a single phage type of 
S. aureus could help to discriminate between isolates. In a hierarchical 
approach coa gene RFLP could occupy an intermediate position between 
phage typing and PFGE. This study d( monstnites the value of PCR-
RFLP {Alul) analysis of the coagulase gene for the rapid initial 
genotyping of 5. aureus isolates, particularly of human and animal origin. 
Twelve RFLP patterns of clinical isolates of S. aureus were obtained in 
the present study. Majority 30 (29.4%) of strains showed bands of 
243 bp and 405 bp were classified in group XII followed by 22 strains 
(21.6%) in group III showing bands of 81 bp, 243 bp while 10 strains 
(9.8%)) were characterized by a distinctive bands pattern of 162 bp and 
243 bp and were characterized in group ^ . Eight strains (7.8%)) having 
bands of 405 bp and 567 bp were classi Fied in group IX. Seven strains 
(6.9%) each showed bands of 81bp, 162 op, 243 bp, 324 bp, 405 bp and 
162 bp, 324 bp, 405 bp, respectively, and were categorized in group I and 
group VIII. Five strains (4.9%) and 4 strains (3.9%) each showed bands 
of 81 bp, 162 bp: and 162 bp and 324 bp respectively, were classified in 
group VII and group II, 3 strains (2.9%) each were classified in group IV 
and group X consisting of band patten.s of 162 bp, 243 bp, 324 bp, 
567 bp and 162 bp, 332 bp, 405 bp, respectively. Two strains (1.9%) 
showed band patterns of 162 bp, 243 bp. 405 bp belonged to group XI. 
However, 1 strain (1.0%) of group V showed band pattern of 243 bp and 
324 bp. 
Eighteen out of 38 pus isolates (47.37%) were classified in group 
VI with band patterns of 81 bp, 162 bp and 243 bp. 
Variability in coa-RFLP pattens have been reported in the 
literature. Shittu et al, (2006), observec 11 Coa-RFLP patterns among 
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221 clinical specimens. Goh et al. (19S2), obssrved 10 distinct RFLP 
patterns out of 30 S. aureus strains. He aljo otiseived additional S. aureus 
strains from local hospital (24 MRS A and 15 MSSA) out of which 
25 MRSA, showed the same pattern while 1 was of a different pattern and 
15 MSSA showed 8 pattern and 2 were not amplified. 
Schwarzkopf et al. (1994), got 10 diffei-ent RFLP patterns from 
150 strains of 5. aureus isolated from cLnical s])ecimens. Hookey et al. 
(1998), observed 95 strains of S. aureis and found 10 distinct RFLP 
patterns. Shopsin et al. (2000), observed 13 unique coa patterns whereas 
Chiou et a/.(2000), studied 71 5. aurei s isolates recovered from nine 
food- borne outbreaks and found 11 coa-l-'J'LP patterns. Montesions et al. 
(2002), observed PCR-RFLP pattern of 124 MRSA isolated from 
university hospital of he Canay Island and found five patterns. Wang et al. 
(2003), observed 229 S. aureus from 36 food borne outbreaks at Taiwan 
and confirmed them as S. aureus by tube coagulase test. 10 SEC 
producing strains were screened for the r pattern by P(I;R-RFLP using 
enzyme and found 4 types of pattern. Sch jrrer etal. (2004), observed 191 
isolates of 5". aureus and found differenl pattams by using Alul. 
Among these 12 patterns observed, 7 group patterns, namely, group 
I, group II, group IV, group V, group VI, group VIII and group XI were 
noticed in MRSA isolates. Rest of the group patterns were found 
associated with MSSA isolates. Briefly, rut of 34 Staphylococcus aureus 
isolates from clinical specimens 7 (20.6%) belonged to Coa-RFLP pattern 
of group I where majority of strains were resistant to six or more 
antibiotics; 10 strains (29.4%) belongt d to Coa-RFLP group VI and 
4 strains (11.8%)) of Coa-RFLP group L were found resistant to six or 
more antibiotics. While 7 (20.6%) strains belonged to Coa- RFLP group 
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VIII having resistance to five or more antibiotics. Coa-RFLP group IV 
and group XI showed resistance to five oi more antibiotics and comprised 
of 3 strains (8.8%) and 2 strains (5.9%) -espectively, however, only one 
strain (2.9%) showed resistance to five antibictics which belonged to 
coa-RFLP group V. 
Among these 12 patterns, 5 gro ips ])atlems, namely, group III, 
group VII, group IX and group X group XII were noticed in MSSA 
isolates. Antibiotic resistance patterns in relatior to Coa - RFLP pattern 
could not be inferred in isolates obtainec fi-ori clinical specimens due to 
variability of resistance patterns; 40 d. fferent types of patterns were 
noticed in these isolates. Majority 10 [9.8'/o) of the MRSA isolates 
showed Coa- RFLP pattern of group /I, followed by group I (6.9%) 
and group II (3.9%), However, no predcnimjit resistance patterns were 
noticed. 
In 100 animal-origin isolates ' types of coa -RFLP were 
observed. A majority of strains (47%) were classified in group VI with 
bands of 405 bp followed by 17% strains chaiacterized by distinctive 
band patterns of 243 bp and 324 bp in group V, 13% sirains in group I 
with a band pattern of 162 bp, 250 bp a id 405 bp , 8% strains showed 
bands of 81 bp and 324 bp and belonged to group VII, and 7% strains 
showed bands of 324 bp and were char; cterized as group II, 3% strain 
showed a band pattern of 162 bp and 40; bp classified in group IV. One 
percent strain of group III showed band patterns of 162 bp and 324 bp. 
Five each out of 29 raw milk isolates v e^re classified in group VII and 
group II with band patterns of 81 bp, 324 bp and 324 bp. To appreciate 
the reproducibility of coa-RFLP the test \ ere performed In duplicate. The 
reproducibility was good as similar result were obtained in both the tests. 
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In the present study, S. aureus isolates :rom animal-origin samples and 
human clinical specimens were found o diffe: in their gene patterns 
whereas animal clinical specimens anjl animal-origin food samples 
showed mixed Coa-RFLP gene patterns. This linding might provide a 
better understanding of the distribution of the S. aureus clones among 
human and animal-origin isolates and ciin be helpful in the control of 
S. aureus infections. 
Marcos et al. (1999), studied S. aureus isolates from human, cows 
and sheep and got two different RFLP patients. Motta et al. (2001), 
observed 555 milk samples and compar'.;d coa gene by phenotypic and 
genotypic method. He found 50% posit ve coagulase staphylococci by 
phenotypic methods and 128 S. aureus classes according to size of PCR 
product. Cucarella et al. (2004), observed 195 S. aureus from 
sub-clinical case of mastitis among cows of Valencia and were identified 
as S. aureus by coagulase tests. Molecular typing >vas done using 
PCR-RFLP and 10 distinct patterns were observed. Salasia et al. (2004), 
studied 35 food isolates and they showed different Coa-RFLP patterns. 
Holeckova et al. (2004), studied 110 samples of raw sheep milk and 
reported 46 (41.8%) coagulase positive (by phenotypic method) out of 
which 6 (13%) were found to be enterotoxigenic. Kalorey et al. (2007), 
studied 37 food isolates and they showed three different Coa-RFLP 
patterns. 
Among these 7 Coa-RFLP patterns, 4 group patterns, namely, 
group II, group III, group I, and group /II, were noticed in 29 MRSA 
isolates from food samples. Rest of the group patterns were in MSSA 
isolates. Briefly, out of 29 Staphylococcus aureus isolates from animal-
origin samples 8 (27.6%) belonged to Coa - RFLP pattern of group VII 
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where majority of strains were resistant to six antibiotics. 13 (44.8%) 
strains belonged to Coa - RFLP group I v ith resistance to five antibiotics. 
Coa-RFLP group III exhibiting resistance to seven or more antibiotics 
was in 7 strains (24.1%). Only one strain (3.4%) showed resistance to ten 
or more antibiotics which belonged to Ci a-R]^ "'L]* group II. Among these 
7 patterns, 3 group patterns, namely, gi 3up IV. group V, and group VI 
were noticed in MSSA isolates. Antibiotic resistance patterns in relation 
to Coa - RFLP pattern could not be inferred hi isolates obtained from 
food samples due to variability of resistance patterns; 40 different types 
of patterns were observed. Majority 13 (44.8%) of the MRSA isolates 
showed Coa- RFLP pattern of group I '^ bllowed by group VII (27.6%) 
and group II (2.4%). However, no predcjiinant resistance patterns were 
noticed. 
Results of coagulase gene typing d imonstiated that the MRSA and 
MSSA strains from clinical specimen.; were classified into 7 and 
5 Coa-RFLP patterns, respectively. However, in animal-origin isolates 
4 MRSA and 3 MSSA Coa - RFLP patterns were observed. The ability of 
the PCR-RFLP typing method of the coagulase gene to differentiate 
between MRSA and MSSA in human cLnical and animal-origin isolates 
was also noted. The MRSA and MSSA strains did not share similar 
PCR-RFLP patterns. MRSA gave distinct Coa-RFLP patterns as 
compared to those of MSSA. We feel that Coa-RFLP technique could be 
incorporated as diagnostic tool to confirm the MRSA. Ii's also observed 
that the Coa-RFLP patterns of the MRSA strains were unique and distinct 
from the MSSA strains from both types of the isolates oi Staphylococcus 
aureus. Coa-RFLP is performed wit i primers, homologous to a 
conserved region with in the coa gene, iii order to amplify the sequence 
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encoding the C-terminals region of this molecule. Sines the number of 
repetitive sequence varies within the coa gene, the resulting PCR 
products of individual strains can be of dififerer.t lengths. Therefore we 
found different length and different patterns of S. aureus strains in coa 
RFLP. It is noted that there is extensive polymorphism with coa gene 
circulating in human and animal sixains. We believe that the 
heterogeneity observed for the coa gene has a potential discriminatory 
power for further epidemiological studies of medical and veterinary 
importance. Further molecular studies ire required particularly at the 
sequence level to study whether the rep Drtecl PCR product size classes 
represent distinct S. aureus strains. Shiloi and Lin, (2006), also found 
coa-RFLP of the coagulase gene able to distinguish MSSA from MRSA 
and offers an attractive option to be considered in the rapid 
epidemiological analysis in South Africa. 
There is paucity of Indian litei aturt; regarding the Coa-RFLP 
especially on Staphylococcus aureus of :linical and animal origin food 
isolates. This is a premium study of this kind. Because of its ease, speed 
and good reproducibility it can be considt red for epidemiological typing. 
It was perceived that Coa-RFLP car be used as an adjunct to 
bacteriophage typing. The strains which were untypeable by 
bacteriophage typing were easily typed by Coa-RFLP. Thus in a resource 
poor country like India, the first line typing method for clinical isolates 
may still be bacteriophage typing which can be supplemented by 
Coa-RFLP . in this study Coa-RFLP wa; extremely useful in typing the 
food isolates which were virtually untyi-cable by bacteriophage typing. 
Further Coa-RFLP showed good discrimi lation between clinical and food 
isolates. In this study MRSA and MSSA type ability was again far better 
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with Coa-RFLP. Coa-RFLP can also b-; a ustful tool for continuous 
surveillance of resistance patterns and characterization. 
The differences in Coa-RFLP pa:tems in the studies mentioned 
point to distinct region to region variatic n in the Staphylococcus aureus 
strains. This difference can be utilized f r the purpose of genotyping as 
mentioned in some studies (Shittu et al, 1006). 
iS. aureus is considered to be an in.portant cause of food poisoning 
because of production of staphylococcal enlerotoxins (SEs). So far at 
least, 20 serologically distinct SEs have been identified. SEA, SEB, SEC, 
SED, SEE (Jones and Khan, 1986; Betley and Mekalanos, 1988; 
Couch et al, 1988; and Bayles and Lai-dole, 1989) represent classical 
types, while SEG, SHE, SEI and SEJ i re newly described enterotoxins 
(Ren et al, 1994; Su and Wong, 19* 5; Munson et al, 1998; and 
Zhang et al, 1998). SEC has been djscribe<l with minor antigenic 
variations and designated SECl, SEC2 and SEC3 (BergdoU et al, 1965; 
Avena and BergdoU 1967; and Reiser et al, 1984). Recent studies 
(Jarraud et al, 2001; Orwin et al, 2001; Leterter ei al, 2003; and 
Omoe et al, 2003) have described other SE genes {se); sek, sel, sem, sen, 
seo, sep, seq, ser and seu which point \o the possible existence of new 
staphylococcal enterotoxin (SE). Not all staphylococci are SE producers, 
or the amount of produced SE may be ir sufficient for food intoxication. 
Among all the enterotoxins, SEA, SEB md SEC are reported to be the 
most common types implicated ii fDod poisoning episodes 
(Asao et al, 2003; Chen et al, 2001; and Tkacikoca et al, 2003). 
Rasooly et al, (1999) reported SEA as most commonly involved 
enterotoxin in out breaks of staphylococcal food poisoning in man. 
According to Wilson (1991), and Mc I auchlir et al, (2000), SEC is 
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commonly associated with bovine, ovine and caprine dairy products. It is 
also reported that SEC was the most i equcjntly found staphylococcal 
enterotoxin produced by animal strains (I [ajek, 1978) in comparison with 
human strains. In this study, the sampes weie tested for commonly 
encountered enterotoxin A, B and C. In the present study, out of the 
102 human clinical isolates 3 (2.94%) isolates were found 
enterotoxogenic, out of which 1 fro n the stool sample was found 
positive for enterotoxin A, 1 vomitus sample showed presence of 
enterotoxin B while 1 from urine showed presence for enterotoxin C. 
Flemming et al. (2007), studied 2,72' stool samples out of which 
36 SEA; 20 SEB; 19 SEC; 68 SED and 2 SEE were found. In a study 
from Central Taiwan Chen et al. (2001) found SEC as a major subtype 
for S. aureus strains isolated from fecal samples from randomly selected 
diarrhoeal patients associated with food borne out •• breaks during 
1995 - 2000. Whereas, Klotz et al. (20->3), studied 93 clinical isolates 
from stool samples and found 58.1% enterotoxogenic strains (SEA in 
12.9%, SEB in 9.7%, SEC in 21.5% aid SliD in 14%). Adwan et al. 
(2008), studied 33 urine and 24 semen samples and found 27.3% and 
12.5% enterotoxogenic strains, respectively, out of theses samples SEC 
gene found along or in combination with jther genes. 
Among the 100 animal-origin isolates, a total of 13 were 
enterotoxigenic. Of these 2% were positive foi" enterotoxin A (1 from raw 
milk sample and 1 from buffalo meat); 3% were positive for enterotoxin 
B (1 from raw milk sample, 1 from sweet and 1 Irom cottage cheese) and 
8% were found positive for enterotoxir. C (1 from raw milk, 1 from 
paneer, 3 from goat meat and 3 from buffalo meat). Holeckova et al. 
(2004), tested 46 raw sheep milk sample >; of which 13% were found as 
i 
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enterotoxigenic (8.7% were SEA, 2.2»/o SEB, and 2.2% SEA+ SEB 
producers). Tkacikova et al. (2003) reported 36.8% enterotoxogenic 
isolates from 87 food samples, out of whi :h 17.2"/o were positive for SEC 
and SED, 1.1% SEA and SEB each. In mother study by Scherrer et al. 
(2004), they found 65.2% enterotoxigenic S. aureus ou. of 293 isolates 
from bulk-tank milk samples of goat and sheep. The occurrence of SEC, 
SEG, SEJ, SEI, SEB and SED was notic id in 42%, 10.6%, 8.9%, 8.2%, 
1.4% and 1.4% respectively. Rosec et al (1997) conducted a study on 
213 5'. aureus isolates from clinical and food samples and reported 30.5% 
as enterotoxigenic isolates. SEC was reported as predominant type in the 
strains belonging to human biovar. Valle et. al. (1990) reported 74.3% 
enterotoxigenic isolates from different anatomical sites m healthy goats. 
SEC was the most frequently produced «nterotoxin either alone (67.9%) 
or in combination with others i.e. SEA + SBC 2.7%, SEB+SEC 2.7% 
SEC +SEE 2.7%, SEA +SEB +SEC 0 9%. Loncarevic et al. (2005), 
studied 386 S. aureus isolates from raw milk and their products and found 
48% and 51% enterotoxogenic strains, in milk and milk products 
respectively.With respect to various raw or cooked food stuffs, 
enterotoxigenicity amongst S. aureus strains ranged from 16 to 86% 
(De Buyser et al, 1985; and Ewald, 1987). Holeckova et al (2002), 
showed variable results regarding the occurrence of enterotoxigenic 
S. aureus strains in food stuffs probably due to the difference among the 
kinds of food items examined, numbe* of samples tested, detection 
methods used and in ecological origin of strains. Nema et al, 2007 found 
a combination of SEB and SED combination enterotoxins among food 
samples. 
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Among the 16 enterotoxigenic Staphylococcus aureus isolates, 
13 different antibiotic resistance patterns A^ ere observed in this study. All 
of the enterotoxigenic isolates from huma i cliiical specimens were found 
resistant to methicillin. However both tyj^ es of strains exhibited different 
antibiotic resistance patterns. Out of 13% enterotoxigenic animal-origin 
isolates 10 different antibiotic resistance patterns were observed. 8% of 
them were noted as MRSA out of which presence of enterotoxin A was 
noticed in 2% isolates, SEB in 2% and SEC in 5% isolates. Similarly, 
Schmitz et al (1998) reported 24% ent Totoxigenic MRSA strains and 
found SEB in 7% and SEC in 11%. 
Since there is paucity of Indian literature on prevalent 
enterotoxins, especially in human clinical isolates, the present study 
would be able to enlighten the Indian scenario. 
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6. SUMMARY AND CONCLUSION 
Staphylococcus aureus is an adaptable, opportunistic 
pathogen, its ability to persist and multiply in a variety of environments 
leads to wide spectrum of diseases in both humans and animals. In 
humans Staphylococcus aureus is the causative agent of many infections, 
ranging from superficial skin suppurations to life-threatening 
septicaemias associated with visceral or bone infect'ons. Successful 
treatment is often hindered by the increasing prevalence of 
methicillin-resistant strains and by antibiotic inefficacy against the 
bacteria involved in chronic infections. 
In lactating female animals. Staphylococcus aureus is a 
common cause of intramammary infectio i^s, fiequently leading to chronic 
mastitis. Because this type of infection h very difficult 1.0 eradicate with 
antibiotic therapy, a premature culling o? animals, involving substantial 
production losses, is the only efficient strategy to control this type of 
mastitis. 
Various global studies are available characterizing the 
Staphylococcus aureus at molecular level, however, the studies are 
fragmentary from India on the current aspect and especially in 
Staphylococcus aureus isolates obtained Irom samples of animal origin. 
Therefore, the present study A^as undertaken with the aim to 
evaluate the phenotypic and genotypic characters of Staphylococcus 
aureus, which might help to understand tl e characters of Indian S. aureus 
isolates obtained from human infections £.nd fionr food samples of animal 
origin. 
A total of Three thousand five hundred and fourteen clinical 
specimens and 1219 animal origin food samples were collected during 
June 2003 to March 2006. Of these 1(;2 Staplrylococcus aureus from 
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human clinical and 100 from animal v)rigin samples were randomly 
selected for further study. Out of 102 Stai hylococcus aureus studied from 
clinical specimens, 38 were from pus samples, 10 from urine samples, 1 
from CSF, 2 from lA^ catheter tips, 3 from body fluids, 3 from ear swabs, 
3 from throat swabs, 14 from conjuctival swabs, 14 from cervical swabs, 
7 from stool samples, 6 from vomitus samples and 1 from semen 
specimen. Out of 100 animal-origin samples, 29 Staphylococcus aureus 
were obtained raw milk, 4 from chamchan (a sweet prepared from milk), 
3 from other sweets, 9 from khoa (milk concenfrate used in sweets), 6 
from paneer (cottage cheese), 27 from raw goat meat, 20 from raw 
buffalo meat, 1 from kabab (Meat cutlet) and 1 from salami sample were 
included in this study. 
98.03% Clinical and 98% animal-origin isolates were found 
positive for slide coagulase test whereas they showed 100% positivity by 
tube coagulase test and by amplification of coagulase gene. 
Out of 102 clinical isolates 80 (78.4%) were p-lactamase 
producers whereas of 100 animal-origii. isolates 69 (69%) were found 
P-lactamase producers by iodometric method. 
Among 102 clinical isolates maximum number of isolates 
were resistant to penicillin 100 (98.03%) Ibllowed by cotrimoxazole 
cotrimoxazole 71 (69.61%), tetracycline 70 (68.63%), amoxycillin 66 
(64.7%), ciprofloxacin 62 (60.79%), erytliromycin 56 (54.9%), amikacin 
35 (35.3%), oxacillin 33 (32.35%), cefaclor 33 (32.35%), ceftriaxone 33 
(32.35%), ceftazidime 33 (32.35%), cefepime 33 (32.35%), 
chloramphenicol 24 (23.53%) and gentaniicin 28 (27.45%). While none 
of the isolates were found resistant to vancomycin and teicoplanin. 
The isolates from animal-origin :$amples showed resistance 
to penicillin 93 (93%), erythromycin 51 (51%), tetracycline 49 (49%), 
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ciprofloxacin 39 (39%), cotrimoxazole 54 (54%), chloramphenicol 34 
(34%), amikacin 27 (27%), oxacillin 27 (27%), celaclor 27 (27%), 
ceftriaxone 27 (27%), ceftazidime 11 {21%), cefepime 27 (27%), 
gentamicin 20 (20%), and amoxycillin 19 (19%)) in descending order. 
Only one isolate was found susceptible to all 16 antibiotics and none 
of the strains were found resistant to vmcomycin and teicoplanin. 
The drug resistance pattern;} of clinical isolates showed 
resistance to two drugs in 3 (2.94%)) i: olattjs, three drags in 10 (9.8%) 
isolates, four drugs in 18 (17.65%) isolates, five or six drugs in 
25 (24.51%)) isolates, seven or eight drugs in 16 (15.67 %)) isolates 
whereas resistance to more than ten or more drugs was found in 
30 (29.47%) isolates. No isolate was resistant to only one drug. 
In animal-origin samples the dmg resistance patterns 
showed resistance to two drugs in 9 (' .0%) isolates, three drugs in 18 
(18.0%)) isolates, four drugs in 16 (16.0%)) isolates, f ve or more than 
five drugs in 25 (25.0%)) isolates whereas resistance to more than ten 
or more drugs was found in 23 (23 0%)) isolates. One isolate was 
found sensitive to all 16 drugs. 
Antimicrobial resistance has been noticed as one of the 
paramount microbial threats ol the twent}'-first century. 
Staphylococcus aureus has always been a stumbling block for 
antimicrobial chemotherapy and the introduction of new classes of 
antimicrobial agents is usually followed b) the emergence of resistant 
forms of Staphylococcus aureus. Therefore, continuous surveillance 
on the resistance patterns and characterization of S. aureus in 
understanding new and emerging trends in human and animal from 
India is of utmost importance. 
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Methicillin resistant Staphyl ^ coccus aurew (MRSA) is a 
major nosocomial pathogen worldwid; and is often c.ifficult to detect 
due to the heterogeneous nature of e> pression of oxacillin resistance. 
A total of 102 clinical and 100 animal origin food isolates were tested 
for oxacillin resistant by disc diffiisic-n method, by screen agar plate 
and detection of mec A gene by PCR. For the detection of mec A gene 
by PCR, the primers described by Prasad et al. (2000) were used, 
which gave a clear cut specific 604 bp amplified product. 
Out of 102 clinical isoktes 33 strains were oxacillin 
resistant by disc diffusion method, !*2 strai)is by screen agar plate 
method and 34 strains were found posi cive for mec A gene by PCR. 
In this study, 29% isolates fr( m a linial-origin samples were 
identified as MRSA by PCR, 27% by disc diifusion method and 26% 
by oxacillin agar plate method. The results of our study on PCR of 
MRSA seem to be promising for early and reliable identification of 
MRSA. 
Bacteriophage typing was performed in 1<)2 clinical isolates. Out of 
these isolates tested, only 55 (53.9%' isolates could be typed by the 
conventional set of phages at RTD. D.stribution of isolates into phage 
groups revealed that maximum numb.;r of isolates 25 (24.51%) were 
typed in group III followed by 20 (19.61^0) in grou]) II, 7 (6.9%) in 
mixed group and (2.94%) isolates in group I. None oithe isolates was 
typed at non allocated group. 
47 non typeable isolates were fiirther tested at 100 RTD, they 
showed 16.67% more typeability. Madmum number of these isolates 
belonged to group III (23.4%) follow.>,d by 8 5% in mixed group and 
4.3%) in group II. 
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The total typeability at 1 RTD and 100 RTD was observed in 
70.58% of clinical isolates including 10 methicillin-producing strains. 
MRSA phage groups were used to type methicillin resistant 
Staphylococcus aureus isolates of < linical specimens. A total of 
14 (41.18%), out of 34 MRSA, were found typeable at RTD and 
100 RTD using MRSA phages. Briefl;, at RTD out of 15 pus isolates, 
3 (20.0%) were found typeable ai.d belonged to mixed group; 
4 (100%) from ex. swab were found typeable (one in group III and 
3 in mixed group); and 1 (100%) fro-n drain tips (group I). Whereas 
all isolates from urine, conj. swab, ear s> a^b, throat swab, stool, 
vomitus, Body fluid and CSF were f( und non typeable at RTD. The 
non typeable isolates at RTD could 3e typed at lOOx RTD and on 
addition 16.6% isolates were typec. Briefly, at lOOx RTD two 
pus isolates, out of 12, were typeable i t mixed group; 3 urine isolates 
(one at group II and two at group III), one vomitus (at group III) were 
found typeable, whereas rest were non typeable. 
Out of 100 animal-origin isulates none of the isolates were 
typeable at routine test dilution and at 100 RID. MRSA phage groups 
were used to type methicillin-resistani Staphylococcus aureus isolates 
of food samples. Out of which only \NO isolates (one from milk and 
the other from buffalo meat) could be typed at 100 RTD which 
belonged to phage group II. 
Two hundred and two coagulase positive Staphylococcus 
aureus isolates including 102 clinical and 100 animal-origin isolates 
were tested for the presence of thermostable nuclease {nuc) gene by 
polymerase chain reaction using Brakstad et al. (1992) method. All the 
202 isolates showed a 270 bp amplified product after gel 
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electrophoresis, which is specific for the presence of nuc gene in 
Staphylococcus aureus. 
The detection of the coa gem; 'w as done by Polymerase 
Chain Reaction using the primer set described by Goh et al (1992). 
Twelve different electrophoretic patterns were; observed in these isolates. 
Thirty strains (29.4%) showed a distinctive bands of 500 bp and 590 bp, 
22 strains (21.6%) showed bands of 480 bp, 680 bp and 800 bp, 10 strains 
(9.8%) showed band of 500 bp and 580 bp, 8 strains (7.8%) showed 
bands of 500 bp, 720 bp and 800 bp, 7 •;trains (6.9%) showed bands of 
500 bp, 580 bp, 700 bp and 800 bp, othe- 7 strains (6.9°/o) showed bands 
of 580 bp, 700 bp and 800 bp, where an othi^ r 5 strains (4.9%) showed 
bands of 480 bp, 500 bp and 580 bp, other 4 strains (3.9°/'o) showed bands 
of 550 bp, 780 bp and 900 bp, 3 strains each (2.9)% showed 500 bp, 
580 bp and 720 bp: and 550 bp, 800 bp and 900 bp respectively, 2 strains 
(1.9%) showed bands of 470 bp, 700 b)., 790 bp and 920 bp, whereas 
1 strains (1.0%) showed bands of 550 bp 600 bp and 820 bp. Maximum 
numbers of strains showed a band patterr of 500 bp and 580 bp and were 
obtained from pus isolates. 
In 100 animal-origin isolates 7 electrophoreiic patterns were 
observed. Forty seven percent strains showed a band pattern of 900 bp, 
17% strains showed bands of 650 bp and 7(»0 bp, 13% strains showed 
bands of 590 bp, 680 bp and 700 bp, 8% strains showed bands of 600 bp, 
7% strams showed bands of 650 bp, other 7% strains showed bands of 
650 bp and 750 bp, whereas 1% strain showed bands of 500 bp and 
820 bp. 
The molecular typing of the clinical isolates and animal-
origin isolates was carried out by Coa-RFLP, after the digestion with 
126 
Summary and Conclusion 
Alu 1 enzyme as described by Goh et al, 1992. A total 12 types of 
Coa -RFLP patterns were observed in clinical isolates. Majority of 
Coa -RFLP patterns were observed in clinical isolates. Majority 30 
(29.4%) of strains showed bands of 243 bp and 405 bp were classified in 
group XII followed by 22 strains (21.6%) in group III showing bands of 
81 bp, 243 bp while 10 strains (9.8%) A /ere chfiracterized by distinctive 
bands pattern of 162 bp and 243 bp and were characterized in group VI. 
Eight strains (7.8%) having bands of 405 bp aid 567 bp were categorized 
in group IX. Seven strains (6.9%) each showed bands of 81bp, 162 bp, 
243 bp, 324 bp, 405 bp and 162 bp, 324 bp, 405 bp, respectively, and 
were classified in group I and group Mil. Fi\'e strains (4.9%) and 4 
strains (3.9%) each showed bands of 81 >)p, 162 bp: and 162 bp and 324 
bp, respectively, were classified in gro.ip MI and group II, 3 strains 
(2.9%) each were classified in group IV find igroup X consisting of band 
patterns of 162 bp, 243 bp, 324 bp, 567 op and 162 bp, 332 bp, 405 bp, 
respectively. Two strains (1.9%) showed )and patterns of 162 bp, 243 bp, 
405 bp belonged to group XI. However, 1 strain (l.(i%) of group V 
showed band pattern of 243 bp, 324 bp. Hett^ rogeneity was observed in 
specimens of a similar type. For example, S. aureus isolates from cervical 
swabs belonged to six different Coa-RFL?. 
Among these 12 patterns, 7 , p-ou]) patterns, aamely, group I, 
group II, group IV, group V, group V , group VIII and group XI were 
noticed in MRSA isolates. Rest of th;: group pattemj were in MSSA 
isolates. Briefly, out of 34 Staphy ococcus aureiis isolates from 
clinical specimens 7 (20.6%) belonged to Coa-RFLP pattern of groupl 
where majority of strains were resistant to six or more antibiotics; 10 
strains (29.4%) belonged to Coa-RPLP group VI and 4 strains 
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(11.8%) of Coa-RFLP group II were also found resistant to six or 
more antibiotics. While 7 (20.6%) sTains belonged to Coa- RFLP 
group VIII having resistance to five 3r norc antibiotics. Coa-RFLP 
group IV and group XI having 3 stra ns (8.8%) and 2 (5.9%) strains 
respectively also showed resistance to fi\e or more antibiotics, 
however, only one strain (2.9%) which belonged to (7oa-RFLP group 
V showed resistance to five antibiotics. 
In 100 animal-origin isolates 7 types of coa -RFLP 
were observed, maximum strains 47% v ere classified in group VI with 
bands of 405 bp followed by 17% stra ns chaj-acterized by distinctive 
band patterns of 243 bp and 324 bp in g roup V, 13% strains in group I 
with a band pattern of 162 bp, 250 bp I'nd 405 bp, 8% strains showed 
bands of 81 bp and 324 bp and belonged to group VII. and 7% strains 
showed bands of 324 bp and were characterized as group II, 3% strains 
strain showed a band pattern of 162 bp ar d 405 bp classified in group IV. 
1% strain of group III showed band patterns of 162 bp and 324 bp. Five 
each out of 29 raw milk isolates were cl assified in group VII and group 
II with band patterns of 81 bp, 324 bp aid 324 bp. In the present study, 
S. aureus isolates from animal-origin samples and human clinical 
specimens were found to differ in theii gene patterns whereas animal 
clinical specimens and animal-origin fo(^ d samples were showed mixed 
Coa-RFLP gene patterns. This fmding might provide a better 
understanding of the distribution of the S. aureus clones among human 
and animal-origin isolates and can be helpful in the control of S. aureus 
infections. 
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To appreciate the reproducibility of coa-RFLP the test were 
performed in duplicate. The reproducibility >vas good as similar results 
were obtained in both the tests. 
Among these 7 patterns, 4 group patteiis, namely, group II, group III, 
group I, and group VII, were noticed in 2') MRSA isolates from food 
samples. Rest of the group patterns > e^re in MSSA isolates. Briefly, 
out of 29 Staphylococcus aureus isolates from food samples 8 (27.6%) 
belonged to Coa - RFLP pattern ol group VII where majority of 
strains were resistant to six antibioses. Wliile 13 (44.8%) strains 
belonged to Coa - RFLP group I having resistance to five antibiotics. 
Coa-RFLP group III having resistance to seven or more antibiotics 
found in 7 strains (24.1%), however, only one strain (3.4%) showed 
resistance to three antibiotics were be longed to Coa-RFLP group III. 
Among these 7 patterns, 3 group patterns, namely, group IV, group V, 
and group VI were noticed in MSSii. isolates. Antibiotic resistance 
patterns in relation to Coa-RFLP p< ttem could not be inferred in 
isolates obtained from food samples due to variability of resistance 
patterns; 40 different types of patterns. Majority 13 (44.8%) of the 
MRSA isolates showed Coa- RFLP pattern of group belonging to 
group I followed by group VII (27.6%) and group II (2.4%). However, 
no predominant resistance patterns we-e noticed. 
We feel that Coa-RFLP technique could be incorporated 
as diagnostic tool to confirm the MRSA. It's also observed that the 
Coa-RFLP patterns of the MRSA si'ains were unique and distinct 
from the MSSA strains from bcth lypes of the isolates of 
Staphylococcus aureus. Coa-RFLP is performed with primers, 
homologous to a conserved region with in the coa gene, in order to 
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amplify the sequence encoding tbj C-teiminals region of this 
molecule. Since the number of repeti :ive secjuence \'aries within the 
coa gene, the resulting PCR produc s of individual strains can be 
of different lengths. Therefore we fou id different length and different 
patterns of S. aureus strains in coa lU-'LP. It is noted that there is 
extensive polymorphism with coa gene circulating in human and 
animal strains. We believe that the heterogeneity observed for the 
coa gene has a potential discpminatoiy power for further 
epidemiological studies of medical anti veterinary importance. 
For the detection of enterot 3xin genes, namely enterotoxin 
A, enterotoxin B and enterotoxin C, *CR asLJay was used to amplify 
specific base pair products. A total of !02 isolates (102 human clinical 
isolates and 100 animal-origin isolates) were tested for the production 
of enterotoxin A, enterotoxin B and eiterotoxm C. For the enterotoxin 
A and enterotoxin B modified method of Jonnson et al. (1991) was 
used, which gave 120 bp and 478 bp gene specific products 
respectively while the modified method of Chen et al. (2001) used to 
amplify enterotoxin gene C which showed a gene specific 234 bp 
product. 
Briefly, of the 102 human clinical isolates thiee were found 
enterotoxigenic, out of which one st< ^ ol sample showed presence of 
enterotoxin A, 1 from vomitus sample sbov^ed enterotoxin B while 
one urine sample showed presence of (nterotoKin C. 
Out of 100 animal-origin i-dates a total of 13 were found 
enterotoxogenic. Out of which 2 w ;re positive for enterotoxin A 
(1 from raw milk sample and 1 from b-iffalo meat); 3 were positive for 
enterotoxin B (1 from raw milk sample, 1 from a sweet and 1 from 
cottage cheese) and 8 were found positive for enterotoxin C 
(1 from raw milk, 1 from paneer, 3 from goat meat and 3 from 
buffalo meat). 
This is amongst the premier report regarding the prevalent 
enterotoxins in Indian Staphylococcus aureus and especially in clinical 
isolates. The phenotypic and genoty]»ic results of the present study 
might help to understand the distribution of prevalent S. aureus clones 
in clinical and food isolates which can be the base to investigate and 
control the Staphylococcus aureus infections. 
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Conclusions: 
On the basis of this study, following conclusions were drawn: 
• 98.03% isolates from human clinical specimens and 98% isolates 
from animal-origin samples were positive for tube coagulase test, 
slide coagulase test and coagula=;e-P(^ R. Remaining 4 (1.98%) 
isolates were positive by tube coa julase lest and coagulase-PCR, 
but missed detection by slide coagi lase test. 
• Multidrug resistance was noticed ii bof i clinical aid animal-origin 
isolates. 
• None of the isolate was found resistant to vancomycin and 
teicoplanin in both human clinical smd animal-origin isolates. 
• Methicillin-resistance was found ir 33.33% of clinical isolates and 
29% of animal-origin isolates. 
• Phage typing of the clinical isol ites showed that only 70.58% 
clinical isolates were typeable usin ;^ conventional ])hages at 1 RTD 
and at 100 RTD including 10 nethicillin-producers. Amongst 
these, maximum number (35.3%) of isolates belonged to phage 
group III. 
• Majority of the MRS A isolates were found non-typeable by 
conventional sets of phages. By uj ing a set of MRSA phages they 
showed a typeability of 41.8% (14/14). 
• In animal-origin isolates, only 2"/) isolates were found typeable 
using MRSA phages at 1 RTD and 100 RTD both of them 
belonged to group II. 
• Disc diffusion, screen agar plate and polymerase chain reaction 
were used for detection of methicillin-resistance. MRSA were 
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detected in clinical isolates by disc diffiisicm method in 32.35%, by 
screen plate agar method in 31.41°/ and by PCR in 33.33%. 
• One mec A positive isolate missed detection by disc diffusion 
while 2 isolates missed detection b^  screen agar plate method. 
• 29% isolates from animal-origin sa uples were identified as MRSA 
by PCR, 27% by disc diffiision method and 26% by oxacillin agar 
plate method. 
• PCR of MRSA seem to be promising for early and reliable 
identification of MRSA. 
• All the human clinical and aniiial-origin isolates tested were 
positive for nuc gene. 
• 12 Coa-RFLP patterns were observ.id in human clinical isolates. 
• In 100 animal-origin isolates 7 types of coa -RFLP patterns were 
observed. 
• In animal-origin samples and human clinical specimens different 
gene patterns were found. 
• In animal clinical specimens and aramal-origin food samples mixed 
Coa-RFLP gene patterns were obsei'ved. 
• Coa-RFLP patterns were different for human clinical and animal-
origin isolates. 
• Coa-RFLP results suggest a divergence between Staphylococcus 
aureus isolates of human and bovine origin. 
• Results of coagulase gene typing demonstrated that the MRSA and 
MSSA strains from clinical specimens could be grouped into 7 and 
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5 Coa-RFLP patterns, respective y. Ho>vever, in animal-origin 
isolates 4 from MRS A and 3 from 14SSA ("oa- RFLP patterns were 
observed. 
• The MRS A and MSSA strains did not share similar PCR-RFLP 
patterns. MRSA gave distinct Co, f-RFLP patterns as opposed to 
those of MSSA. 
• The ability of the PCR-RFLP typir g method of the coagulase gene 
to differentiate between MRSA ard MSSA in human clinical and 
animal-origin isolates was also noticed. It offers an attractive 
option to be considered for rapid epidemiological analysis of 
iS. aureus strains. 
• 102 human clinical isolates were ..ested for commonly countered 
enterotoxins; three of them were found enterotoxin producers, out 
of which 1 was positive for enterot oxin A, 1 for enterotoxin B and 
the other 1 for enterotoxin C. 
• Out of 100 animal-origin isolates, a total of 13 were found 
enterotoxogenic. Of which 2% wer^ positive for enterotoxin A; 3% 
were positive for enterotoxin B and 8% were found positive for 
enterotoxin C. 
• Among the 16 enterotoxogenic Staphylococcus aureus isolates, 
13 different antibiotic resistance patterns were observed in this 
study. All of the enterotoxogenic isolates from human clinical 
specimens were found resistant to methicillin. However all of the 
strains exhibited different antibiotit resistance patt<;ms. 
• In the remaining 13% enterotoxogenic; animal-origin isolates 10 
different antibiotic resistance patterns were observed. A total of 8% 
of them showed methicillin-resistance. Out of which, methicillin 
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resistance was noticed in 2% isolates, each, producing enterotoxin 
A and enterotoxin B, while in 4% i olates producing enterotoxin C. 
In a nutshell diversity betw .;en human clinical and animal-
origin isolates of Staphylococcus aun us was noticed and that the 
incidence of methicillin resistance was quite high in tliis collection of 
isolates. Concomitant high resistance to othe:* c-asses of antibiotics was 
also noted. Phage typing was found to be of low discriminatory value 
whereas Coa-RFLP could discriminatt s a fairly large numbers of 
bacterial isolates and suggest that Co i-RFLP could be used as an 
epidemiological typing method for Staphylococcus aureus. The 
enterotoxins A, B and C were detects d in our collection of human 
clinical, animal-origin food and animel clinical (raw milk) isolates. 
However, in animal-origin food isolates enterotoxin C was the 
predominant type. 
A continuous surveillance on resistance patterns and 
characterization of Staphylococcus aureus in understanding new and 
emerging trends in India is of utmost in portance for the formulation of 
infection control policies. 
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IPPENDIX 
M^W^IX 
A) Reagents for genomic DNA e fraction 
1. Sodium dodecyl sulphate (10%) 
SDS 10.0 gm 
Deionized water 100.0 ml 
Warmed to dissolve completely and adjusted pH to 7.0 
2. Proteinase K 20 mg/ml 
Proteinase K 2t).0 nrig 
Distilled Water 1 0 nl 
Stored at -20°C in small aliquots 
3. Tris HCl (Im: pH 8.0) 
Trisbase 121.1 gm 
Dissolved in 800 ml water, adjusted the pH to 8.0 by 
adding concentrated HC1. Made the volume t( 1000 ml. 
Autoclaved and stored at 4°C 
4. Tris EDTA (TE buffer pH 8.0) 
TrisHCl lOmM 
EDTA 1 mM 
5. 0.5 M EDTA (pH 8.0) 
EDTA 18.612 gm 
Distilled water 100.0 ml 
A<P(PEm)lX 
B) Reagents for agarose gel electrophoresis 
6. Tris-borate (EDTA BE) buffer (5x) 
Tris base '-4.0 gjn 
Boric acid 27.5 gm 
EDTA (0.5 M; pH 8.0) 20.0 ml 
Distilled water 1000 ril 
7. Ethidium bromide 
Ethidium bromide 1 )0.0 mg 
Distilled Water 1.0 ml 
8. Loading dye (6x) 
Orange G 0.2% 
Bromophenol blue 0 05% 
Glycerol 60% 
EDTA 6)mM 
Stored at ' °C 
C) General purpose solutions 
9. *Phosphate buffered saline ( pH 7.2) 
Sodium chloride 8.0 gm 
Potassium chloride 0 02 gm 
Disodium hydrogen 115gm 
Phosphate (anhydrous) 
Potassium dihydrogen 0 20 gm 
phosphate 
Distilled water K.OOml 
A<P^PEm>IX 
10. Normal saline solution 
Sodium chloride 8.5 gm/1 
Distilled water 1000 ml 
• Sterilized by autoclaving at 15 psi, 121°C for 15 min and stored at 4°C until 
used. 
• The above materials autoclave at 121°C for 15 min and allov^ed to cool to 50°C 
-60°C and poured into petridishes. 
Media and Reagents 
11. Baird Parker Agar (PE 7.0) 
Peptone 10.0 gm 
Beef Extract :5.0 gm 
Yeast extract 1.0 gm 
Glycine 12.0 gm 
Sodium pyruvate 10.0 gm 
Lithium Chloride 5.0 gm 
Agar 20.0 gm 
Distilled Water 950 ml 
The above base autoclaved and allowed to cool to 40-50°C and then about 50ml 
concentrated egg yolk emulsion and 3ml sterile 3.5% potassium tellurite solution added 
properly mixed poured in petridishes. 
12. Oxidation - Fermentation Medium (g tn/ml) 
Peptone 2.0 gm 
Sodium Chloride 5.0 gm 
Dipotassium Hydrogen Phosphate 0.3 gm 
Agar 3.0 gm 
Bromothymol Blue (1% aqueous solution) 3.0 ml 
Distilled Water 1000ml 
A<P(PEm>ix 
The pH was adjusted to 7.1 before adding of the bp •motliyniol blue i\nd then medium 
was autoclaved in a flask at 121°C for 30 minutes, ilien 0.5 ml, 1% carbohydrate 
solution (pre-sterilized) was added to medium asepcically. The medium was then tubed 
to a depth of about 4 cm. 
13. Brain heart infusion Broth (pH 7.4+0.2) 
Peptic digest of animal tissue 10.0 gm 
Calf Brain Infusion (solids) 12.5 gm 
Beef Heart Infusion (solids) 5. Ogm 
Dextrose 2.0 gm 
Sodium chloride 5.0 gm 
Di-Sodium phosphate 2.5 gm 
Distilled Water 1000 ml. 
14. 5 % Sheep blood agar 
Base: blood agar (Hi Media) 5.0 gm 
Distilled water 100ml 
Dissolved the ingredients by boiling and autoclav< at 121 °C for 15 min 
For complete mediiun: the autoclaved base was a lowed to cool to 46- 48°C and then 
add 10ml of aseptically collected defribinated she;p blood was added properly mixed 
and pour into petriplates. 
15. Nutrient broth 
Lean meat, ox heart or beef 500.0 gm 
Peptone 10-20.0 gm 
Sodium chloride 5.0 gm 
Distilled water 1 liter 
The above materials autoclave at 121 °C for 15 min ; nd allowed to cool to 50 - 60 °C 
and poured into petridishes. 
16. Nutrient agar: 
Nutrient broth 1000ml 
Agar 20.0gm 
The above materials autoclave at 121°C for 1 > mi)i and allowed to cool to 50 -
60 °C and poured into petridishes. 
A<p(PEomix 
17. DNAse agar (pH 7.3) 
Tryptose 2.0gm 
Deoxyribonucleic acid 2.0gm 
Sodium chloride S.Ogm 
Agar powder 12.0gm 
Toludineblue 0.15% 
The above materials autoclave at 121 °C for 1 > miii aiid allov^ed to cool to 50 
60 °C and poured into petridishes. 
18. Mueller - Hinton agar (pH 7.4) 
Beef infusion 300.0ml 
Casein hydrolysate 17.5 gm 
Starch 1.5gm 
Agar lO.Ogm 
Distilled water 1 liter 
The above materials autoclave at 121°C for 15 min and allowed to cool to 50 
60 °C and poured into petridishes. 
19. Mueller - Hinton agar with 5% Nacl (pH 7.4) 
Mueller-Hinton Agar (Hi Media) 3.8 gm 
Sodium chloride 5.0 gm 
Distilled water 100.0 ml 
The above materials autoclave at 121°C for 15 min and allowed to cool to 50 
60 °C and poured into petridishes. 
20. Phenolphthalein phosphate agar (pll 7.4) 
Peptic digest of animal tissue 5.0gm 
Beef extract 3.0gm 
Sodium chloride 5.0gm 
Sodium phenolphthalein phosphate 0.012gm 
Agar 15.0gm 
Distilled water 1000ml 
A<P(PE!m)lX 
The above materials autoclave at 121 °C for 1 > min a)id allowsd to cool to 50 
60 °C and poured into petridishes. 
21. Voges-Proskauer 
Peptone 5.0 gm 
Dipotassium hydrogen phosphate (K 2 HP04) 5.0gm 
Distilled water 1000ml 
Glucose 10% solution (sterilized separatelj ) 50 ml 
Peptone and phosphate were dissolved; pH was adjusted to 7.6; filtered and 
then dispensed in 5.0 ml amoimts in test lubes and sterilized at 121 C for 15 
minutes. Glucose solution was sterilized by filtrations and 0.25 ml was added 
to each tube (final concentration 0.5%). 
22. Triptone soya broth ( pH 7.3 + 0.2) 
Casein enzyme hydrolysate 17. Ogm 
Peptic digest of Soya bean meal 3.Ogm 
Sodium chloride 5. Ogm 
Di- potassium hydrogen phosphate 2.5gm 
Dextrose 2.5gm 
Distilled water lOOOml 
The above materials autoclave at 121 °C for 15 min i nd allowed to cool to 50 - 60 °C 
and poured into petridishes. 
